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Abstract 
 
Biophotonics techniques are showing great potential for practical tissue diagnosis, 
capable of localised optical spectroscopy as well as wide field imaging. Many of 
those are generally based on the same concept: the spectral information they enable 
to acquire encloses clues on the tissue biochemistry and biostructure and these 
clues carry diagnostic information. Biophotonics techniques present the added 
advantage to incorporate easily miniaturisable hardware allowing several modalities 
to be set up on the same systems and authorizing their use during minimally invasive 
surgery (MIS) procedures. The work presented in this thesis aims to build on these 
advantages to design biophotonics instruments for tissue diagnosis. Fluorescence 
and diffuse reflectance, the two modalities of interest in this work, were implemented 
in their single point spectroscopic and imaging declinations. Two “platforms”, a 
spectroscopic probe setup and an optical imaging laparoscope, were built; they 
included either one of the two aforementioned modalities or the two of them together.  
The spectroscopic probe system was assembled to detect lesions in the 
digestive tract. In its first version, the setup included a dual laser illumination system 
to carry out an ex vivo fluorescence study of non-alcoholic fatty liver diseases 
(NAFLD) in the mouse model. Outcomes of the study demonstrated that healthy 
livers could be distinguished from NAFLD livers with high classification accuracy. 
Then, the same fluorescence probe inserted in a force adaptive robotic endoscope 
was applied on a fluorescence phantom and a liver specimen to prove the feasibility 
of recording spectra at multiple points with controlled scanning pattern and 
probe/sample pressure (known to affect the spectra shape). This approach proposed 
therefore a convincing method to perform intraoperative fluorescence measurements. 
The fluorescence setup was subsequently modified into a combined 
fluorescence/diffuse reflectance spectroscopic probe and demonstrated as an 
efficient method to separate normal and diseased tissue samples from the human 
gastrointestinal tract.   
Following the single point spectroscopy work, imaging studies were 
conducted with a spectrally resolved laparoscope. The system, featuring a CCD/filter 
wheel unit clipped on a traditional laparoscope was validated on fluorescence 
phantoms and employed in two experiments. 
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The first one, building on the spectroscopy study of the gastrointestinal tract, 
was originally aimed at locating tumour in the oesophagus but a lack of tissue 
availability prevented us from doing so. The system design and validation on 
fluorophores phantoms were nevertheless described. In the second one, the 
underarm of a pig was imaged after injection of a nerve contrast agent in order to test 
the feasibility of in vivo nerve delineation. Fluorescence was detected from the region 
of interest but no clear contrast between the nerve and the surrounding muscle tissue 
could be detected. Finally, the fluorescence imaging laparoscope was modified into a 
hyperspectral reflectance imaging laparoscope to perform tissue vasculature studies. 
It was first characterized and tested on haemoglobin phantoms with varying 
concentrations and oxygen saturations and then employed in vivo to follow the 
haemoglobin concentration and oxygen saturation temporal evolutions of a porcine 
intestine subsequently to the pig’s termination. A decrease in oxygen saturation was 
observed. The last experiment consisted in monitoring the tissue re-oxygenation of a 
rabbit uterus transplant on the recipient animal, a successful tissue re-perfusion after 
the graft was highlighted. 
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Chapter 1  
 
Introduction 
 
Lesions of any type are spotted and graded based on their appearance making the 
surgeon’s eye the main tool to diagnose pathologies. This explains why some of the 
most important milestones in the history of medicine have been the results of the 
introduction of instruments extending imaging capabilities by enabling the clinician to 
visualize regions of the body difficult to access. For instance, flexible endoscopes 
permitted tumour location in the oesophagus and the colon, and rigid laparoscopes 
enabled abdominal cavity inspection minimally invasively. Later, medical imaging 
also had a dramatic impact on disease diagnostics by permitting the non-invasive 
volumetric visualisation of tissue. X-ray, positron emission tomography (PET), 
computed tomography (CT) and magnetic resonance imaging (MRI) provide 3-D 
macroscopic structural views of brain, chest, and bones allowing estimation of the 
extent of a tumour or diagnosis of heart diseases with very high resolutions.  
In spite of the enormous benefits brought by these medical imaging 
technologies, the most common criticism towards them, besides their cost, 
infrastructure constraints and inadequacy for infants and old patients, is the absence 
of functional and molecular contrast. This prevents detection of early stages of 
diseases characterized by molecular changes which precede and trigger anatomical 
modifications. Another limitation of the current imaging techniques is the impossibility 
to use them intraoperatively to provide real time information (with the exception of X-
ray fluoroscopy). Consequently, clinicians can only rely on tissue pre-operative 
images and palpation to spot lesions during an operation. This may either result in 
tissue regions being wrongly assessed as diseased leading to unnecessary biopsies 
or missed lesions.  
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It is proposed in this thesis to enrich the limited spectral information provided 
by white-light illumination and the eye of the surgeon through the use of biophotonics 
techniques in order to improve the available diagnosis information. Biophotonics 
methods consist in studying the interaction between light and tissue that can yield 
data at microscopic spatial resolution and nanometre spectral resolution, with the 
added benefit that most biomedical photonics techniques can be extended to an 
imaging mode. Biophotonics techniques encompass a broad range of modalities and 
wavelength range (from gamma rays to the infrared). The type of light-tissue 
interaction (absorption, transmission, diffuse reflection, fluorescence etc.) used may 
differ, but they share the common goal to supply tissue diagnostic information to the 
surgeon with a minimum of trauma for the patient and in a minimum time.  
Biophotonics techniques are of interest as they have the potential to address 
the two main shortcomings of current medical imaging techniques. Firstly, some 
biophotonics modalities such as fluorescence or Raman spectroscopy can probe 
biochemical alterations presaging diseases. Secondly, they can be used 
intraoperatively because they can be implemented in a compact way and generate 
data in real-time, conducive to their use during operations. In fact, as will be 
demonstrated, photonics systems enable excellent system integration with 
laparoscopes and endoscopes, which could bring enormous benefits in terms of 
clinician training length, and cost of installation in hospitals if these technologies are 
to be brought in operating theatres in the future. Also, biophotonics techniques do not 
cause trauma to the patients, in contrast to medical imaging, which often uses 
ionising radiation and biopsy, which is synonym for tissue removal. Finally, another 
advantage is the possibility to combine several modalities (fluorescence, reflectance, 
Raman, etc.) in one setup relatively easily giving access to a broad range of 
functional contrasts.  
Several tools stemming from biomedical photonics are now well-established 
and commonly used in hospitals: endoscopes, pulse-oximeters (which give 
information on the patient’s oxygen saturation); microscopes used to examine 
histological sections; optical coherence tomography systems provide longitudinal 
scans of the retina in ophthalmology; colposcopes act as a magnifying binocular to 
recognize anomalous tissue during cervix cancer screening. Other biophotonics 
techniques show promising results for diseased tissue detection. Fluorescence and 
diffuse reflectance spectroscopy and imaging, the modalities of interest throughout 
this thesis, are among them. Fluorescence spectroscopy and to a lesser extent, 
diffuse reflectance spectroscopy applications, have been heavily concentrated on 
cancer diagnosis, which, with ischemic heart disease, is the principal cause of death 
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in developed countries. The first major goal of this thesis was to assess the 
ability of fluorescence spectroscopy to diagnose non-alcoholic fatty liver 
diseases, a condition associated with diabetes (expected to become the biggest 
killer together with heart diseases in developing countries over the next decades, 
according to the World Health Organisation (WHO)). The second objective of this 
work was to combine fluorescence and diffuse reflectance spectroscopy to 
attempt to enhance the diagnostic performance provided by the individual 
modalities. Furthermore, the vast majority of the fluorescence and diffuse 
reflectance studies to date were performed ex vivo or on external organs, and the 
question of their translation to theatres for Minimally Invasive Surgery (MIS) has not 
been addressed despite their appropriateness for these procedures. The third key 
aim of this work was hence to provide and test solutions to make these 
technologies amenable to MIS procedures.  
 The general approach chosen was to apply fluorescence, reflectance 
spectroscopy and imaging to clinical applications. For each of them, the existing 
diagnosis methods as well as the fluorescence and reflectance work performed to 
date (where they existed) were reviewed and their limitations highlighted. Chapter 2 
gives a description of light-tissue interaction as well as a review of fluorescence and 
reflectance spectroscopy studies on diseased tissue diagnosis. The material required 
for fluorescence/reflectance spectroscopic experiments is also detailed. In the next 
two chapters, a spectroscopic optical fibre probe was used to detect tissue lesions. 
The outcomes of a fluorescence spectroscopy study on non-alcoholic fatty liver 
diseases (NAFLD) diagnosis realized during two mice trials (chapter 3) are 
presented. Furthermore, a solution for in vivo spectroscopic tissue diagnosis 
combining the spectroscopic probe with an articulated robotic arm is suggested. A 
modified version of the spectroscopic probe combining fluorescence/reflectance is 
used in chapter 4 in a study on precancerous/cancerous lesion detection in human 
gastrointestinal tract samples.  
The transition from spectroscopic point-limited system to imaging systems 
begins chapter 5. A summary of the different imaging filtering systems alongside a 
review of endoscopic fluorescence imaging systems is provided. A 
fluorescence/reflectance laparoscope system of our conception is described and 
could be used to extend the work presented in the previous chapter to delineate a 
tumour in a resected human oesophagus. The system design and testing on 
phantoms is presented as well as the use of the same imaging system in a study 
which distinguishes itself from the rest of the thesis by using an exogenous dye. The 
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laparoscopic system was applied to assess the feasibility of in vivo imaging of the 
brachial plexus nerve of a pig after injection of a contrast agent.  
In chapter 6, a hyperspectral laparoscopic system was employed to monitor 
in vivo tissue blood concentrations and saturation of a porcine colon after 
termination, as well as the re-perfusion of a uterus transplant on a rabbit recipient. 
Chapter 7 concludes the manuscript by summarising the thesis contributions and 
limitations, and by tackling the question of the possible diffusion of fluorescence and 
reflectance spectroscopy and imaging systems into hospitals.  
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Chapter 2  
 
Light-tissue interaction and 
tissue spectroscopy 
 
In this chapter, we describe how light is modified by tissue. The spectral range of 
interest in this thesis lies in the non-ionizing and richly diagnostic visible domain (400 
nm – 700 nm). The light-tissue interaction is a complex phenomenon; a photon 
incident on a tissue surface can undergo a variety of processes. This chapter outlines 
some of the most important of them and presents in more detail fluorescence and 
diffuse reflectance, the two types of light-matter mechanism relevant to this work. 
The physical principles, biological origins, as well as the existing models which 
describe them are then presented. The use of fluorescence and diffuse reflectance is 
then motivated and their implementations, together with their medical applications to 
date are reviewed.  
2.1 Light-tissue interactions  
 
When incident on the tissue, light can either be reflected or refracted. The directly 
reflected light does not penetrate the tissue and therefore contains no useful 
information. It is referred to as a specular reflection and does not contain significant 
diagnostic information, but may result in signal saturation. The amount of refracted 
and reflected light is governed by the Snell-Descartes law and depends on the 
refractive index at the air/tissue interface and the angle between the incident light 
beam and the tissue normal. 
Tissue can be seen as a set of scattering and absorption centres [1]. The 
photons forming the refracted light can be absorbed or scattered by the tissue 
chromophores and scatterers. The fraction of the photons which emerge from the 
tissue after multiple scattering events is called diffuse reflectance as the scattering 
induces the spreading and the loss of directionality of the incident beam. 
Absorption may result in fluorescence, and in such a case the chromophores are 
referred to as fluorophores. The fluorescent photons may in turn be absorbed and/or 
scattered, and only a portion of the fluorescent light escapes the tissue after 
backscattering. These different scenarios are summarized in Figure 2-1. 
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Figure 2-1: Different types of light-tissue interactions: specular highlight (reflection), 
scattering, absorption, fluorescence.  
 
The following paragraphs will detail fluorescence and diffuse reflectance phenomena 
as they are the two modalities used in this thesis. 
2.2 Tissue fluorescence spectroscopy 
2.2.1 Fluorescence phenomenon 
 
Fluorescence and absorption are two related phenomena. Fluorescence can be seen 
as one method by which an illuminated molecule is excited by light before releasing 
its stored energy. The amount of light (or energy) absorbed by the molecule as well 
as the quantity of fluorescent light it emits both depend of its molecular structure and 
the light wavelength, this is described by the molecule absorption spectrum and 
emission fluorescence spectrum, respectively. Jablonsky diagrams model the 
electronic energy levels of molecules and provide a convenient way to visualise what 
may happen once a molecule is excited by light [2]. 
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Figure 2-2: Partial Jablonsky diagram illustrating the electronic and vibrational 
transitions involved in light absorption and fluorescence emission. Only the two first 
electronic (ground and first excited) states are represented here. 
 
Figure 2-2 illustrates that a molecule undergoes a transition from its ground 
state to an excited electronic state after light absorption if the excitation photon 
energy equals the energy difference between two energy levels. The excited state 
energy level reached by the electron depends on the wavelength and therefore on 
the energy of the excitation light. After vibrational relaxation from the initial excited 
state to the lowest excited state energy level, the molecule may then relax to the 
ground state by releasing its energy either in the form of light by emitting a photon 
(fluorescence or phosphorescence) or through a non-radiative relaxation (such as 
heat) [2]. The wavelength of the emitted photon matches the energy level difference 
between the excited state and one of the ground state energy levels (Bohr’s 
frequency condition). 
The length of time spent by a molecule in its excited state before returning to 
its ground state corresponds to its lifetime, whose order of magnitude is one 
nanosecond for fluorescence and several milliseconds or longer for 
phosphorescence [3]. Absence of fluorescence may hence be the consequence of a 
non-radiative relaxation (thermal dissipation for instance) or a slow radiative 
relaxation (phosphorescence) [4]. 
Another parameter characterising molecule fluorescence is its quantum yield, 
that is, the ratio of the number of emitted photons over the number of absorbed 
photons. Both lifetime and quantum yield can be modified by pH and temperature [2]. 
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One could expect that absorption and fluorescence spectra totally overlap, 
but the latter is red shifted compared to the absorption spectrum. This phenomenon 
is known as the Stokes’s shift and comes from the partial loss of energy by 
intermolecular collisions (also called vibrational relaxations) preceding the 
fluorescence emission [5]. 
In summary, the fluorescence spectrum of a given fluorophore is a function of 
its intrinsic parameters: extinction (or absorption) coefficient at the excitation 
wavelength and quantum yield at the emission wavelength, which gives each 
fluorophore a unique spectral signature but also depends on the fluorophore 
concentration and the intensity of the excitation light [5, 6]. 
2.2.2 Tissue fluorophore spectra 
 
The fluorescent signal recorded from tissue comes from endogenous fluorophores 
and the detection of this signal in medical diagnostic instruments has the advantage 
of not relying on exogenous fluorophores whose toxicity, dose optimization, injection 
timing need to be considered [4].  
The fluorescence spectra of the main endogenous fluorophores responsible 
for native fluorescence are summarised in Figure 2-3. Their excitation maxima 
stretch out from 250 nm to 450 nm while their emission maxima lie between 280 nm 
and 700 nm [7] (Table 2-1).  
They can broadly be classified as follows: connective tissue proteins: collagen 
and elastin; enzymes such as reduced nicotinamide adenine dinucleotide (NADH) 
and flavins (such as flavin adenine dinucleotide (FAD) involved in the cellular energy 
metabolism; aromatic amino-acids (tryptophan, tyrosine, phenylalanine); 
lipopigments that include products resulting from lipid peroxidation (e.g. lipofuscin); 
and different sorts of porphyrins and vitamins [8].  
 
Table 2-1: Excitation and emission maxima of some key endogenous fluorophores of 
interest in this thesis. 
Endogenous fluorophore Excitation maxima Emission maxima
Collagen 325 400
NAD(P)H 340 450
FAD 450 515
Porphyrins 400-450 630, 690  
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Figure 2-3: Excitation and emission spectra of the main endogenous fluorophores. 
Reprinted from [7] with permission from John Wiley and Sons. 
 
The excitation spectrum (Figure 2-3-a) is the fluorescence intensity recorded 
at a fixed emission wavelength for different excitation wavelengths and similarly the 
emission spectrum (the spectrum of interest in this report, Figure 2-3-b) plots the 
fluorescence intensities at a fixed excitation wavelength for different emission 
wavelengths.  
The fluorescent signal generated from a tissue is complex to model as it 
varies with numerous factors such as:  
• the nature and the concentration of the fluorophores as well as their depth 
distribution. Fluorophores are unevenly spread with depth [4, 7]. For instance, the 
liver’s extracellular matrix is rich in collagen [9] and lies on top of hepatocytes, 
where NADH, FAD, vitamin A are present [10]. Another example is the layered 
architecture of the epithelial tissue of the intestinal wall where NADH, FAD and 
tryptophan are the main fluorophores of the mucosa (first layer [11]) and collagen 
is the primary fluorophore of the underlying stroma [12]. 
• the concentration of the scatterers and non-fluorescent chromophores (mainly 
haemoglobin in the visible (see section 2.3.2.1) surrounding the fluorophores, 
which can significantly distort the fluorescence with a wavelength-dependent 
magnitude. Scattering and absorption also tend to decrease with increasing 
wavelength in the visible [8]. 
• the excitation light wavelength, which determines which fluorophores will be 
excited depending on their excitation spectrum, as well as the depth and 
therefore the fluorophores reached by the light. The fluorescence escaping the 
tissue reflects therefore the contribution of the fluorophores integrated over 
excitation light penetration depth. 
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• photobleaching, which is another important factor affecting the fluorescence 
signal. It may occur when the excited fluorophores react with surrounding 
molecules instead of going back to the ground state. This reaction leads to the 
chemical modification of the fluorophores and may cause, in turn, a permanent 
fluorescence loss [13]. 
2.3 Diffuse reflectance spectroscopy  
2.3.1 Absorption and scattering phenomena 
 
The diffuse reflectance is a measure of the portion of light backscattered after 
undergoing a series of absorption and scattering events and hence is a function of 
both the absorption and scattering coefficients.  
Absorption corresponds to the energy transfer of a photon to a molecule 
which arises when Bohr’s frequency condition is met. The portion of absorbed light 
depends hence on the concentration of the tissue absorbers (see section 2.3.2) 
fulfilling the Bohr’s criteria in the visible. Tissue absorption is quantified by the 
absorption coefficient µa, which represents the amount of absorption per unit 
pathlength [3] and is proportional to the product of the wavelength-dependent 
absorber extinction coefficient ε and concentration c according to: 
ca ⋅⋅= εµ )10ln(  
 
Equation 2-1 
 
Measured absorption coefficients range from 0.12|λ=633nm cm
-1 (in the chicken muscle) 
to 85|λ=630nm cm
-1 (in the gallstones) in the visible [14]. The Beer-Lambert law enables 
the estimation of the portion of the incident light I0 absorbed in a scattering-free 
medium after having travelled a certain distance x: 
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Equation 2-2 
 
When considering several absorbers and using Equation 2-1, Equation 2-2 can be 
rewritten as follows:  
[ ]xcccIxI nn ⋅⋅++⋅+⋅−= ).......(exp)( 22110 εεε  
 
Equation 2-3 
 
The Beer-Lambert was originally developed for transmission through an absorbing-
only medium with a known width so that the distance x travelled by the photons is 
known; whilst this work is concerned with the light diffusely reflected from tissue after 
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absorption, but also scattering events. However, the Beer-Lambert law remains 
useable in a scattering media where the pathlength is a priori unknown and 
wavelength-dependent (since the scattering affects the length travelled by photons 
and varies with wavelength), provided some adaptations are made. 
Biological scattering originates from microscopic variations in refractive index 
stemming from complex tissue organisation [15]. Collagen fibres [14], the main 
component of connective tissue, cell nuclei [16], lipid membranes [17], and 
mitochondria [18] have been identified as contributors to such scattering events. 
Scattering in the body is mostly elastic, that is without variation in photon energy. It 
depends on the scatterer concentration and light wavelength, but also on the 
scatterer refractive index and on the scatterer size/wavelength ratio, which 
determines the scattering regime. Rayleigh scattering originates from particles much 
smaller than the wavelength of the visible light, i.e. cell membranes or micelles [3], it 
is isotropic and its magnitude depends on the wavelength as λ-4 [19]. Tissue 
constituents with sizes similar to the visible wavelengths, i.e. cell nuclei and 
mitochondria as well as collagen fibres [3], scatter light with weaker wavelength 
dependence (λ-x|0.4≤x≤0.5) and primarily in a forward direction. This regime is referred to 
as Mie scattering [19]. The equivalent of the absorption coefficient for scattering is 
the scattering coefficient µs and is defined as the quantity of scattering in a medium 
per unit pathlength [3]. Measured scattering coefficients span the range of 4.1|λ=633nm 
cm-1 in chicken lungs to 1410|λ=685nm cm
-1 in whole blood [14]. In other words, light is 
more diffusive in highly vascularised tissue than in lung tissue. 
However, the scattering coefficient is not sufficient to fully describe the 
scattering phenomenon. The scattering anisotropy factor g is used to take into 
account the anisotropy of the scattering, and the optical parameter usually chosen to 
fully describe scattering is the reduced scattering coefficient µs’ defined as: µs’ = (1-g) 
µs. Values of g close to 1 correspond to forward scattering, a value of 0 to isotropic 
scattering, and equal to -1 to backward scattering. The values of g in tissue are within 
the interval [0.74|λ=476nm, 0.995|λ=665nm], which indicates a predominantly forward 
scattering, and light emitted from tissue has been therefore multiply scattered [8, 14]. 
Both the absorption and scattering coefficients affect the depth of penetration 
of the light d. A good approximation of d is given by: 
as
d
µµ +
=
'
1
 [15]. This 
expression enables, for instance, the estimation of the depth reached in the liver, one 
of the organs of interest of this work, at the excitation wavelengths of the two lasers 
used here: 375 nm and 405 nm (see chapter 3). The depth of light penetration at 
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these two wavelengths calculated using the absorption and reduced scattering 
coefficients measured in a rat liver [20] is 35 µm and 40 µm at 375 nm and 405 nm 
excitations, respectively.  
2.3.2 Tissue chromophores 
 
The tissue absorbers, also called chromophores, and their contribution to the diffuse 
reflectance is known in more detail than the properties of the scatterers. 
Chromophores are functional groups of molecules which absorb light, some of which 
reemit light following absorption, which are the fluorophores mentioned earlier. 
Chromophores’ light absorption depends on both their concentration and their 
extinction coefficient (“absorbing power”). For instance, water represents up to 75% 
of the body weight [21], but its extinction coefficient is very low in the visible making 
its absorption insignificant in this region of the electromagnetic spectrum. In contrast, 
protoporhyrin IX extinction coefficients are high in this spectral region, but its 
concentration is very low also leading to insignificant absorption in the visible [22]. 
The extinction coefficient changes with wavelength in a characteristic way so that 
each chromophore has a distinct spectral signature, in a similar way to fluorophores 
which have distinctive emission fluorescence spectra. 
The three main absorbers found in the body are haemoglobin, water and 
melanin [3, 23]. Proteins and DNA absorb in the ultraviolet (UV), but not in the visible 
[6]. Melanin is only present in the skin, eyes and the hair, and the water absorption 
coefficient is negligible compared to haemoglobin in the visible range as illustrated in 
Figure 2-4.  
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Figure 2-4: Absorption coefficients of some of the main tissue absorbers between 100 
nm and 12000 nm. Reprinted from [24] with permission from American Chemical 
Society. 
 
 Haemoglobin: the main absorber in the visible range 
Haemoglobin is therefore the main absorbing compound in the body for the visible 
range. It is present in the body in two main forms: deoxyhaemoglobin and 
oxyhaemoglobin. Its normal level in blood vessels is 150 g/L [25], which can drop to 
120 g/L for anaemic patients [26]. Given its importance in this work, the haemoglobin 
characteristics are presented in more detail than the other chromophores. 
Haemoglobin is a protein present in the cytoplasm of red blood cells. Those transport 
the oxygen from the lungs to the tissue, which is possible thanks to haemoglobin 
since it has the ability to bind with oxygen [27]. Haemoglobin comprises of four amino 
acid chains, each containing a heme group which hosts an atom of ferrous iron that 
connects with a molecule of oxygen [28]. One haemoglobin molecule can therefore 
host four oxygen atoms to become oxyhaemoglobin. Once it releases its oxygen 
molecules, it becomes deoxyhaemoglobin. During this process, the colour of 
haemoglobin changes from bright red, while fully saturated with oxygen to deep 
purple for deoxyhaemoglobin [27].  
The main factor governing oxygen binding to haemoglobin is the partial 
pressure of oxygen in the blood. The haemoglobin saturation, defined as the ratio of 
the oxyhaemoglobin concentration over the total haemoglobin concentration raises 
with oxygen partial pressure with a sigmoid relationship (Figure 2-5) and is normally 
around 97% in arteries. This behaviour is explained by the preferential oxygen 
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binding with haemoglobin molecules that are already occupied by at least one 
oxygen molecule. Temperature and pH are among the other factors influencing the 
oxygen binding [27]. 
 
 
Figure 2-5: Oxygen dissociation curve, haemoglobin saturation increases with oxygen 
partial pressure. Reprinted from [29] with permission from BMJ Publishing Group Ltd. 
 
Haemoglobin, a protein, absorbs in the visible which can seem contradictory 
with Figure 2-4 which shows protein weak absorption in the visible. The absorption 
actually originates from the heme group of the haemoglobin, which is a variety of 
porphyrin. Haemoglobin absorption is a well-documented subject, and several groups 
have measured extinction (or absorption) coefficients of oxyhaemoglobin and 
deoxyhaemoglobin for various spectral ranges and with different resolutions (Table 
2-2) [30-35]. 
 
Table 2-2: Haemoglobin absorption spectra reported in the literature. 
Source Wavelength range (nm) Resolution (nm)
Prahl 250  - 1000 2
Zijlstra 450 - 1000 10
Van Assendelft   350 - 700 2
Takatani 450 - 995 5
Wray infrared unknown 
Schmitt 630 - 950 10  
 
There are discrepancies in the absorption values between these different 
sources mainly due to the instrumentation used to record spectra. These extinction 
coefficients are often used as basis spectra in fitting procedures of diffuse reflectance 
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spectra recorded from tissue to extract the concentrations of oxyhaemoglobin and 
deoxyhaemoglobin, allowing diagnostically useful parameters like tissue oxygen 
saturation to be obtained. The utilization of different basis extinction coefficient can 
sensibly impact the retrieved oxygen saturation [36], and therefore a careful choice of 
the tabulated data is required if absolute values of oxy and deoxyhaemoglobin 
concentrations are desired. We have chosen to use Prahl’s data (see chapter 6) as it 
offers the highest resolution in the [450 – 700] nm interval, which is the range of 
interest in this work. Figure 2-6 illustrates the molar extinction spectra from Prahl as 
well as the ones from Schmitt, and Takatani to illustrate the deviations between 
them. 
 
 
Figure 2-6: Molar extinction coefficients of oxyhaemoglobin and deoxyhaemoglobin 
from different sources. Data compiled from [30, 33, 35]. 
 
Regardless of the source, the same general shape and characteristic spectral 
features are observed in the 450-700 nm range: the oxyhaemoglobin spectrum peaks 
at 542 nm and 577 nm, whilst the deoxyhaemoglobin spectrum reaches a single 
maximum at 555 nm. The spectra intersect five times over the considered spectral 
region. These crossing points are referred to as isosbestic points, where the total 
haemoglobin absorption remains constant whatever its composition is. All the optical 
techniques used to measure tissue oxygenation exploit the marked spectral 
differences between oxyhaemoglobin and deoxyhaemoglobin  
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2.3.2.1 Other chromophores 
All the chromophores mentioned in the rest of this paragraph have absorption 
negligible compared to haemoglobin due to their low concentration and are 
mentioned for completeness. Methemoglobin, sulfhemoglobin, and 
carboxyhemoglobin are all haemoglobin derivates absorbing in the visible, but 
present in the body in low concentration. Myoglobin has a similar absorption 
spectrum and molecular structure than haemoglobin and provides oxygen to muscles 
[37]. Lipids, mainly known as scatterers, are also absorbers [38]. Cytochromes, 
(including cytochromes aa3, b and c) from the hemoprotein family (like haemoglobin) 
are involved in the electron transfer chain and are found in mitochondria [39]. 
Bilirubin, a by-product of haemoglobin breakdown localizing in the spleen and liver 
[40] and β-caroten, a carotenoid present in the skin and the aorta [41] also absorb in 
the visible. 
2.4 Models of light transport in tissue 
 
Spectra recorded from tissue are used to separate normal sites from pathologic sites. 
There are two main approaches to process them: either the spectral features are 
directly used to separate normal from diseased sites, or a light-tissue interaction 
model is used to extract tissue optical properties, which are then used as diagnostic 
variables. While the former approach was used in this work, the latter approach is 
described in this section as it permits to further understand the transport of light in 
tissue.  
2.4.1 Radiative transfer equation 
 
Modelling of the light-tissue interaction aims to determine the absorption and 
scattering coefficients characterizing a tissue which can then be used as a disease 
marker. 
In the classical theory, light is modelled as an electromagnetic wave and its 
propagation in a medium is analytically described by Maxwell’s equations. However, 
the highly heterogeneous structure of tissue, and therefore the important spatial 
variations in its optical properties, makes the application of the classical theory 
impossible. The radiation transport theory, which ignores fluorescence as well as 
electromagnetic wave phenomena such as interference or polarization, may be used 
instead [17]. The radiation transport theory states that in the steady–state regime, the 
divergence of a non-collimated beam of radiation with intensity I, propagating from a 
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given position with a given direction in tissue (considered as a homogeneous 
continuum with randomly distributed scattering and absorbing centres) is decreased 
by the portion of the beam either absorbed or deviated from its original trajectory by 
scattering, and is increased by radiation scattered alongside its direction and by 
neighbouring external light sources. 
This model uses the radiative transfer equation, which takes the following 
form in the steady–state regime when tissue is considered as a homogeneous 
continuum with randomly distributed scattering and absorbing centres:  
)ˆ,(')',()'ˆ,ˆ()ˆ,()()ˆ,(.ˆ
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The interpretation of Equation 2-4 is straightforward and provides a good summary of 
the events undergone by a packet of photons of energy I called the specific intensity 
or radiation (power per unit area, per unit angle more exactly) at a position r
r
and 
propagating in the direction sˆ  in a tissue characterized by an absorption coefficient 
aµ and a scattering coefficient sµ . The first term right hand side represents the drop 
(hence the minus sign) in the light energy packet caused by absorption and 
scattering. The energy of this packet is increased by all the photons of initial direction 
'sˆ  scattered along sˆ  ( )'ˆ,ˆ( ssp  being the scattering phase function, i.e. the probability 
that a photon of direction 'sˆ  will be scattered in the sˆ  direction) and by any external 
source )ˆ,( sr
r
ε  present in this region [17].  
2.4.2 Analytical models 
 
In spite of its apparent simplicity, the solution of the radiation transport is difficult and 
limits its use. However, it has been analytically solved in the limiting cases of 
predominant scattering or predominant absorption and isotropic scattering. As stated 
earlier, scattering is dominant over absorption in most tissues (and hence the 
absorption coefficient may be set to zero), and the scattering dominant hypothesis, 
commonly called the diffusion approximation, is therefore the model of interest here. 
The transport equation (Equation 2-4) simplified with the diffusion approximation is 
called the diffusion equation. 
A more accurate approximation of the transport equation is the PN 
approximation. It consists in expressing the specific intensity and the source 
distribution in a series of spherical harmonics, and the phase function as well as the 
scattering angle in a series of Legendre polynomials [42]. The diffusion 
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approximation is equivalent to the P1 approximation; they both assume that the 
specific intensity, the source distribution, and the phase function are isotropic. Apart 
from the P1 approximation, the most common implementation of the PN approximation 
is the P3 approximation, which truncates the spherical harmonic series at the fourth 
order (numeration starting at 0), which can then be simplified in Legendre 
polynomials [43, 44]. This higher order approximation permits a more exact account 
of the anisotropy effect near sources and boundaries [44]. The P3 approximation has 
been shown to be accurate for highly absorbing media and short source-detector 
separation [44, 45]. The diffusion equation and the transport equation in the P3 
approximation may be solved to give an analytical expression of the diffuse 
reflectance in the improbable assumption that the tissue is an infinite homogeneous 
medium, but its resolution becomes complicated in the common hypothesis of mono 
or multi-layer tissue with one or several boundary index mismatches and a fortiori 
when source-detector geometry is taken into account. 
Methods, categorized into the analytical, empirical and numerical ones, have 
consequently been developed to solve practical situations. The analytical methods 
are based either on the diffusion or the P3 approximation. The Kubelka-Munk model, 
equivalent to a one dimension diffusion model, represents one of the earliest 
attempts to give an analytical expression of the diffuse reflectance [46]. It expresses 
in one dimension the reflectance and transmittance of a diffuse irradiance within an 
isotropically scattering medium as a function of the scattering and absorption 
coefficients and ignoring the reflections at the boundaries. This enables their 
calculation directly from the measured transmission and reflectance. The numerous 
hypotheses (matched boundaries, isotropic scattering, and diffuse irradiance) limit 
nonetheless the applicability of the Kubelka-Munk model [14, 47]. 
The exponential model is a simple way to calculate the total diffuse 
reflectance from a semi-infinite homogeneous medium whose essential assumption 
is that incident and backscattered light are diminished following 
zsae
).'( µµ +−
, where 
µa, µ’s and z are the absorption, reduced scattering coefficient and depth of 
penetration respectively. This is equivalent to neglecting the integral term in Equation 
2-4. This method can be generalized to the multi-layered tissue with index 
mismatches to give an expression of the diffuse reflectance in function of the 
scattering and absorption coefficients of the different layers [15]. 
Photon migration [48] and path integral models [49, 50] both propose a 
probalistic approach to the analytical estimation of the diffuse reflectance from a 
semi-infinite continuum using the notion of photon weight. All the analytical models 
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described so far permit the calculation of the total diffuse reflectance from a semi-
infinite medium, yet this quantity is not of interest since, during real experiments, 
diffuse reflectance is collected with finite size measurement devices at a given 
location and angle.  
Zonios’ model fulfils this requirement as it provides an angularly and spatially 
resolved expression of the diffuse reflectance from a semi-infinite medium in the 
diffusion approximation. This makes its use very suitable for modelling the diffuse 
reflectance measured with an optical fibre probe (probably the most common 
measurement tool to collect light from tissue) which has finite diameter and numerical 
aperture [51]. Besides the spatial variables, the diffuse reflectance expression is a 
function of the absorption and scattering coefficients as well as a constant which is 
determined after calibration against phantoms with known optical properties. The 
absorption coefficient is assumed to be only dependent on haemoglobin and the 
scattering coefficient is compelled to decrease with increasing wavelengths. Then, a 
non-linear optimisation routine is iteratively used to minimize the dissimilarity 
between modelled and measured diffuse reflectance spectra to retrieve the 
absorption and scattering coefficients.  
A similar approach referred to as the hybrid P3 approximation is also used to 
provide a spatially resolved expression of the diffuse reflectance from a semi-infinite 
medium [45, 52]. It is one type of implementation of the P3 approximation presented 
in [44] and is called hybrid because it combines elements from both the diffusion and 
the P3 approximation. Like in the Zonios’ model (based on the diffusion 
approximation), it uses the Green’s function of the diffuse equation for an isotropic 
steady-state source, but substitutes the absorption coefficient by a constant denoted 
ν- stemming from the P3 approximation and which depends on the absorption and 
reduced scattering coefficients. Like the Zonios’ model, this approach is applicable to 
complex optical fibre probe geometries and presents the additional advantage not to 
require a calibration on phantoms. 
2.4.3 Numerical and experimental models  
 
Monte Carlo simulations are a versatile numerical method to simulate the light 
propagation process. This approach provides the most accurate approximation to the 
transport equation, while enabling the implementation of complex source-detector 
geometry, multi-layered tissue with refractive index mismatch boundaries [53], finite 
size incident radiance [54] and can even account for reemitted fluorescent photons 
[55-59]. In Monte Carlo simulations, light is viewed as a packet of photons travelling 
 35
in tissue which can undergo absorption, scattering within a layer and transmission or 
reflection at layer interfaces. The inputs of the model are the absorption and 
scattering coefficients, the refractive indices, the anisotropy factor, the number of 
photons forming the packet and the geometry of the problem. The photon packet is 
given an initial weight of 1, which is decreased after each absorption event. The step 
size of the photon packet between two light-tissue interactions and its deflection 
angle after a scattering event are both random variables sampled from their 
probability density functions, which is a function of the absorption and scattering 
coefficients for the step size and a function of the anisotropy factor for the deflection 
angle. When the photon group is transmitted through an interface into the air, the up-
to-date photon weight is counted as a diffuse reflectance. The photon packet is 
terminated when the weight goes below a set threshold.  
Because the model output of interest is not the diffuse reflectance, but the 
absorption and scattering coefficients, inverse Monte Carlo methods have been 
developed to extract these coefficients. They consist of simulating a diffuse 
reflectance spectrum with an initial guess on the aforementioned coefficients and 
then comparing it with the measured spectrum. The sum of the squared errors 
between simulated and acquired spectra is calculated and reduced iteratively with 
updated absorption and scattering coefficients using an optimization algorithm. The 
retrieved absorption and scattering coefficients minimise the error [59]. Depending on 
the geometry complexity and the number of launched photons, the Monte Carlo can 
be time consuming.  
Another means to model the diffuse reflectance is to use empirical methods 
such as artificial neural networks. After being trained on phantoms, the algorithm is 
used to extract absorption and scattering coefficients from tissue. The accuracy of 
this approach depends on the phantoms used during the training [60]. 
In summary, all the aforementioned methods enable the retrieval of the 
absorption and scattering coefficients with different degrees of accuracy depending 
on the hypotheses they are based on. Monte Carlo simulations provide the most 
accurate solutions as no assumption regarding the tissue optical behaviour is made. 
It also enables implementation of complex source detector geometry and boundary 
conditions (multiple layer tissue with index mismatches). Nonetheless, it furnishes 
numerical solutions only and can be time consuming while real time diagnostic 
information is sometimes required. It should, however, be mentioned that techniques 
exist to reduce this processing time [61]. Analytical models have the advantage of 
speed and help to understand the physics of the light-tissue interaction. Yet, almost 
all of them provide inaccurate solutions for high absorption tissue since they are 
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based on the diffusion approximation; this makes them useable in brain or dense 
connective tissue for instance, which are highly scattering or in low absorption tissue, 
but they are not valid in highly vascularised tissue such as muscles. 
2.5 Implementation of fluorescence and diffuse 
reflectance 
 
Fluorescence and diffuse reflectance spectroscopy can be employed in a contact and 
a non-contact way. The two methods each have their advantage; the contact 
approach allows the probing of internal organs difficult to access like colon, 
oesophagus, while the non-contact approach enables the acquisition of spatial 
information by scanning the excitation light beam (see section 2.6.2). Furthermore, 
fluorescence spectroscopy is implemented either in steady-state mode, which looks 
at wavelength-resolved intensity or time-resolved mode which examines wavelength 
resolved-fluorescence lifetime. The latter requires expensive and bulky ultra-short 
pulsed lasers and time-gated detection. In this thesis, fluorescence and diffuse 
reflectance has been used in contact and steady state mode.  
2.5.1 Fibre-optic probe based spectroscopy 
 
In addition to the optical fibre probe, fibre-optic probe based spectroscopy setups 
include: an excitation light source, coupling optics to adapt the light source f-number 
to the numerical aperture (NA) of the probe excitation fibre for optimal irradiance, a 
second set of coupling optics to match the NA of the probe detection fibres to the 
disperser f-number for maximum coupling of the collected light from the sample to 
the disperser, a disperser to separate this light intensity according to its wavelength, 
a detector to record the dispersed light (Figure 2-7). The rest of this section highlights 
the different elements required to perform this in clinical settings. The shape of 
fluorescence and diffuse spectra is known to be modified by changes in tissue 
biochemistry and biostructure, respectively, which are triggered by disease 
progression. The two modalities give hence completive information on the tissue 
condition and their combination is hoped to improve the diagnostic accuracy. 
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Figure 2-7: Outline of a typical optical spectroscopic system of tissue diagnosis. 
 
Light sources 
Light sources are chosen according to the following characteristics: coherence, 
bandwidth, spectral range of interest, power, and portability. Lasers are highly 
temporally and spatially coherent light sources allowing a very narrow spectral output 
and a high coupling efficiency into optical fibres. They are the typical light sources 
used for fluorescence spectroscopy. Among the lasers emitting in the UV/visible are 
the frequency-doubled Nd:YAG emitting at 532 nm; dye lasers emitting between 400 
and 800 nm, the argon-ion laser emitting at 488 nm and 514.5 nm, the Ti:sapphire 
laser tuneable between 690 nm and 1000 nm, and the nitrogen laser (337 nm 
emission) [19]. Laser diodes (emitting between 350 nm and 1900 nm) are more and 
more employed as they represent an advantageous substitute to traditional lasers in 
terms of portability, energy consumption, and usability. Another possible type of light 
source for fluorescence is a broadband light source normally used for diffuse 
reflectance spectroscopy in combination with a bandpass filter or a monochromator. 
This approach has the advantage of wavelength tunabilty when the broadband light 
source is employed with a filter wheel. 
Figure 2.8 deleted 
Broadband sources commonly include filament sources (tungsten-halogen), 
and arc lamp sources (xenon, mercury, metal-halide). Spectra are shown in for 
xenon and mercury lamps. The boost in emitting power of LEDs (light-emitting 
diodes) means they may now be employed as they are more compact and energy 
efficient than the aforementioned sources [63, 64]. 
 
Optical fibre probe 
Fibre probes may be classified as: mono-fibre probes or bifurcated probes. The first 
type contains a unique fibre which is used for illumination and detection, whereas 
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bifurcated probes have one or several excitation fibres and one or several detection 
fibres. They are named “bifurcated” because they have two arms: one excitation arm 
linked to the light source and one detection arm connected with the 
disperser/detector system. Mono-fibre probes are the easiest to build and permit the 
smallest diameter as well as a high light collection efficiency compared to bifurcated 
probes. However, they require additional optics such as an additional beamsplitter to 
separate excitation and emission light. More importantly, the mono-fibre approach is 
restricted because of the large amount of specular light collected, the internal 
reflection at each internal surface, and the induction of autofluorescence by the 
generation of parasite autofluorescence by the optical fibre excited by the illumination 
light [65].  
The optical fibres used are multimode for a higher light gathering efficiency 
and have diameters in the order of hundreds of microns and a numerical aperture 
typically around 0.22. In order to limit parasitic autofluorescence from the fibre itself, 
high-grade silica is preferred to silica as the material for the fibre core as silica 
generates fluorescence when excited in the UV (which is the case in this work see 
chapter 3) [66]. Also, flection of the fibres and defects mean that the light may exit 
the core and reach the jacket. Consequently, polyimide is chosen instead of nylon 
because nylon fluoresces under UV light [65].  
The materials constituting the probe are chosen not only to minimize 
autofluorescence, but also to allow light transmission in the UV/visible. More 
importantly, the probe is the only part of the fluorescence spectroscopy setup in 
contact with tissue, and its material must hence be biocompatible. The two probes 
used in this thesis meet this criterion (see chapters 3 and 4). All the materials used 
for optical fibre probe packaging are required to meet the standards of the American 
norms, the USP (U.S. Pharmacopoeia), the European norm ISO 10993 and the 
Japanese norms, MHLW (Ministry of Health, Labour and Welfare). For instance, 
substances such as stainless steel 302, polymers, polyimide used for optical fibre 
housing and glue from the manufacturer Epotek utilized to seal the probe are all 
biocompatible [65].  
 
Disperser/detector 
Monochromators and spectrographs are the two main types of light disperser. The 
former separates light intensity at individual wavelength one at a time, while the latter 
provides the complete spectrum forthwith, making its acquisition time for full 
spectrum shorter than the monochromator. Important parameters to consider when 
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choosing a disperser are: the spectral range and resolution (which depends on the 
slit width), the transmission efficiency, and the numerical aperture.  
The choice of the detector depends on the number of wavelengths and the 
number of pixels being acquired. Photomultiplier tube or avalanche photodiode used 
together with one or several bandpass filters or monochromators are utilized for 
single pixel and single or few wavelengths acquisition. A spectrograph combined with 
a linear photodiode array enables the instantaneous acquisition of a reflectance or 
diffuse reflectance spectrum, whilst a spectrograph/ coupled-charged device (CCD) 
permits the recording of a spectrum for several pixels. Intensified CCDs are 
sometimes used for fluorescence spectroscopy as fluorescent light levels are low.  
2.5.2 Importance of the probe geometry 
 
Probe geometry, and in particular the probe-to-target distance (PTD), source-to-
detector separation (SDS), fibre numerical aperture (NA) and diameter, has a 
dramatic impact on the origin of the excited and collected light (Figure 2-8). As 
mentioned in 2.4.3, inverse Monte Carlo simulations can quantify tissue optical 
properties; forward Monte Carlo simulations are also very useful to define the extent 
of excited and probed tissue volumes, as well as assessing the influence of probe 
geometry on them. 
 
Figure 2-8: A common geometry of optical fibre probe. PTD denotes probe-to-target 
distance and SDS the source-to-detector separation. 
 
In [67], the effect of NA, fibre diameter, SDS and PTD on the emitted 
fluorescence light at 630 nm from tissue-like optical phantoms after 400 nm excitation 
was studied. The probe consisted of one excitation fibre surrounded by a ring of 
detections fibres. Increasing the NA was found to increase collection efficiency (CE) 
as well as inducing a higher sensitivity to superficial layers, because many of the 
photons propagating at higher angles were likely emitted directly below the 
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illumination fibre. The main effect of decreasing the fibre diameter was to increase 
the spatial selectivity as the diversity of pathlength travelled by the photons is 
diminished. Raising the SDS led to an increase in the mean path length and the 
probing depth together with a decrease in the detected fluorescence and the spatial 
selectivity. Finally, the CE evolution with the PTD was non-monotonic because of the 
competing effect of illumination and detection area overlap and decay of light 
collection with distance. In [12], the CE and the probing depth of fluorescent light 
emitted at 520 nm from a two layer phantom (mimicking epithelial/stromal tissue) 
after 460 nm excitation were compared between a single fibre probe and a multiple 
fibre probe. The CE was higher with the single fibre probe but the probing depth was 
more important with the multiple fibre probe. Also, the CE increased with NA for both 
probes. 
Effects of the illumination and CE have also been assessed for diffuse 
reflectance. The influence of PTD on the collection efficiency at 337 nm was 
evaluated for three probe geometries: one single fibre probe (probe 1) and two 
multiple fibre probes: the first one consisted of one central illumination fibre 
surrounded by a ring of 18 collection fibres (probe 2), the second one was made up 
of a 24 fibre central illumination area surrounded by the same number of collection 
fibres (probe 3) [68]. The evolution of the CE of probes 2 and 3 with PTD was found 
to be non-monotonic for the same reasons as mentioned above, whereas it 
decreased monotonically with increasing PTD for probe 1 as illumination and 
collection areas overlap at all PTD for single fibre probes. Also increased PTD 
generated increased sensitivity to superficial layers for probe 3 and the average CE 
was higher with probe 1 than with the two other probes. 
The diffuse reflectance CE of a single fibre probe and a bifurcated probe 
consisting of one excitation surrounded by a ring of collection fibres was computed 
from a semi-infinite medium with varying optical properties [69]. The main conclusion 
of the study was that the CE was proportional to sin2(NA) in the case of highly 
scattering samples for both the single optical fibre and multiple fibre probe. The CE 
was highly dependent on the sample absorption coefficient only in the latter case 
because the mean pathlength of collected photons is longer for multiple fibre probe, 
(the photons travelling from the source fibre to the detector fibre) giving the 
absorption a larger distance to wield its effect. 
As highlighted above, the probe geometry determines the extent and location 
of the probing volume as well as the CE. The diameter and NA of the fibres 
incorporated in the two probes employed in this work were optimized to maximize 
CE, while ensuring a total probe diameter inferior to 2 mm (for endoscope working 
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channel compatibility). In both probes, the SDS was minimized to raise the CE. A 
consequence of this, as mentioned above, is an increased sensitivity to superficial 
layers, which suits the diagnosis of the pathologies of interest in this thesis as they 
affect the superficial tissue layers. 
2.6 Fluorescence and diffuse spectroscopy of 
diseased tissue: Main application to date: detection 
of precancerous and cancerous tissue 
2.6.1 Fluorescence spectroscopy  
 
Fluorescence spectroscopy consists in recording and studying the wavelength 
distribution of a sample’s fluorescence. In a clinical context, the value of fluorescence 
spectroscopy to make a distinction between normal and diseased tissue through the 
modifications of spectral features with disease progression has been recognized 
since Policard in 1924 [70]. He noticed that tumours exposed to UV-visible light 
emitted red fluorescence relatively higher than normal issue following spectra 
normalization that was attributed to porphyrins, an observation later confirmed by 
Gougerot in 1939, who studied skin epithelioma (cancer of the skin superficial layers) 
[71]. More recently, Alfano provided further evidence of the diagnostic power of 
fluorescence spectroscopy to discriminate cancerous rat and mouse kidney and 
prostate from healthy tissue [72]. An argon laser emitting at 488 nm was focussed on 
tissue and the fluorescent light was dispersed by a spectrometer and recorded 
between 500 nm and 750 nm with a photomultiplier tube. Normal and cancerous 
spectra peaked in the 520-530 nm range due to flavin fluorescence but cancerous 
spectra all presented a secondary peak occurring in the 590 nm – 600 nm range 
originating from porphyrins. 
Vo-Dinh proposed fluorescence spectroscopy as a tool to diagnose 
oesophagus cancer in vivo in 1995 [73]. Two hundred measurements from 48 
patients were acquired with an optical fibre inserted in the working channel of an 
endoscope. The probe included seven illumination fibres linked to a pulsed nitrogen-
pumped dye laser tuned at 410 nm, as well as twelve detection fibres picking up 
tissue fluorescence, which was then dispersed by a polychromator and recorded with 
a photomultiplier tube. Spectra were displayed between 430 nm and 720 nm. 
Fluorescence in the 520 nm - 540 nm band and 590 nm – 650 nm band were 
attributed to flavins and porphyrins respectively. Overall fluorescence intensity (non-
normalized) from normal oesophageal tissue was found to be considerably higher 
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compared to the cancerous ones (see Figure 2-9-a). Spectra were then divided by 
their area under the curve and subtracted from a “baseline” spectrum determined as 
the average of a selection of 15 normalized spectra from normal tissue sites (see 
Figure 2-9-b). This procedure enabled additional spectral differences between normal 
and cancerous samples to be highlighted such as a relatively higher fluorescence of 
normal samples compared to cancerous samples in the 450 nm – 550 nm domain. 
This trend was reversed from 550 nm, and between 640 nm and 670 nm, cancerous 
fluorescence intensity was markedly relatively superior to normal fluorescence 
intensity. These relative intensity discrepancies peaked at 480 nm and 670 nm. 
Intensities at these two wavelengths were therefore chosen as markers to separate 
normal sites from cancerous ones. Using a linear boundary decision, all the sites 
except two tumour samples were correctly classified with the intensities at 480 nm 
and all the sites were correctly classified with intensities at 670 nm making 
fluorescence spectroscopy a promising approach to diagnose oesophageal cancer 
that could be used in combination with white light endoscopy to improve its sensitivity 
and specificity. In the chapter 4 of this thesis, a spectroscopic study of 
gastrointestinal tissue including oesophageal samples was performed. A larger 
variety of pathologies was examined than in the Vo-Dinh’s experiment and diffuse 
reflectance was used together with fluorescence to attempt to enhance the diagnostic 
power that would be obtained with either modality alone. 
In 1996, Ramanujam employed fluorescence spectroscopy to detect early 
stage cervical cancer in vivo [74]. A seven optical fibre probe consisting of three 
illumination fibres connected to a nitrogen pumped dye laser provided excitation light 
at 337 nm, 380 nm and 460 nm. Four detection fibres were used to collect the 
fluorescence light between 400 nm and 650 nm from 381 cervical sites in 95 patients. 
A multivariate statistical algorithm used on 161 excitation - emission wavelength pairs 
allowed discrimination of precancerous lesions form normal sites with a sensitivity of 
82% and specificity of 68%. Also, high-grade precancerous lesions were 
distinguished from non-high grade ones with a specificity and sensitivity of 79% and 
78% respectively making fluorescence spectroscopy a promising cervical cancer 
screening tool. 
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Figure 2-9: (a) Non-normalized and (b) normalized (divided by the area under the curve) 
fluorescence emission spectra from normal and malignant oesophagus tissues. 
Reprinted from [73] with permission from John Wiley and Sons. 
 
The aforementioned examples are just a few of a multitude of fluorescence 
spectroscopy experiments conducted to detect cancerous tissue on a large diversity 
of living systems including cell cultures, animal models and human organs. Among 
the latter are colon, cervix, bronchus, bladder, brain, oesophagus, oral cavity, larynx, 
skin, bile duct, breast and stomach [4, 7]. 
It is remarkable that some of the spectral differences between normal and 
malignant tissue appear consistently across these studies in spite of the differences 
of biochemistry and biostructure between these organs and despite the variety in the 
implementation of the fluorescence spectroscopy (excitation wavelength, probe 
geometry, data analysis, see section 2.5). A drop in the overall fluorescence intensity 
is the most characteristic dissimilarity between healthy and cancerous tissue [75-85].  
Another spectral marker of cancer is a red-shifted spectrum [70, 76, 77, 80, 
86-97]. This observation has been turned to good account to build a fluorescence 
imager (LIFE, Xillix Tech. Corp. (acquired by QImaging Corp.), Canada) which 
localised tumour in lungs and bronchus based on the red band/green band 
fluorescence intensity [85, 98, 99]. The fluorophores responsible for the spectral 
discrepancies between normal and cancerous tissues are collagen, elastin as well as 
NADH, and flavins which are both involved in the electron transport chain, indicating 
(a) (b) 
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disorder in the cell metabolism of cancerous tissue. Also involved are porphyrins, 
heavily present in the blood (heme), whose relative larger emission in the red 
together with the overall drop of fluorescence in cancer sites attributed to 
haemoglobin absorption indicates increased vasculature in tumour [73, 79, 81, 96, 
97]. 
Among other applications of fluorescence spectroscopy are the detection of 
atherosclerotic plaques (marked by increased presence of collagen) [100], as well as 
caries enamel characterization [101]. 
2.6.2 Diffuse reflectance spectroscopy  
 
Diffuse reflectance spectroscopy can be seen as a colour analysis of the excitation 
light diffusely backscattered from a sample at a higher spectral resolution than the 
eye, providing richer and more detailed information on the tissue state. The colour of 
this light depends on the absorption (chiefly from haemoglobin in the visible) and 
scattering of the sample, which are both altered during disease progression. 
Consequently, diffuse reflectance spectroscopy can probe the biostructure of the 
medium under study and provides diagnostic information. 
In 1980, Ikeda used a two fibre probe to illuminate and collect the diffuse 
reflectance from rat brains [102]. He showed that the reflectance intensity varied with 
brain structures, white matter having a significantly higher reflectance than grey 
matter. Similarly to fluorescence spectroscopy, diffuse reflectance spectroscopy has 
been extensively used to identify tumours. In 1991, Marchesini recorded the diffuse 
reflectance between 400 and 800 nm from different skin lesions and demonstrated 
statistically significant differences between pigmented nevi and malignant 
melanomas [103]. Mourant collected diffuse reflectance spectra between 250 nm and 
800 nm with a system essentially consisting in a pulsed xenon arc lamp from healthy 
and dysplastic bladder sites from ten patients [104]. Using the slope of the diffuse 
reflectance spectra between 330 nm and 370 nm (negative for spectra from 
cancerous tissue, positive otherwise) as a criterion to separate malignant sites from 
the non-malignant ones, a sensitivity of 100% and a specificity of 97% were reached. 
A similar system has been employed by the same group in the gastrointestinal tract 
and showed promising results as for its capacity to separate normal, inflamed and 
dysplastic (precancerous modification of the cell development) mucosa [105]. 
Zonios performed diffuse reflectance spectroscopy during colonoscopy on 13 
patients with suspected adenomatous polyps (benign tumourous tissue) with an 
optical fibre through the working channel of an endoscope [51]. An analytical model 
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(described in section 2.4.2) was employed to extract four parameters from the 
spectra recorded between 350 nm and 700 nm: haemoglobin concentration and 
oxygen saturation, effective scatterer size and density. The knowledge of these 
parameters allowed not only discrimination of normal from cancerous tissue, but it 
also enabled an insight into the biological modifications entailed by the development 
of cancer. Adenomatous polyps exhibited higher haemoglobin concentration, but 
similar oxygen saturation than normal colons. The effective scatterer density was 
found to be lower in adenomatous polyps and their effective size more important.  
Figure 2-11 deleted 
Using the hybrid P3 approximation, Wang also observed an increased 
haemoglobin concentration in colon polyps and malignant colon tumours compared 
to normal adjacent tissue, yet he also found a statistically significant lower 
oxygenation for diseased sites [45]. A similar conclusion to Zonios’ for the increased 
scatterer size was made while studying adenocarcinoma (cancerous epithelium 
tissue) in the pancreas [106]. Diffuse reflectance spectra indeed revealed an 
increased size of the cancerous cell nuclei. Fluorescence spectra were also acquired 
and showed an increased collagen content in cancerous tissue. 
Diffuse reflectance spectroscopy has also been applied in breast cancer 
tissue diagnosis [107]. Seventy-two spectra (13 cancer sites and 59 normal sites) 
were collected from 24 patients with an optical fibre probe and recorded with a 
spectrometer. Sensitivity and specificity of 69% and 85%, respectively, were obtained 
using artificial neural networks. Reflectance spectroscopy was also utilized to 
recognize benign neoplasms (tissue characterized by an uncontrolled of production 
of cells) and cancer in ovary. An optical fibre with three different SDS (1.1 mm, 2.1 
mm, and 3 mm) was used to illuminate and collect reflected light, which was 
dispersed by an imaging spectrograph and recorded with a CCD camera [108]. As 
mentioned in section 2.5.2, increasing SDS means increasing probing depth, 
consequently the light collected at higher SDS originated from deeper tissue layers. 
The study conducted at 64 sites from 16 patients yielded an average specificity and 
sensitivity of 86±6% and 79±5% to separate normal ovary from benign neoplasms 
and cancers with a linear boundary decision and spectral features statistically found 
to maximize differences between disease groups. The same type of probe with four 
distinct SDS has been used to record spectra from 324 sites in 161 patients to 
assess diffuse reflectance spectroscopy performance for cervical precancer 
diagnosis [109]. A principal component analysis was performed to retain the main 
spectral features among the spectra collected at the four SDS and feature selection 
and classification were achieved by using Mahalanobis distance with cross-
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validation. By doing so, normal epithelial sites were discriminated from high-grade 
intraepithelial lesions with a sensitivity of 72% and a specificity of 81%. More 
recently, reflectance spectroscopy has been employed for in vivo paediatric brain 
tumour detection. Statistical analysis led to the choice of intensities between 600 and 
800 nm as optimal spectra parameters to distinguish normal tissue from tumours 
[110]. 
Myocardial infarction is another condition studied with diffuse reflectance 
spectroscopy in the rat model [111]. During the four weeks following the infarct, 
diffuse reflectance spectra together with fluorescence spectra were collected from 
normal sites, areas surrounding the infarct and infarcted sites with a system 
consisting of a tungsten halogen source for reflectance and a nitrogen laser for 
fluorescence linked to a three optical fibre probe. Reflectance and fluorescence light 
were dispersed and recorded with a spectrometer. Statistically significant spectral 
profile differences were found between 500 nm and 600 nm and intensity alteration at 
480 nm attributed to changes in local haemodynamic was noticed. In particular, 
deoxygenation arose in the infarcted area and surrounding region one week post-
infarction due to blood flow reduction. Partial reoxygenation of infarcted and 
surrounding area occurred two weeks post-infarction as shown by the transition to a 
single valley profile characteristic of deoxyhaemoglobin to a double valley profile 
characteristic of oxyhaemoglobin. 
 Figure 2-12 deleted 
Point-limited spectroscopy studies were only considered so far. These 
methods, like the traditional biopsy approach, suffer from spatial under sampling for 
large tissues and do not allow assessing the extent of tumours. To overcome this 
limitation, some groups proposed scanning the illumination light beam on the tissue 
surface with a 2D mirror scanner and record the diffuse reflectance spectrum at each 
position. By extracting haemoglobin concentration, oxygenation, and scattering 
coefficient with one of the methods mentioned in 2.4, it is therefore possible to build a 
pseudo-colour map where the contrast arises from the difference of values of these 
parameters. A resected colon tissue containing a normal area and a cancerous area 
below was imaged in this approach [112]. Both reflectance and fluorescence spectra 
were collected in this study, the reduced scattering coefficient at 700 nm and 
haemoglobin concentration were retrieved from the reflectance spectra, and the ratio 
of collagen concentration over the NADH concentration (the two major contributors of 
colon fluorescence) was deduced from fluorescence spectra. Assuming a 
multivariate Gaussian prior for these three parameters and using Bayes’ rule, the 
posterior probabilities of belonging to the cancer class were calculated for each of the 
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pixel of the image: pixels with posterior probability superior to 0.5 were classified as 
cancer and normal otherwise, hence generating the probability map, which enables 
delineation of tumour margins. Scattering property changes of murine tumours in the 
prostate and the pancreas have been imaged in the same way [113].  
2.7 Summary 
 
This chapter highlighted how to measure and extract the diagnostic information 
contained in fluorescence and diffuse reflectance light. Typically, a fibre optic probe 
is employed to deliver excitation light to, and gather remitted light from a tissue site of 
interest. Secondly, a biopsy from the same site is taken in a second time. Then, 
fluorescence and diffuse reflectance spectra are sorted in disease groups according 
to the diagnostic obtained with the histopathological inspection (the gold-standard 
method) of the biopsies. Spectral differences between the groups detected 
qualitatively, statistically or via a model to extract the tissue absorption and scattering 
coefficients are exploited to discriminate the normal sites from the diseased sites with 
a binary or probability based algorithms. As will become apparent in the next chapter, 
our approach has been to choose a statistical algorithm to select the best 
discriminating spectral features followed by a probalistic classification scheme.  
This chapter focussed on single point spectroscopic methods, of interest in 
chapter 3 and chapter 4, a review of the spectral imaging techniques, employed in 
chapter 5 and chapter 6, is provided at the beginning of chapter 5.  
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Chapter 3  
 
Fluorescence spectroscopy as 
a liver disease diagnostic tool 
 
A novel biophotonic approach to assess liver tissue state is presented in this chapter 
including building of the optical system and testing it on liver tissue. For the first time, 
a multi-fluorescence spectroscopy system has been used to diagnose non-alcoholic 
fatty liver diseases (NAFLD) in mouse model. Non-alcoholic fatty liver diseases 
(NAFLD), already with high prevalence, are set to increase in the coming years 
stressing the need of a fast, robust method to diagnose it. In this chapter, after briefly 
exposing their causes, the current methods of diagnosis of NAFLD are introduced 
and their limitations highlighted. The results of two experiments, performed in 
collaboration with Hoa Nguyen, M.Sc. Student and with our clinical collaborators Dr. 
Adam Levene, Dr. Quentin Anstee, and Pr. Robert Goldin (St Mary’s hospital, 
Imperial College Healthcare NHS trust) are presented. The first one, looking at 
separating normal, steatotic and steatohepatitic livers, and the second one, 
differentiating normal, mild steatotic and severe steatotic tissue were conducted in 
the mouse model.  
The vast majority of studies looking at using spectroscopic probes for tissue 
diagnosis are performed ex vivo or in vivo, but on external organs easy to access like 
breasts or the skin. Intraoperative measurements on internal organs like liver raise 
some challenges among which is the accurate positioning of the probe on a target 
site and the control of the pressure applied to tissue, which alters the optical 
properties, and hence the spectra of the probed tissue, which can potentially lead to 
error in spectroscopic based diagnostic. The contribution of an articulated robotic 
endoscope, designed by Dr. David Noonan, Dr. Jianzhong Shang, and Chris Payne 
(Mechatronic group, Hamlyn Centre, Imperial College London) including a force 
sensor and used in combination with the spectroscopic probe was demonstrated ex 
vivo on a phantom and liver tissue. This allowed probe pressure control and 
monitoring, as well as probe scanning. 
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3.1 Dual excitation fluorescence spectroscopy 
system  
 
Figure 3-1 presents the optical system used this chapter. It essentially consisted in 
two laser diodes emitting at 375 nm (model NDU1113E, Nichia Corp., Japan) and 
405 nm (model GH04P21A2GE, Sharp Corp., Japan), a custom-built optical fibre 
probe (Leoni Fiber Optics, Inc., (previously Romack, Inc.), USA), and a CCD (Retiga 
EXI, QImaging, Canada)/spectrograph (model V10, Specim Ltd, Finland) unit. The 
probe included one excitation fibre, conveying the laser light to the sample, and 
surrounded by six hexagonally packed fluorescence collection fibres. The diameters 
and numerical apertures of the fibres were 200 µm and 0.22, respectively, and they 
were selected to have low autofluorescence and attenuation in the near UV spectral 
region. The probe distal tip was covered by a 1.5 mm thick glass spacer allowing 
excitation and emission beams to overlap and the fibres and window were housed in 
a stainless steel tube with an external diameter of 2 mm, allowing its insertion into 
endoscope working channels, needles or small orifices. The proximal end was 
divided into two arms, the first one contained the excitation fibre and was coupled to 
the laser optics; the second arm included the six emission fibres arranged in a linear 
array. The 375 nm beam was reflected by the dichroic mirror (model FF409-DI02, 
Semrock, Inc.; USA) and was aligned and coupled into the excitation fibre with two 
steering mirrors. The light from the 405 nm laser was transmitted by the dichroic 
mirror and coupled to the excitation fibre. It should noted that the angle of incidence 
of the two laser beams on the dichroic was not 45° as it is normally the case because 
its cut-off wavelength was 409 nm and was therefore not included between 375 nm 
and 405 nm (a dichroic mirror with adequate cut-off wavelength was not found at the 
time of the experiment). The dichroic mirror was orientated to enable the 
reflection/emission pattern described above. Two beam shutters (one for each laser 
diode) enabled the selection of the excitation wavelength delivered to the sample. 
The optical power at the distal end of the probe was 3.5 mW for both lasers. The 
fluorescence emission from the six fibres was focussed with a lens doublet onto the 
80 µm wide input slit of an imaging spectrograph. A 430 nm long-pass filter (model 
3RD430LP, Omega Optical, Inc., USA) was inserted between the fibres and the slit 
to stop the light of the laser diodes reflected by the sample. The light dispersed by 
the prism-grating-prism element of the spectrograph was then acquired with a 
sensitive cooled CCD camera. All the optics was assembled together using a cage 
system and a breadboard, so that the system was robust and portable. A LabVIEW 
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program controlled the exposure time (typically 100 ms) and beam shutters, and 
enabled acquisition of fluorescent signals from the laser diodes sequentially with an 
adjustable number of measurements. Full details of the system can be found in [1]. 
 
Figure 3-1: Experimental set-up of dual-excitation wavelength fluorescence 
spectroscopy probe. From [1]. 
 
Fluorescence spectroscopy 
The six normally identical emission spectra recorded for each excitation wavelength 
were processed from the CCD images and the intensities at different spatial locations 
on the image were converted into spectra using calibration data obtained with a 
number of specific laser wavelengths. The spectrum of a tungsten-halogen calibrated 
light source (Ocean Optics, Inc., USA) was also recorded at the start of the 
experiment to take into account the system spectral response and the ratio of this 
spectrum over the real spectrum was used to correct the raw spectra. Spectra were 
normalized by the area under the curve and truncated between 450 and 750 nm.  
Fluorescence spectra at 375 nm excitation from a 3 mM solution of FAD have 
been acquired with a spectrometer (Ocean Optics, Inc., USA) (the “reference” 
spectrum) and with our CCD/spectrograph system (the “measured” spectrum) to test 
the calibration procedure (Figure 3-2). The spectral accuracy defined as the ratio of 
the area in common under the two spectra over the area under the reference 
spectrum was found to be equal to 93 %. The non-perfect overlap between the two 
spectra was likely to arise from differences of specifications between the gratings 
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detection elements of the spectrometer and the spectrograph/CCD systems, such as 
the grating’s optical resolution and the detector’s spectral sensitivity.  
 
 
Figure 3-2: Emission fluorescence spectrum of a FAD solution excited at 375 nm and 
recorded with a spectrometer (reference) and with the dual-excitation wavelength 
fluorescence spectroscopy system (measured). 
3.2 Non alcoholic fatty liver disease 
3.2.1 Clinical characteristics, prevalence and current 
diagnostic method limitations 
 
NAFLD comprise a large array of progressive liver diseases arising without major 
alcohol consumption, ranging from steatosis (fatty liver), through steatohepatitis (fat 
and inflammation) to liver fibrosis, and eventually cirrhosis [2]. NAFLD are 
characterized by an accumulation of triglycerides (fat) in the liver and are linked to 
obesity and insulin resistance/diabetes. While steatosis has usually been considered 
as a benign pathology [2], its evolution into more serious progressive fibrosis and 
cirrhosis is problematic. NAFLD, already the third most important cause for liver 
transplantation, are set to become the first indication in coming decades [3]. The 
global prevalence of NAFLD is estimated to be between 10 and 39% [4] reaching 
57% to 74% among the obese population, and 50% among diabetic patients [5]. The 
general prevalence is predicted to rise with the global growth of obesity and diabetes 
(obese adult population rise from 400 million in 2005 to 700 million by 2013 [6], and 
diabetic population augmentation from 285 million in 2010 to 438 million in 2030 [7]). 
Meanwhile, the waiting list for liver transplantation stretches out, and 354 patients 
were registered for a liver transplant in the UK in January 2011 [8].  
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The combined effects of the organ donors shortage and the important 
prevalence of NAFLD, led the increasingly frequent use of steatotic ‘marginal’ grafts, 
i.e. grafts more prone to primary non-function, in liver transplantation [9]. However, 
severe steatosis and steatohepatitis are associated with increased risk of primary 
graft non-function [10, 11]. Consequently, to aid effective organ selection, a fast and 
reliable method of donor organs evaluation for degree of steatosis and the presence 
of significant oxidative stress is needed as these are the signs of grafts at greater risk 
of non-function following transplantation. 
 
Table 3-1: Methods used to diagnose NAFLD 
Marker Advantages Drawbacks
Use in clinical 
settings
Diagnostic 
length (day)
Microscopic 
visualisation of 
tissue section
Reliable (gold 
standard)
Subjective         
Time consuming  
Yes
2              
(after biopsy)
ALT
Biochemical 
hepatitis
Ease of blood 
sample obtention
Insensitive         
Non-specific
Yes but not as 
specific marker 
for NAFLD
1
AST
Biochemical 
hepatitis
Ease of blood 
sample obtention
Insensitive         
Non-specific
Yes but not as 
specific marker 
for NAFLD
1
CK 18 
fragments
Apoptosis
 Ease of blood 
sample obtention, 
Differentiation of 
steatosis /NASH 
Not yet at 
diagnostic level 
Research only 1
TBARS Oxidative stress
Specific marker of 
oxidative stress in 
the tissue
Insensitive         
Non-specific      
Time consuming 
Laborious
No 1
Ultrasound Fat content
High sensitivity & 
specificity  if fat 
content > 33%
No differentiation 
steatosis/NASH
Yes 3 (approx.)
CT Fat content
High sensitivity & 
specificity if fat 
content > 33%
No differentiation 
steatosis/NASH
Occasionnaly 3 (approx.)
MRI Fat content
High sensitivity & 
specificity when 
fat content over 
33%
No differentiation 
steatosis/NASH
Yes 3 (approx.)
Method
Histopathology
Biochemical 
tests
Imaging
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Table 3-1 details the existing tests to diagnose NAFLD or non-alcoholic 
steatohepatitis (NASH). Information available to the practicing clinician when faced with 
a patient who may have NAFLD includes the medical history and physical examination, 
routine laboratory investigations, and typically, an ultrasound. Since most patients with 
NAFLD are asymptomatic and the symptoms, when they occur, are nonspecific (e.g. 
fatigue, right upper quadrant discomfort, weight loss), the examination of symptoms is an 
unreliable way of estimating the severity of NAFLD [12]. 
Biopsy, collected percutaneously or by transjugular catheterization [13], is used as a 
definitive diagnosis, but is time-consuming and not well suited to peri/intraoperative 
assessment of fatty liver [13].  
Blood biochemistry is another NAFLD diagnostic approach. In practice, the 
clinical diagnosis of NAFLD is based on the identification of raised alanine 
transaminase (ALT) and/or aspartate aminotransferase (AST) levels in the blood, 
indicating liver damage (mostly hepatitis), in patients with features of the metabolic 
syndrome (e.g. obesity, diabetes) with supporting evidence of fatty liver on 
ultrasound imaging [3]. Yet, increased ALT and AST levels alone only indicate liver 
damage without informing on the disease causing it, also normal ALT and AST levels 
have been found in patients suffering from NAFLD [14] making these tests non-
specific and insensitive. Other blood tests include cytokeratin-18 (CK 18) fragment 
levels and thiobarbituric acid reactive substance (TBARS) assay. CK-18 fragment 
levels are indicators of cell apoptosis shown to correlate with NALFD presence [15]. 
TBARS assay is an accepted research method to measure lipid peroxidation as a 
substitute measure for free radical damage (‘tissue oxidative stress’) within the liver, 
a key driver of disease pathogenesis, inflammation and progression in NASH [3]. 
None of the latter two are used in standard practice. 
Several imaging techniques have been tested for NAFLD diagnosis. 
Ultrasound probes steatosis with a weak sensitivity (67%) and specificity (77%) [16], 
and becomes more reliable when the severity of the steatosis raises [17]. Computed 
tomography (CT) imaging enables sensitivity and specificity for steatosis diagnosis of 
100% and 82-93% respectively [18]. Magnetic resonance imaging (MRI) allows the 
most precise triglycerides quantification and hence has the best sensitivity (100%) 
and specificity (92%) for steatosis diagnosis [10]. Using these imaging techniques, 
steatosis can be detected optimally only if the liver fat content is more than 33% [19].  
Nevertheless, the imaging approach is limited to steatosis grading because all 
the imaging methods just mentioned only measure the fat content, and can not 
differentiate steatosis from steatohepatitis or cirrhosis, which are characterized by 
tissue inflammation and fibrosis, rather than by triglyceride quantity. In fact, in some 
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livers where steatohepatitis and cirrhosis are well established, fat content may 
diminish, leading to an underestimation of the pathology gravity [20].  
Finally, the length of all the aforementioned diagnostic methods is one day 
minimum. Therefore, a fast and minimally invasive method able to differentiate 
normal tissue from steatosis and from steatohepatitis would be desirable. 
3.2.2 Fluorescence spectroscopy to assess liver state: 
incentive and previous work 
 
As mentioned in the last chapter, fluorescence spectroscopy has been widely used 
for cancer diagnosis in different organs. It could also have potential applications in 
liver tissue classification. In ex vivo setting, it could be a substitute or a complement 
to histopathology and would also allow for non-destructive NAFLD diagnosis in liver 
transplant grafts, which are more prone to primary non-function. In vivo, it could 
replace biopsy in biopsy intolerant patients. Fluorescence spectroscopic probes 
could, in particular, be an advantageous alternative to needle biopsy during 
transjugular liver biopsy. This type of procedure, which consists in the introduction of 
a catheter in the right hepatic vein after puncturing of the right internal jugular vein 
and needle biopsy of the liver through the catheter [13], is performed when 
percutaneous liver biopsy is contraindicated (massive obesity or, coagulopathy for 
instance) [21]. Samples collected with transjugular liver biopsy are undersized and 
fragmented, which can prevent diagnosis [13, 21]. The inner diameter of the 
catheters (in the mm range [22]) would permit the introduction of a fluorescence 
spectroscopic probe, although effects of the blood absorption on the liver 
fluorescence properties would remain to be assessed in this particular approach. 
Fluorescence spectroscopy could also be employed as an adjunct in patients already 
undergoing an operation, such as bariatric surgery or to evaluate the donor organ at 
harvest.  
Liver autofluorescence has previously been studied by Croce et al [23-27] 
who demonstrated that NAD(P)H, vitamin A, flavins, porphyrins were major 
contributors to liver autofluorescence when excited at 366 nm. The main 
differentiation markers recognized to differentiate healthy, steatotic and fibrotic livers 
were NAD(P)H, vitamin A and collagen. Importantly, a parallel increase of lipids and 
vitamin A was demonstrated. Other fluorophores including flavins, riboflavin, 
arachinoid acid, lipopigments, and porphyrins, all present in liver [28-31] and emitting 
in the visible range [32], are also expected to contribute to the liver fluorescence. 
Croce’s studies were crucial to comprehend liver fluorescence and to assert 
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fluorescence spectroscopy as a possible NAFLD detection method. However, the 
instrumentation used in this work forbids its use intraoperatively as it requires an 
histological preparation of the excised liver tissues. Sankarankutty et al. proposed 
fluorescence as a tool to evaluate the viability of liver grafts [33]. The evolution of the 
fluorescence signal with time has been shown to follow the time course of 
mitochondrial respiratory capacity, one of the usual indicators used to judge liver 
viability. De Oliveira et al. demonstrated that the ratio of the maximum fluorescence 
signal emitted by liver after 532 nm excitation over the amplitude of the 
backscattered light at this wavelength was linearly correlated with the hepatic fat 
content with a correction factor of 0.983 [34]. While the most severe steatosis cases 
were clearly distinguished from the normal ones through this ratio, intermediate study 
groups could not be differentiated from one another. This study demonstrated the 
potential of fluorescence spectroscopy for NAFLD analysis, but only exploited a very 
limited spectral range to separate disease groups as only two wavelengths were 
used. Furthermore, none of the studies to date quantified the fluorescence diagnosis 
performance. 
Consequently, the building of a fluorescence spectroscopy probe system 
providing excitation at a wavelength that will allow autofluorescence from vitamin A, 
collagen, NADH and porphyrins, together with a classification algorithm utilising the 
whole spectrum appears to be a favourable candidate to swiftly and non-invasively 
diagnose steatosis and steatohepatitis. 
3.3 Data classification with Sparse Multinomial 
Learning algorithm 
 
For each of the measurements acquired in the NAFLD experiments (see sections 3.4 
and 3.5), the spectra from the two excitation wavelengths were concatenated prior to 
processing rather than treated separately as it was initially assumed that combining 
the spectra at the two excitation wavelengths might potentially improve the 
classification. Then, a sparse multinomial logistic regression (SMLR) was applied to 
classify the concatenated spectra. SMLR has previously been successfully 
demonstrated to distinguish autofluorescence and diffuse reflectance spectra from 
healthy, marginal, and tumourous brain tissue [35, 36]. Most of classification 
algorithms are binary, but more than two disease categories were considered in our 
study. The SMLR, which enables multi-class separation, was therefore chosen. 
SMLR belongs to the family of statistical pattern recognition algorithms; a 
pattern corresponds here to the set of fluorescence intensities (spectral features) 
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building up a fluorescence spectrum. Statistical pattern recognition usually involves, 
firstly, a dimensionality reduction step to select the features or combinations of 
features which optimize the separation between patterns belonging to the different 
classes. Secondly, the patterns are classified after decision boundaries separating 
the selected features have been established. Decision boundaries are defined by 
assigning probability mass functions to features of a set of training patterns 
conditioned on the pattern class and by choosing a decision rule; this corresponds to 
the training of the classifier [37]. 
In the context of our work, SMLR as previously developed by Krishnapuram 
et al. [38], was used to separate the 106*2 fluorescence intensities (106 intensities at 
each excitation wavelength) at the 106*2 wavelengths sampled between 450 nm and 
750 nm comprising each concatenated spectrum, into three disease classes (control, 
moderate steatosis and steatohepatitis in the first experiment, and control, mild 
steatosis and severe steatosis in the second experiment) with an open source 
software package [39].  
The probability mass function P(Ci|s,wi) (Equation 3-1) that a spectrum made 
up of 212 spectral features belongs to a class Ci represented by its weight vector wi 
is assumed to follow the multinomial logistic regression model, where the regression 
coefficients are the numbers of the classifier weight vector wi of the corresponding 
class Ci [38]: 
∑
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The spectrum is assumed to belong to the class whose weight vector maximises this 
probability. The estimation of the weight matrix (212 lines, three columns) for the 
three different classes (in other words the result of the classifier learning process), is 
calculated using Bayes’ decision rule (Equation 3-2) stating that the spectrum s 
belongs to class Ci if:  
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The sparsity of the classifier is achieved by introducing a prior on the weights. This 
approach differs from the traditional maximum likelihood estimation (Equation 3-3) in 
that it is not only the log-likelihood function which is maximised to estimate the weight 
vectors but the sum of the log-likelihood function and the logarithm of a prior on the 
weights distribution. A Laplacian prior is chosen because the logarithm of this 
distribution is proportional to the l1-norm of the weights. Consequently, this 
maximisation problem is similar to an l1-penalised regression, which presents the 
major advantage to promote sparse coefficient vectors, i.e. vectors with coefficients 
either large or null. The details of the maximisation process are beyond the scope of 
this work, but can be found in [38]. At the end of the optimization step, the estimates 
of w are known and the spectra posterior probabilities of class membership can 
therefore be calculated. A spectrum belongs to the class whose weight vector 
maximizes the estimated posterior probability as stated in Equation 3-2. 
The benefits of sparse estimates are numerous: as many coefficients are set to 
zero, their variance is low, which produce a stable model with high generalisation 
ability, that is the performance in classifying new spectra [37], inherent feature 
selection [40], and handling of large dataset as the weights of the spectral features 
inconsequential for the classification are set to zero [37]. Finally, as the probability of 
spectrum class membership is known, SMLR presents the advantage to identify 
“boundary cases” i.e. spectra close to a decision boundary for which the diagnostic 
need to be more finely-shaded than the spectra with a high-probability of class 
membership.  
3.4 Distinguishing healthy liver from steatotic and 
steatohepatitic livers in the mouse model-
Experiment 1 
 
In this experiment, the fluorescence spectroscopy probe described in Figure 3-1 was 
used to excite different subspecies of the endogenous fluorophores present, and the 
concatenated emission spectra at the two excitation wavelengths could then be used 
to distinguish different tissue states. The SMLR algorithm enabled differences 
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between normal, steatotic and steatohepatitic livers to be detected in the mouse 
model. 
 
3.4.1 Study design 
 
Research was approved by the local ethics committee and performed in accordance 
with the UK Animal (Scientific Procedures) Act 1986. Mice were housed under 
standard conditions and fed with a commercial chow (#801722, SDS, UK) and free 
access to water. The study was performed to examine the autofluorescence 
spectroscopy of liver tissue from mice with different NAFLD severities and used 
mouse models with steatosis and steatohepatitis induced by a combination of genetic 
and dietary modulation [41]. A ‘control group’ of 8-week old male non-obese mice 
were fed with a control diet (Charles River, Belgium) and compared to genetically 
modified mice fed either with a nutritionally replete control diet (Research Diets, USA 
- ‘mild steatosis group’) or with a choline deficient diet (Research Diets, USA - 
‘steatohepatitis group’). There were initially five animals per group but two of the mice 
from the mild steatosis group died prematurely during the experiment and were 
excluded from the study. 
At the end of the study, animals were culled by exsanguination under general 
anaesthesia and liver tissue was rapidly harvested. The liver was bisected and half 
was immediately snap-frozen in liquid nitrogen for subsequent biochemical analysis. 
Blood was also taken for biochemical analysis. Without any treatment or staining, 
liver tissues were submitted to measurements immediately after culling to minimize 
air-exposure effects, cleaned of blood to minimize haemoglobin absorption and 
brought from the operating table to the optical bench. Emission spectra were 
recorded and the livers were then fixed in formalin solution for further 
histopathological study. 
Fluorescence data were recorded at between three and five different 
locations on each liver. At each location, six measurements (one measurement 
consisted of two spectra – one for 375 nm and one for 405 nm excitation) were 
recorded from the six emission fibres in the probe, probing an overlapping but 
different tissue volume. This generated a total of 114 (19 investigated locations × 6 
fibres) measurements (also referred to as sites in the rest of this chapter) for the 
normal group, 72 (12 investigated locations) measurements from the steatotic group, 
and 114 (19 investigated locations) measurements for the steatohepatitic group. The 
SMLR classification was completed with a K-fold cross validation rather than with a 
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leave-one-out cross validation because the six spectra from one acquisition cannot 
be regarded as being entirely independent. In this approach, the sample pool of 300 
spectra was divided in 50 subsets (K=50), each including the six spectra from the 
same acquisition so that during the classifier learning groups of six were held out at a 
time. 
3.4.2 Measurement protocol and data processing 
 
The liver tissue preparation and analysis described in this paragraph was performed 
by Dr. Adam Levene, Dr. Quentin Anstee, and Pr. Robert Goldin. 
 
Histopathology 
Formalin fixed liver tissue was treated into paraffin wax and sections were stained 
with Haematoxylin and Eosin (H&E). H&E stained sections were examined using the 
NASH Clinical Research Network histological classification system [42]. The NAFLD 
activity scoring system (NAS), detailed in Table 3-2, includes the steatosis score 
(between 0 and 3), which refers to the amount of surface area with steatotic 
hepatocytes as evaluated on low to medium microscope power, the lobular 
inflammation score (from 0 to 3), which evaluates the number of inflammatory foci 
per x200 magnification field, and the hepatocyte ballooning score (0-2), which grades 
the number hepatocytes with a balloon appearing before their death. The NAS is 
hence ranging from 0 to 8. 
 
Table 3-2: Details of NAFLD activity scoring. 
NAFLD activity 
scoring
Steatosis (% of 
hepatocytes involved )
Lobular inflammation 
(foci per×200 field)
Hepatocyte 
ballooning (number of 
balloon shape 
hepatocytes)
0 ≤5 0 0
1 5-33 2 few
2 33-66 2-4 many
3 >66 ≥4  
 
TBARS Assay and ALT Biochemistry 
The methionine choline deficient (MCD) mouse model of NASH is characterized by 
elevated reactive oxygen species production such as malondialdehyde (MDA). A 
TBARS assay was carried out in order to quantify this. MDA reacts with thiobarbituric 
acid (TBA) as a thiobarbituric acid reactive substance (TBARS) to produce a red 
colored complex which has peak absorbance at 532 nm [43]. The amount of TBARS 
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was expressed as µmol MDA equivalent formed per 100mg cell protein measured. 
For a quantitative determination of TBARS, MDA standard solutions were employed. 
About 100 mg of frozen liver was placed into a ceramic beads tube. 300 µl of   
radioimmunoprecipitation (RIPA) buffer was subsequently added and the tubes 
positioned into a Precellys rotor at 6500 rpm for one cycle of 50 seconds to 
homogenise the samples. Then, the supernatant was put on ice and used in the 
assay. 100 µl of the lysate was put into a 1.5 ml microcentrifuge tube and 200 µl of 
ice cold, 10% trichloracetic acid was added. The sample was incubated for 15 min on 
ice followed by centrifugation at 3000 g for 10 minutes. Standards were prepared 
with distilled water and 500 µM MDA to give known MDA concentrations from 0 µM 
to 50 µM. 300 µl of the samples and standards were then mixed with 300 µl of 0.67% 
TBA and incubated at 95 °C for 10 minutes. The samples were then allowed to cool. 
Using a 96 well plate, 150 µl of each standard and sample was placed into a well, 
performed in duplicate. Spectrophotometry at 532 nm was measured using a plate 
reader. For each sample, the MDA concentration in µM per 100 mg of liver was 
calculated from the absorbance values and standard curve. 
ALT levels were also quantified. The blood took when the mice were culled 
was placed in a plasma collection tube which when centrifuged at 3000 rpm for 10 
minutes separated the plasma from the erythrocytes. The supernatant plasma was 
separated from the blood and stored at -80°C until analysed in an automated 
biochemical analyser to provide ALT measurements in IU/L. 
3.4.3 Results 
 
Histopathology 
Marked differences were visible on the H&E stained sections of the three groups. 
The control group (non-obese mice fed chow) had normal liver histology. The mild 
steatosis group (genetically modified mice fed chow) displayed features of isolated 
steatosis without lobular inflammation and steatohepatitis group (genetically modified 
mice fed a MCD diet) had NASH with marked steatosis, moderate lobular 
inflammation and numerous ballooned cells (see Table 3-3 and Figure 3-3). 
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Figure 3-3: Typical H&E stained liver sections at x 400 magnification showing (a) 
mouse liver fed standard chow, (b) genetically modified mouse liver fed standard chow 
showing steatosis only , (c) genetically modified mouse liver fed MCD showing 
steatosis, lobular inflammation and hepatocyte ballooning. From [1] 
 
Table 3-3: Median NAFLD activity score for the mice. From [1] 
Study Group Steatosis
Lobular 
inflammation
Hepatocyte 
ballooning
NAFLD activity
score
Control 0 0 0 0
Mild steatosis 2 0 0 2
Steatohepatitis 3 2 2 7
  
 
TBARS Assay 
There were notably raised MDA concentrations in the livers of the steatohepatitis 
group compared to the two other study groups, as expected - p=0.028 with the 
control group and p=0.011 with the mild steatosis group, see Figure 3-4.  
 
Figure 3-4: Mean malondialdehyde concentration in the livers of the mice ± standard 
error of the mean (SEM). From [1] 
 
(a) (b) (c) 
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The mean MDA concentrations (µM per 100mg of liver) were 0.26±0.02 for the 
control group, 0.28±0.02 for the mild steatosis group, and 1.79±0.46 for the 
steatohepatitis group (Table 3-4). These results verified that there was increased 
oxidative stress within the livers of the steatohepatitis group. No major difference was 
found between the steatosis group and the control group (Figure 3-6).  
 
Table 3-4: Mean malondialdehyde concentration in the livers of the mice ±SEM. From 
[1]. 
Pilot Study Group Malondialdehyde Concentration 
(µM per 100mg of liver) ± SEM
Control 0.26±0.02
Mild steatosis 0.28±0.02
Steatohepatitis 1.79±0.46  
 
ALT Biochemistry 
There was significantly increased ALT levels in the plasma of steatohepatitis group 
compared to the two other study groups, as expected (p=<0.001 for the mild 
steatosis group and control group – see Figure 3-5). The mean ALT levels in the 
plasma (IU/L) were 26.40±4.07 for the control group, 91.77±4.78 for the mild 
steatosis group and 307.34±33.38 for steatohepatitis group (Table 3-5).  
 
 
Figure 3-5: Mean ALT levels in the plasma of the mice ±SEM. From [1] 
 
These observations proved that there was biochemical hepatitis within the liver for 
the steatohepatitis group which is in keeping with the lobular inflammation and 
ballooning identified on H&E stain. No important difference was detected between 
0 
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the mild steatosis group and the control group although there did appear to be a 
trend towards increased ALT in the steatotic mice.  
 
Table 3-5: Mean ALT levels in the plasma of the mice ±SEM. From [1] 
Pilot Study Group ALT biochemistry (IU/L) ± SEM
Steatohepatitis 307.34±33.38
26.40±4.07
91.77±4.78
Control
Mild steatosis
 
 
Fluorescence spectroscopy results 
Figure 3-6 presents the mean spectra at 375 nm and 405 nm excitation and error 
bars (one data standard deviation). At 375 nm excitation, liver autofluorescence 
peaked at around 475 nm which was attributed to the combined fluorescence of 
NAD(P)H (emission at around 475 nm) and vitamin A (emission at around 490 nm) 
[26]. Mild steatotic tissue exhibited higher 475 nm intensity than healthy tissue, with 
intensity raising together with the steatosis severity in these two groups. The 
steatohepatitis group showed weaker peak fluorescence than healthy and steatotic 
tissue. The relative increase in intensity at 475 nm for 375 nm excitation from the 
normal (steatosis score 0) to the mild steatosis group (steatosis score 2, see Figure 
3-6-a) is consistent with an augmentation in vitamin A content associated with the 
augmentation of lipids [26]. The concentration of NAD(P)H, also emitting in this 
spectral domain (emission peak at 475 nm), was found to soar with steatosis [44]. 
Based on these considerations, the steatohepatitis group with a steatosis score of 3, 
indicating a higher fat content than the two other groups, may hence have been 
believed to have a greater intensity at 475 nm. Nonetheless, it actually had an inferior 
intensity (Figure 3-6-a). A possible explanation for this could lie in the biochemical 
and biostructural changes provoked by fibrosis in this steatohepatitis model. First, 
collagen, which is induced by fibrosis, is a well known scatterer and fluorophore and 
will hence change the fluorescence and scattering properties of the liver tissue. 
Second, the vitamin A contribution to the fluorescence spectrum of fibrotic liver was 
found to be half that of normal liver at 366 nm excitation [39]. Consequently, the 
existence of fibrotic tissue in the steatohepatitic livers is expected to lead to the peak 
intensity drop in this group. Moreover, the evolution of NAD(P)H concentration with 
fibrosing steatohepatitis is not known. 
The 405 nm excitation spectra revealed a main peak intensity at 500-510 nm 
and secondary peak at 610 nm attributed to porphyrins, synthesised in liver, whose 
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excitation spectrum peaks close to 405 nm and emission spectrum peaks at 610 nm 
[33]. Spectra at both excitation wavelengths included a weak peak at 575 nm, which 
could come from lipofuscin, a lipopigment present in the liver, whose concentration 
increases with age [31] and exhibiting a maximum of fluorescence emission near 575 
nm [32]. At 405 nm, spectral differences between the three groups appeared visually 
less noticeable than at 375 nm excitation, although the difference was still statistically 
significant, as the SMLR analysis will show. Vitamin A and NAD(P)H are poorly 
excited at 405 nm, their contributions to the fluorescence spectra will appear slightly 
less important than at 375 nm excitation. The spectral shape also results from the 
contributions of the other fluorophores present in the liver including flavins [28], which 
have an emission band between 500 nm and 600 nm [32], and arachidonic acid, a 
free fatty acid metabolized by the liver [29] that fluoresces between 400 and 550 nm 
[23].  
 
 
 
Figure 3-6: Mean spectra at (a) 375 nm and (b) 405 nm excitation and error bars 
representing standard deviation. From [1] 
 
The results of the SMLR classification performed with a K-fold cross validation are 
presented in the confusion matrices in Table 3-6 for the concatenated dataset. The 
overall classification accuracy obtained reached 95%. This table can be reinterpreted 
in terms of diagnostically more meaningful parameters by considering the sensitivity, 
specificity, positive and negative predictive values (PPV, NPV) of one group against 
the two others. The normal tissue (control group) could be differentiated from the mild 
steatotic and steatohepatitic tissue with 96% sensitivity, 97% specificity, 95% PPV 
and 97% NPV. The steatotic tissue was discriminated from the normal and 
steatohepatitic tissue with 92% sensitivity, 96% specificity, 88% PPV, and 97% NPV. 
Steatohepatitic tissue was separated from the two other groups with 97% sensitivity, 
100% specificity, 100% PPV and 98% NPV.  
 
(a) (b) 
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Table 3-6: Confusion matrix presenting the ability of fluorescence spectroscopy to 
distinguish between control, mild steatosis and steatohepatitis disease groups with 
the concatenated spectra. From [1] 
Disease group Control Mild steatosis Steatohepatitis
Control 114 0 0
Mild steatosis 0 72 0
Steatohepatitis 0 1 113
Fluorescence spectroscopy
Histopathology
 
 
The posterior probabilities calculated by SMLR of fluorescence spectra belonging to 
the correct disease group as classified by histopathology are plotted in Figure 3-7. 
Fifteen sites were spectrally misclassified with a probability below 50%, with the 
remainder classified with an average probability of 98.9% indicating a strong 
confidence in the classification of the tissues. 
 
Figure 3-7: Posterior probability of fluorescence spectra from interrogated tissue sites 
belonging to their correct disease group (as classified by histopathology): control (114 
sites), mild steatosis (72 sites), steatohepatitis (114 sites). From [1] 
 
For single excitation, the classification accuracy of the first experiment was 80% and 
95% for 375 nm and 405 nm excitation, respectively. The classification with the 
combined spectra at the two excitation wavelengths reached 95%, and thus did not 
enhance the classification achieved with the single 405 laser diode. 
IIn conclusion, this proof-of-concept experiment demonstrated the value of 
fluorescence as a tool for NAFLD diagnosis. However, the mouse model used here 
was pretty extreme with clearly distinct differences between disease groups which 
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might not reflect a real case diagnostic scenario. A second study which included 
disease groups with more subtle differences was hence conducted to evaluate the 
diagnostic power of fluorescence spectroscopy in more ambiguous conditions. 
3.5 Grading steatosis-Experiment 2 
 
A second experiment was conducted in the mouse model to assess the fluorescence 
spectroscopy capacity to differentiate steatosis of different severity.  
3.5.1 Study design  
 
The protocol included harvesting the mouse livers, recording fluorescence spectra 
and processing tissue for further histopathology, and was similar to the one indicated 
in section 3.4.1. No blood tests were performed in this experiment. A total of 25 mice 
were examined within three groups as follows: Twelve mice in the control group, nine 
mice in the moderate steatosis group, and four mice in the severe steatosis group. 
The total numbers of measurements (one measurement consisted of two spectra – 
one for 375 nm and one for 405 nm excitation) acquired from each of these groups 
were respectively 252 (42 investigated locations × 6 fibres), 258 (43 investigated 
locations) and 102 (17 investigated locations), and they were classified using SMLR. 
3.5.2 Results 
 
The histopathology scores attributed to the control, moderate steatosis, and severe 
steatosis after microscopic evaluation of the aspect of tissue sections were 
respectively, 0, 4, 5-6. Fibrosis was detected in none of the mice. 
The spectra at 375 nm excitation and 405 nm excitation are presented Figure 3-8. 
They both peak at the same wavelength as the first experiment, that is 475 nm and 
500-510 nm respectively. Like in the first experiment, a secondary peak present at 
610 nm attributed to porphyrin was observed in the 405 excitation spectrum, yet the 
secondary peak at 575 nm present in both spectra of the first experiment and 
attributed to lipofuscin was absent in both spectra of the second experiment, 
signifying a difference in lipofuscin content between the mice of the first and second 
experiment.  
As expected, the peak intensity at 475 nm in the mean 375 nm excitation 
spectra rose with the disease severity. This evolution was attributed to an increase in 
vitamin A concentration. Spectral differences between the mean 405 nm excitation 
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spectra of the different disease groups were again visually less obvious, as in the first 
experiment, yet statistically very significant, as shown in the following paragraphs.  
In this experiment, fibrosis was detected in none of the mice, collagen optical 
properties were hence less likely to impact the shape of the fluorescence spectra as 
in the first study. The increase of peak intensity observed at 475 nm in the 375 nm 
excitation spectra is hence consistent with the augmentation of the vitamin A 
concomitant with the development of the steatosis. 
 
  
 
Figure 3-8: Mean spectra at (a) 375 nm and (b) 405 nm excitation and error bars 
representing standard deviation. 
 
A classification accuracy of 91% was obtained after SMLR K-fold 
classification. Table 3-7 shows the confusion matrix obtained following classification 
with SMLR. The control group was discriminated from the moderate and severe 
steatotic groups with 92% sensitivity, 93% specificity, 94% PPV and, 90% NPV. The 
moderate steatotic tissue was separated from the normal and severe steatotic tissue 
with 97% sensitivity, 95% specificity, 93% PPV, 95% NPV. Finally, the severe 
steatotic tissue was differentiated from the two other ones with 98% sensitivity, 82% 
specificity, 97% PPV, and 90% NPV. 
 
Table 3-7: Confusion matrix presenting the ability of fluorescence spectroscopy to 
distinguish between control, moderate and severe steatosis disease groups with the 
concatenated spectra. 
Disease group Control Moderate steatotis Severe steatosis
Control 232 13 7
Moderate steatotis
15 241 2
Severe steatosis 12 6 84
Fluorescence spectroscopy
Histopathology
 
 
(a) (b) 
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Figure 3-19 presents the posterior probabilities obtained for each site and for each 
disease group. A high number of measurements were classified with probability close 
or equal to 100% as indicated by the numerous points clustered close to the value 1 
on the graph. The total averaged probability calculated from all the points in was 
found to be equal to 92% indicating a strong confidence in the classification similarly 
to the first experiment.  
 
 
Figure 3-9: Posterior probability of fluorescence spectra from interrogated tissue sites 
belonging to their correct disease group (as classified by histopathology): control (252 
sites), moderate steatosis (258 sites), severe steatosis (102 sites). 
 
As in the first experiment, the classification accuracy obtained in the second 
experiment with the combination of the lasers did not exceed the classification 
accuracy obtained with 405 nm excitation alone (91 %), this suggests that the optical 
system could be simplified by keeping only the 405 nm laser diode, although the 
combination of the 375 nm and 405 nm might improve the classification performance 
of other liver diseases. The slightly lower classification accuracy obtained in the 
second experiment is probably due to smaller differences in the severity of the 
pathologies between the disease groups than in the first experiment as attested by  
the histopathological score gaps (0 , 2, 7 in the first experiment against 0, 4, 5-6 in 
the second experiment). 
3.5.3 Summary  
 
In conclusion, an excellent discrimination between the disease groups in both studies 
was obtained with fluorescence spectroscopy which was not feasible with ALT and 
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TBARS in the first experiment. The added advantage of fluorescence spectroscopy 
over these blood tests and the gold standard method of histopathology is its speed, 
as it is nearly real-time. In addition, one of the strengths of the SMLR algorithm lies in 
its capacity to provide the posterior probability of a sample to belong to a pathology 
group. According to the probability value of the sample, the clinician could decide to 
pursue or not further sample analysis. This would contribute to the diminution of the 
diagnosis procedure duration by exempting samples with low probability of being 
diseased from biopsy and histopathological examinations, if fluorescence 
spectroscopy is performed intraoperatively (for in vivo liver diagnosis or graft 
selection), or from histological examinations only if the technique is performed on 
freshly excised liver explants or biopsy material. 
3.6 Towards in vivo diagnostic of liver diseases with 
the joint use of the multi-excitation fluorescence 
spectroscopy probe and a robotic endoscope 
 
The study presents results from the work of Dr. David Noonan, Dr. Jianzhong Shang, 
and Chris Payne who designed and built the force adaptive robotic endoscope. Our 
contribution was to incorporate the fluorescence probe in this instrument as the 
endoscopic robot has the potential to greatly improve the intraoperative use of 
fluorescence spectroscopy.  
3.6.1 Motivation of endoscopic liver disease diagnosis and 
importance of the control of the pressure applied by 
the probe on tissue 
 
Transcutaneous and transjugular biopsies, sometimes guided by radiological 
modalities, are the preferred approaches of gastroenterologists to collect tissue from 
liver. There are, however, indications for endoscopic liver surgery including staging of 
cancer [13] and cirrhosis detection [45]. In spite of its lesser use, laparoscopic visual 
inspection of the liver followed by a forceps biopsy is generally considered as the 
best liver diagnosis method [45, 46] because it enables: 
• inspection of 85% of the liver surface area, 
• retrieval of larger size biopsies and therefore increased accuracy of the diagnosis 
(in a study regrouping 200 patients, 25 patients were diagnosed liver malignancies 
with laparoscopic biopsy, 8 of these were missed by ultrasound guided 
transcutaneous biopsy [47])  
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• monitoring for bleeding 
• inspection of liver’s neighbouring organs [45].  
It is also worth noting that technique stemming from natural orifice transluminal 
endoscopic surgery (NOTES) (less traumatic than the traditional transabdominal 
laparoscopic approach) still at the research stage, enabling sampling of liver biopsies 
via a transgastric approach of the liver [48]. 
A spectroscopic probe could be beneficial to endoscopic visual inspection of 
the liver to assess liver tissue state to diminish the number of unnecessary biopsies 
and help identify suspicious tissue areas, which will require a biopsy for histological 
confirmation. However, the in vivo use of spectroscopic probe has two main 
challenges, the accurate targeting of the site of interest and the control of the probe 
pressure applied to the tissue. The evaluation of the distance separating the probe 
from the tissue surface can be difficult through an endoscope and can result in an 
excessive force applied by the probe on the tissue. However, it has been 
demonstrated that rise of the probe contact pressure induced alterations in the 
spectra and in turn the diagnostic information extracted from them [49-51]. This is 
especially true for soft tissue with a low young modulus like liver, whose fluorescence 
and diffuse reflectance properties were shown to be affected by pressures above 
25.8 mN/mm2 [49]. It was also reported that a pressure superior to 9 mN/mm2 could 
impact the diagnosis of skin cancer with fluorescence and diffuse reflectance 
spectroscopy [50]. These spectral modifications have been explained by the creation 
of a local ischaemia at the tip of the probe, which affects the blood volume and 
oxygenation (and therefore the diffuse reflectance spectrum), as well as the tissue 
metabolism (and hence the fluorescence spectrum as the NAD(P)H and FAD are 
fluorophores involved in the electron chain transport) [49, 50].  
3.6.2 Enabling in vivo control of probe pressure applied on 
tissue and probe guidance 
 
To the best of our knowledge, there is no in vivo study where the probe pressure 
applied on tissue during the acquisition of spectra was monitored. A system 
consisting of a spectroscopic probe used in combination with a robotic endoscope 
(Figure 3-10) including a force sensor could permit such a procedure. Additionally to 
the force sensing capability, the articulated endoscope allowed for the probe 
accurate positioning and scanning over the tissue surface so that spectra could be 
continuously acquired over large areas. It was also possible to relocate the site 
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where each spectrum was acquired thanks to the evaluation of the position of the 
distal tip. 
 
 
Figure 3-10: (a) Force sensor mechanism including four main elements: a clamp (1) a 
linear motor which translates backward and forward the probe (2) the force sensor (3) 
housing (4), moving parts are indicated in red illustration of the robotic endoscope,  (b) 
the probe and the camera are also showed. From [52]. 
 
The endoscopic robot consisted of three serially attached sections linked to each 
other with two joints and connected to a 50 cm rigid aluminium tube with a third joint 
enabling to reach five degrees of freedom, each of them actuated by an embedded 
rotatory micromotor (Namiki Precision Jewel Ltd, Japan). In practice, the proximal 
and the medial joints were used to position the probe in a region of interest (ROI), 
while the distal joint was then employed to scan the probe in the surface of the 
chosen ROI. The position of the distal joint was assessed by counting the pulses 
emitting by the micromotor control electronics after each of its rotation. The 
endoscope contained three channels, one for motors driving electronics, one for the 
probe and one for a CCD video camera (Medigus Ltd, Israel) (Figure 3-10-b). The 
fluorescence spectra were acquired at 405 nm excitation with the system described 
in Figure 3-1.  
The fluorescence probe was fastened in a force sensor (ATI Industrial 
Automation, USA) measuring the load along the probe main axis. A linear actuator 
was utilized to move the probe forward towards the tissue surface. The joint driving 
motor controls, the linear actuator motor control, the CCD video camera and the 
fluorescence spectra acquisition were synchronised so that it was possible to identify 
the sites where fluorescence spectra and images have been recorded during the 
scanning of the probe.  
Camera 
Probe 
To distal tip 
(a) (b) 
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Three experiments were conducted ex vivo. In a first experiment, the system 
was used to acquire 405 nm excitation fluorescence spectra at different pressures 
from a liver and, in a second experiment, fluorescence spectra were continuously 
acquired while the robotic endoscope was scanning the probe above a phantom 
made up of alternative yellow and green fluorescent stripes. In the third experiment, 
the probe was scanned over a liver, with a constant pressure and spectra were 
recorded. Spectra were acquired with an exposure time of 1 ms when acquiring 
signal from the fluorescent dye phantom, and of 130 ms when recording spectra from 
liver tissue. 
3.6.3 Results and discussion 
 
In the first experiment, looking at the influence of the pressure on the acquired 
spectrum, the probe was advanced towards the liver until a distance of approximately 
1 mm separated the tip of the probe from the liver, a spectrum and a picture from the 
CCD video camera were then acquired (referred to as “non-contact”), the probe was 
then moved forward further and its pressure on the tissue was increased by 
increment of 10 mN from 0 mN to 150 mN. Figure 3-11 shows the fluorescence 
spectra for the non-contact case and for the pressures 50 mN, 100 mN, and 150 mN, 
together with the simultaneously acquired CCD video camera images, which enabled 
to note the gradual tissue deformation with increasing pressure. In addition to the 
autofluorescence signal which reached a maximum at 510 nm, additional peaks 
originating from the ambient light back reflected from tissue and particularly visible at 
490 nm, 540 nm, 595 nm and 670 nm could be observed. Their intensity decreased 
with the pressure and almost disappeared at 150 mN. Another observation was that 
the peak intensity slightly increased with pressure from 7.10-3 a.u. at 50 mN to 7.9.10-
3 a.u. at 150 mN.  
In a previous study [49] (see section 3.6.1), it was found that pressures per 
area unit above 25.8 mN/mm2 could affect liver spectral characteristics in vivo; this 
corresponds to a pressure of 81 mN in this work given that the diameter of our probe 
was 2 mm, yet the parasite ambient light peaks were still present at 100 mN. This 
suggests that during the spectra acquisition, endoscopic light source should be 
switched off, which would deprive the surgeon of visual feedback. Alternatively, a 
background spectrum acquired with the laser light turned off could be acquired and 
then subtracted from the fluorescence spectrum. Of note, the shape of the 
fluorescence spectra barely changed (apart from the magnitude of the ambient light 
peaks) from 50 mN to 150 mN. The ex vivo nature of this study makes this 
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observation difficult to interpret as the main modifications of fluorescence spectral 
features with pressure arise from alteration of blood volume and oxygenation as well 
as metabolism change which can only occur in in vivo conditions. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 3-11: (a) Fluorescence spectra acquired at 0 (non-contact), 50, 100 and 150 mN 
and (b) the corresponding images acquired by the video camera. From [52]. 
 
In the second experiment, a phantom with spatially varying fluorescence properties 
consisting of 1.5 mm large green and yellow dye stripes separated by 1.5 mm gap 
was created and fluorescent spectra were acquired while the probe was scanned 
with the robotic endoscope. In Figure 3-12, three sets of measurements consisting in 
the spectra from each of the six emission fibres, an image from the onboard CCD 
video (top-right) camera, and an image recorded with a second external camera (top 
left) were acquired at different points of the trajectory described clock wisely by the 
probe above the phantom. The first point in the trajectory was situated in a green dye 
band, whose spectrum had a main peak at 505 nm and a secondary peak at 640 nm. 
(a) 
(b) 
100 mN 
Non- contact 50 mN 
150 mN 
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The second point lied in a “white band” namely paper, which peaked at 460 nm. The 
last point showed had the particularity to be positioned at the boundary of a paper 
band and yellow dye band: fibre 1 and fibre 2 were in the paper stripe, fibre 4 and 
fibre 6 were lying exactly at the frontier between the two bands as their fluorescence 
spectrum included two peaks, one at 460 nm corresponding to the paper 
fluorescence, and one at 510 nm corresponding to the yellow dye fluorescence. 
Finally, fibre 3 and fibre 6 were situated in the yellow stripe. Consequently, because 
the spectrum acquisition and the robot driving motor were synchronised, it was 
possible to locate the boundary between two tissue regions of different fluorescence 
properties. This could be exploited in the future to locate the transition between 
normal and diseased tissues whose fluorescence properties differ with healthy tissue.  
Of note, the peaks caused by the ambient light back-reflection were not 
visible in this experiment as opposed to the previous one because the set exposure 
time was 1 ms, that is ten times smaller than the previous time experiment which is 
too short for the ambient light parasite signal to be recorded.  
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Figure 3-12: Fluorescent spectra acquired by the 6 emission fibres at different points 
along the probe trajectory traced clock wise (as indicated by the red arrow) on the 
phantom consisting of yellow and green fluorescent stripes separated by white paper 
stripes. Measurement sequences at 3 points along the trajectory are detailed each 
consisting of a fluorescence spectrum (bottom), an onboard camera image (top-right) 
and an external camera image (top-left). From [52]. 
 
The third experiment was similar to the previous experiment, except that it was 
performed on a liver and no secondary exterior camera was used. The probe was put 
in contact with the liver tissue with a 40 mN pressure and scanned along the 
trajectory presented in Figure 3-13 where the spectra and corresponding images are 
shown at five points of the probe displacement. The maximum intensity of the 
fluorescence peak remained stable at 8.10-3±1.5.10-4 a.u., indicating a steady probe 
pressure along the trajectory. The intensity of the ambient light peaks varied between 
the points, it might originated from local differences in the tissue surface topology or 
 83
stiffness, which caused the probe to bury more or less, impacting therefore its 
isolation from the ambient light. 
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Figure 3-13: Fluorescent spectra acquired by each of the six emission fibres at 
different points along the probe trajectory on liver and their corresponding images 
acquired by the onboard camera. From [52]. 
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3.7 Conclusion 
 
In summary, we have built a compact dual excitation spectroscopy system using 
laser diodes and a fibre probe that can be used minimally invasively with 
endoscopes. Fluorescence spectra at two excitation wavelengths were recorded from 
healthy, steatotic and steatohepatitic mice and analysed with SMLR. Classification 
accuracies above 90% in the two experiments with strong confidence (mean 
posterior probabilities above 90 % in both studies) in the classification were obtained, 
which supports the use of a spectroscopic probe as a tool to quickly assess liver 
tissue graft ex vivo or in vivo at harvest. Another possible promising application could 
be to use the spectroscopic probe instead of needle biopsies during transjugular 
procedures.  
In a second time, the same spectroscopic probe was used together with a 
force sensitive articulated robotic endoscope. This system offers the possibility to 
circumvent obstacles to reach a region of interest and to perform on it pressure 
controlled series of spectral acquisitions, opening the door to in vivo wide area 
covering spectroscopy. Importantly, it was possible to reconstruct the probe trajectory 
and relocate to a site where a spectrum of interest was previously acquired. A 
significant application of this system would be cancer tumour delineation.  
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Chapter 4  
 
Combined fluorescence and 
reflectance for GI tract tissue 
analysis 
 
Fluorescence and diffuse reflectance light contain complementary information. The 
former informs about the fluorophores’ distribution, while the latter provides 
biostructural information such as the scatterers size and density, as well as 
chromophore concentration. Our major aim here was to evaluate and compare the 
diagnostic ability for usual pathologies (inflammation, dysplasia, Barrett’s 
oesophagus, cancer) of upper (oesophagus and oesophagus/stomach junction) and 
lower (colon and rectum) of the two modalities and assess if their combination 
enabled enhancement of the spectroscopic diagnostic accuracy. Furthermore, results 
from this study enabled the selection of adequate filters used in a spectrally resolved 
laparoscope designed for oesophagus tumour imaging. The move towards imaging 
(see chapter 5) subsequent to the single point approach followed in this chapter was 
prompted by the need to assess the spatial extent of tumours. As opposed to 
NALFD, uniformly spread over the liver, tumours are localized. The knowledge of 
their boundary is necessary to ensure a complete removal. 
A combined fluorescence-diffuse reflectance spectroscopy system is 
presented. Measurements have been first performed on a phantom with known 
spectral characteristics to test the diffuse reflectance channel of the system. 
Fluorescence and diffuse reflectance spectra have then been recorded from upper 
and lower GI biopsies with various conditions. The performance of both modalities in 
separating normal biopsies from the diseased ones have been evaluated using an 
algorithm computing the pair of wavelengths whose ratio maximizes the 
discrimination followed by a cross-validation performed with SMLR. The wavelength 
pair selected to discriminate oesophageal normal tissue from the cancer tissue 
enabled to select bandpass filters used during oesophageal tumour imaging 
presented (see chapter 5). 
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4.1 Diagnosis of diseased tissue in the upper and 
lower GI 
 
Upper and lower GI diseases including pathologies such as inflammation, Barrett’s 
oesophagus (a precursor pathology of oesophageal adenocarcinoma), dysplasia and 
cancers are a significant cause of morbidity and mortality. For instance, 7,966 people 
were diagnosed with oesophageal cancer in 2007 in the UK, making it the ninth most 
common cause of cancer, and just under 40,000 people were diagnosed with colorectal 
cancer in 2008 in the UK (third most common cause of cancer. The five years survival 
rates were 8% and 50% respectively [1, 2].  
Improved survival depends on early detection and monitoring of these 
lesions, which can subsequently be managed at an early stage with surgery, 
chemo/radiotherapy or even novel new endoscopic therapies [3]. The current gold 
standard for detecting disease and cancers of the upper and lower GI system is 
visualization via conventional white light endoscopy, selection of biopsy sites by the 
endoscopist, followed by histological examination of those biopsies. However, this 
approach presents several limitations already mentioned in chapter 2, which are: 
difficulty to visualize precancerous lesions both in the upper GI [4] and the lower GI 
[3]; subjectivity, potentially leading to sampling error; time taken to process the result, 
which delays the diagnosis [5]. 
CT scan of the abdomen and pelvis is another lower GI cancer diagnosis 
technique, used mainly in elderly patients, as it is non-invasive. Problems arise when 
occasional spasms of the right side of the abdomen produce an abnormal image, 
which mimics the appearance of cancer [6]. Faecal occult blood testing is used to 
screen for colorectal cancer as it is safe and inexpensive. However the sensitivity of 
the test is low as not all cancers bleed, and therefore the test is negative in 50% of 
cancers [7]. 
Fluorescence and diffuse reflectance spectroscopy appear to be an ideal 
complement to endoscopy since fluorescence serves as an indicator of tissue 
biochemistry and diffuse reflectance provides morphologic information on tissue 
biostructure. Both offer the possibility to be performed with an optical fibre small 
enough to be inserted through the endoscope working channel. The fluorescence 
and diffuse reflectance spectroscopy in combination with endoscopy could help the 
surgeon to quickly determine the state of a tissue site without the need to remove it 
and to perform histopathology.  
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4.2 Fluorescence-diffuse reflectance setup 
4.2.1 System description, data acquisition, and processing 
 
The fluorescence-diffuse reflectance spectroscopy system is mainly an extension of 
the dual-fluorescence spectroscopy system presented in chapter 3, where a 
tungsten-halogen lamp (model HL2000HP232R ,Ocean Optics, Inc., USA) has been 
added in addition to the two laser diodes and acts as the diffuse reflectance light 
source. Only the elements differing from the dual-fluorescence system are described 
here. 
The probe (Leoni Fiber Optics, Inc., (previously Romack, Inc.), USA) has 
been modified and consists in two excitation fibres, one for delivering the 
fluorescence light to the sample, and the other for white light conveyance and one 
detection fibre for both fluorescence and diffuse reflectance light collection (Figure 
4-1). The diameter and NA of the three fibres were 400 µm and 0.22 respectively and 
the total diameter of the probe distal tip was 2 mm. Unlike the previous probe, this 
one did not contain a glass window (whose function was to enable excitation and 
emission beams overlap and hence maximising the amount of collected light), 
because white light from the tungsten-halogen lamp would be reflected at the glass 
surface and hence introduce parasitic light in the emission fibre. 
 
Figure 4-1: Fibre arrangement at the distal end of the probe consisting of two 
illumination fibres, one for each modality, and a detection fibre. 
 
The proximal end was divided into three arms, each containing one fibre and 
each terminated with a SMA connector; the first one was connected to the laser 
system, the second one to the tungsten-halogen source and the last one to the 
spectrograph/ CCD unit (Figure 4-2). The measured optical powers at the tip of the 
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probe for the 375 nm laser diode, 405 nm laser diode and the tungsten-halogen light 
source were 3.5 mW, 2.1 mW and 2.5 mW respectively.  
 
 
 
Figure 4-2: Fluorescence- diffuse reflectance system featuring an additional white light 
tungsten-halogen lamp in addition to the two laser diodes of the dual-excitation 
fluorescence system presented in chapter 3. 
 
A LabVIEW program enabled control of the camera settings and the 
sequential acquisition of florescence and reflectance spectra.  
The fluorescence spectra were processed as described in section 3.4.2 and 
the spectra measured under white light illumination were divided by the spectrum of 
a spectralon reflectance standard (Labsphere, Inc., USA) to produce the diffuse 
reflectance spectra. 
4.2.2 System testing on a colour chart  
 
Spectral accuracy, understood here as the similarity between measured and real 
spectra, has been evaluated for the diffuse reflectance channel (the fluorescence 
channel has been already assessed in chapter 3) to validate the data calibration and 
processing procedures to produce the diffuse reflectance spectra. 
To do so, a Macbeth chart (X-rite, Inc., USA) was chosen as phantom. It is a 
colour chart used to calibrate digital cameras. It comprises of 24 patches of different 
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standardized colours (Figure 4-3) numbered between 1 and 24 from left to right and 
from top to bottom. In order to test the diffuse reflectance spectral accuracy, the 
spectrum of each colour patch was measured and compared with the average 
spectrum from a database including twenty spectra recorded by different users (and 
referred to as mean database spectra in the rest of this paragraph) [8]. 
 
 
Figure 4-3: Standard colour chart containing 24 patches with standardized colours. (X-
rite, Inc., USA) 
The measured spectra and the mean database spectra are shown in        
Figure 4-4. The overlap was excellent for the grey patches (last row), demonstrating 
the system high spectral accuracy. Minor divergences, mostly in the 700 nm - 750 
nm spectral domain, appeared in the patches 5-8-10-12-17. Interestingly, the 
variability of the data base spectra in this domain was higher than in the rest of the 
spectrum as shown by the larger errors bars. It is important to remember that the 
mean database spectra are by no mean reference spectra and therefore the 
dissimilarities between them and our measured spectra can originate from 
inaccuracies in our measurement protocol and setup, as much as in theirs.  
Instead of using the similarity function (see chapter 3) to quantify the system 
spectral accuracy, the sRGB values (sRGB being one of the several RGB colour 
spaces) of each colour patch have been computed from the recorded spectra and 
compared with the sRGB values provided by the manufacturer. This has been done 
in two steps: the spectral data were first transformed in the CIE (Commission 
Internationale de l’Eclairage) 1931 XYZ colour space using the three relations of the 
Equation 4-1 which, for discrete spectral data acquired by reflection, are written as 
follows [9]: 
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Where zyx ,,  are the CIE 1930 colour matching functions, S the spectrum measured 
from the chart, I the spectrum of a reference illuminant (chosen to be D65 because, 
subsequently, the XYZ values were converted in the sRGB colour space whose 
reference illuminant is D65 that is a black body heated at 6500 K). This conversion is 
done using Equation 4-2 [10]: 
 




















−
=










Z
Y
X
B
G
R
0572252.12040259.00556434.0
0.04155601.87601080.9692660-
0.4985314-1.5371385-3.2404542
 Equation 4-2 
 
At the conclusion of the XYZ to sRGB conversion process, negative results and 
results above 255 were set to 0 and 255 respectively. It is commonly the case that 
the R value of the patch 18 produces negative values (found to be equal to -40 here) 
and this was set to zero and ignored in the error calculation.  
Table 4-1 summarises the sRGB values round to the nearest integer obtained 
from the reflectance spectra, together with the manufacturer’s ones. The percent 
errors (ratio of the absolute difference between the manufacturer’s data and the 
measured ones multiplied by 100) have been calculated for each of the sRGB values 
and averaged to produce the averaged error for every colour patch. The mean error 
ranged from 0.3 % (patch 20) to 27.8 % (patch 13). This was caused by 
inexactnesses of the spectral measurements but also by the conversion process from 
XYZ to sRGB values, which introduced additional errors due to the approximation of 
the conversion matrix constants [11].  
The total mean error was found to be equal to 5.6% when averaged over the 
24 colour patches indicating a good accuracy in the reproduction of the reflectance 
spectra of the colour patches by the reflectance channel of the spectroscopic setup.  
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4.3  GI diseased tissue diagnosis with fluorescence 
and reflectance spectroscopy 
 
The general goal of this study was to evaluate the ability of fluorescence, diffuse 
reflectance spectroscopy, as well as the combination of the two to discriminate 
different types of tissue in the upper and lower GI. This has been done by using the 
setup described in Figure 4-2 to record spectra of biopsies resected from 
oesophagus and oesophagus/stomach junction (Upper GI) and colon and rectum 
(lower GI). This study was conducted in collaboration with Mr. Shalil Solanki, Mr. 
Hussain Selmi, Iakovos Amygdalos, and Pr. George Hanna, who provided tissue 
samples and realised spectroscopy measurements. 
4.3.1 Study design and measurements protocol 
 
The Royal Free Hospital and Medical School Research Ethics Committee granted 
ethical approval for this study. Written informed consent was obtained from patients 
undergoing an upper GI and a lower GI endoscopy at St Mary’s Hospital, 
Paddington. Biopsies were only taken at the discretion of the endoscopist, and no 
additional biopsies were taken for the pure purpose of research in accordance to the 
consent form. 
 Biopsies were placed in normal saline, in order to maintain hydration. They 
were all measured when fresh with the fluorescence/diffuse reflectance setup prior to 
being fixed in formal saline and stained using standard histological procedures. 
During the measurements, the probe was placed in gentle contact with the tissue. 
Fluorescence and reflectance spectra were sequentially acquired with exposure 
times varying between 100 ms and 300 ms for fluorescence and 10 and 50 ms for 
reflectance. Since the 405 nm laser diode broke down at the start of this study, only 
fluorescence at 375 nm excitation was acquired. Consequently, it has not been 
possible to check whether, unlike the NAFLD studies (chapter 3), the combination of 
two excitations wavelengths would allow the enhancement of the classification 
performance. 
Spectra were recorded between 450 nm and 750 nm with a spectral 
resolution of 2.9 nm leading to a total of 103 spectral features for each spectrum. 
A total of 71 spectra were recorded from 19 patients in the upper GI and 66 
spectra from 15 patients in the lower GI. In some pathology groups, the number of 
spectra and patients differed between fluorescence and reflectance which was 
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caused by the shape and dimensions of the samples. As illustrated Figure 4-5, GI 
tract biopsies have the form of a thin filament so that in some instances the biopsy 
was only cover by the detection fibre and one of the illumination fibre (fluorescence 
or reflectance) leading to an incomplete dataset consisting of only one spectrum of 
two  
 
 
Figure 4-5: Cross-section (top view) of a probe-sample configuration where only the 
detection and fluorescence illumination probes are in contact with the sample causing 
an incomplete measurement sequence where the diffuse reflectance spectrum is 
missing. 
 
Nevertheless, one of the aims of this work was to assess whether the combination of 
the two modalities could increase the spectroscopic diagnostic power which meant 
that only the biopsies for which both fluorescence and reflectance spectra had 
recorded were considered for this part of the study. Table 4-2 shows the breakdown 
of spectra and patients by modalities in the upper and lower GI. Classification 
accuracy could then be obtained with fluorescence only, reflectance only and the 
combination of both.  
 
Table 4-2: Number of spectra recorded and patients investigated with each modality 
and their combination. 
spectra # patients # spectra # patients # spectra # patients #
Upper GI 35 17 36 19 29 15
Lower GI 42 15 31 13 28 12
Fluorescence Reflectance Combined
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4.3.2 Data classification 
 
The spectra were processed in two steps, the first one involving a receiving operating 
characteristic (ROC) analysis for feature selection, and a second one using the 
SMLR algorithm to perform the classification of the spectra into normal or diseased 
classes. ROC analysis plots the sensitivity versus 1-specificity obtained with a binary 
classification scheme using a numerical variable to separate the two classes with 
different thresholds of separation. The area under the ROC (AUC) is a measure of 
the performance of the classification algorithm in discriminating two classes. An AUC 
of 0.5 indicates a non-existent discrimination and an AUC of 1 signifies a perfect 
discrimination [12]. Spectra from the two classes to be distinguished were analyzed 
with an algorithm developed in our group by Tobias Wood. It enabled the selection of 
the pair of wavelengths whose ratio maximized the AUC. Secondly, a SMLR 
classification was performed on the intensity ratios (or pair of ratios when evaluating 
the combination of the two modalities) obtained following the ROC analysis using a 
leave-one-out cross validation. This type of cross validation is equivalent to a K-fold 
cross validation (see section 3.4.1) where K would be equal to 1. This means that the 
intensity ratios of the site to be classified was excluded from the training set during 
the classifier learning, which was then used to classify the excluded sample. This 
process, repeated on all the sites, allowed assessment of the classification accuracy 
in an optimal way since all the samples of our restricted dataset were used for the 
classifier training and in an unbiased manner since test and training sets were 
separated. 
  This procedure has been applied for computing the sensitivity, specificity, 
positive and negative predictive values obtained with fluorescence only, reflectance 
only and the combination of the two modalities for distinguishing the disease groups 
in the upper and lower GI.  
4.3.3 Results and discussion 
 
Following histopathological procedures, upper GI biopsies were diagnosed with 
conditions including inflammation, Barrett’s oesophagus and cancer in the upper GI 
(Table 4-3). Pathologies such as inflammation and dysplasia were detected in the 
lower GI (Table 4-4). 
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Table 4-3: Distribution of biopsies as classified by histopathology in the upper GI. 
spectra # patients # spectra # patients # spectra # patients # spectra # patients #
Fluorescence 10 7 13 7 9 2 3 1
Reflectance 12 8 13 8 8 2 3 1
Cancer Normal  Inflammation Barrets
Upper GI
 
 
Table 4-4: Distribution of biopsies as classified by histopathology in the lower GI.  
spectra # patients # spectra # patients # spectra # patients #
Fluorescence 24 9 12 3 6 3
Reflectance 19 7 8 3 4 3
Dysplasia
Lower GI
Normal  Inflammation
 
 
Figure 4-6-a shows the mean normalized fluorescence and reflectance spectra 
collected from the upper GI biopsies for healthy tissue (blue line), inflamed tissue 
(red line), Barrett’s oesophagus (green line) and cancer tissue (black dotted line) 
alongside the standard error displayed every 10 nm. The fluorescence spectra were 
found to peak in the band 450 nm – 465 nm. For comparison, tissue sites in the 
oesophagus have been found to peak at 415 nm and 470 nm when excited at 337 
nm and 397 nm respectively [13], and around 500 nm when excited at 410 nm [14]. 
The endogenous fluorophores flavins and porphyrins both absorbing at 375 nm and 
emitting in the 520-540 nm range and between 590 nm and 650 nm, respectively, are 
among the fluorophores likely to contribute to the oesophagus fluorescence. The 
cancerous spectra were most obviously different from the others. Its normalized 
fluorescence intensity is relatively lower than the other groups in the blue-green 
region and higher in the red. Also, its total non-normalized integrated intensity was 
significantly lower than the others, 5.1 times smaller than the normal one, for 
instance. These two observations have been commonly made (see section 2.1.6) 
when comparing tumours to healthy tissue in a variety of organs, in particular in the 
oesophagus [14], and have been linked to differences in the distribution and 
oxidation states of the coenzymes NADH and FAD between normal and cancerous 
tissue [15, 16]. 
Reflectance spectra exhibited characteristic dips at 540 nm and 570 nm 
caused by haemoglobin absorption (Figure 4-6-b). Differing haemoglobin absorption 
between tissue types were difficult to interpret due to the ex vivo nature of this study. 
The normal tissue mean spectrum had a lower intensity in the 450 nm – 575 nm 
band than in the diseased group spectra which is in accordance with what has been 
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observed in a previous study looking at dysplasia and cancer detection in the 
oesophagus with diffuse reflectance spectroscopy [17]. 
 
 
 
Figure 4-6: Mean (a) fluorescence and (b) reflectance spectra of upper GI tissues. Error 
bars represent standard deviation. 
 
Lower GI fluorescence spectra are shown Figure 4-7-a (healthy group in blue, 
inflammation group in red, and dysplasia group in green), they reached a maximum 
at around 470 nm. Fluorescence spectra obtained following a study aimed at 
separating healthy tissue from hyperplastic and cancerous tissue with 370 nm 
excitation were previously found to climax at 465 nm [18].  
NAD(P)H, whose maximum intensity is at 475 nm, has been shown to 
contribute to colonic fluorescence [19]. Contrary to the upper GI reflectance spectra, 
normal reflectance spectra from the lower GI had higher intensities than the spectra 
of diseased groups from 450 nm to 600 nm. The normal and dysplasia spectra 
intersected at 601 nm. A similar observation has been noted in a preceding analysis 
where the mean diffuse reflectance intensities of colonic dysplastic polyps was found 
to be smaller than the normal tissue intensities until 605 nm where the two spectra 
crossed [20]. 
 
 
Figure 4-7: Mean (a) fluorescence and (b) reflectance spectra of upper GI tissues and 
mean fluorescence. Error bars represent standard deviation. 
(a) (b) 
(b) (a) 
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The classification procedure was performed to distinguish (1) the healthy 
group from each of the diseased group in the upper GI (Inflammation, Barrett’s 
oesophagus, cancer); (2) the cancer group from all the other groups (normal, 
Barrett’s oesophagus, inflammation) in the upper GI; (3) the healthy group from each 
of the diseased group in the lower GI (inflammation and dysplasia); and (4) the 
dysplasia group from all the other groups (normal and inflammation). 
Table 4-5 summarises the wavelengths pair obtained after ROC analysis, 
whose intensity ratio maximised the area under the ROC curve. When analysing 
these results, it is important to remember that this feature selection technique was 
based on ratios of intensities that measures proportional changes between spectra of 
two different classes. Therefore, even though there were wavelengths at which two 
spectra appeared visually well separated, there might be some other spectral region 
where this difference was proportionally higher. This explains the selection of the 
wavelength pairs (662 nm, 697 nm) and (659 nm, 697 nm) as optimal wavelengths to 
discriminate normal sites from inflamed tissue and Barrett’s oesophagus, 
respectively, instead of wavelengths in the 450 nm - 500 nm region where the 
spectra overlap seemed less important. 
The classification accuracy averaged over all the classifications in the upper 
and lower GI and over the two modalities was found to be equal to 81%. It is 
interesting to note that using the full spectra instead of the intensity ratios at the 
selected wavelengths yielded a classification accuracy of 82%. Consequently, the 
use of the 88 spectral features constituents of each spectrum did not significantly 
improve the classification. In fact, when the training sample set is small compared to 
the number of classification variables, as is the case here (24 training samples at the 
most -see Table 4-4- against 88 spectral features for single modality spectra and 176 
features for the combined spectra), added features do not necessarily improve and 
can even diminish classification performance. This is referred as the “curse of 
dimensionality” [21]. 
 In the rest of the chapter, the diagnosis performance was evaluated with the 
intensity ratios only (and not with the full spectrum).  
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Table 4-5: Pairs of wavelength chosen after ROC analysis. 
Fluorescence Reflectance
Normal  vs Inflammation 662, 697 497,613
Normal vs Barrets  659, 697 451, 531
Normal vs Cancer 491, 662 605, 676
Cancer versus Normal, Barret's, 
Inflammation
491, 546 448, 514
Normal  vs Inflammation 526, 572 526, 563
Normal vs Dysplasia 592, 630 549, 580
Dysplasia versus Normal, 
Inflammation
581,627 613,647
Pair of wavelengths (nm)
Upper GI
Lower GI
 
 
The performance of fluorescence, diffuse reflectance and the combination of the two 
in separating pathologies are presented in Table 4-6. This shows the sensitivity, 
specificity, PPV and NPV obtained following classification of the selected intensity 
ratios. The best outcomes obtained for each classification are highlighted in bold.  
Following classification of normal tissue versus cancer tissue and 
classification of cancer sites versus normal, Barrett’s oesophagus and inflamed sites 
with diffuse reflectance data, all the normal sites were correctly classified, yet all the 
cancer sites were misclassified, which led to a sensitivity equal to 0 and NPV equal 
to zero divided by zero, hence the grey box in the NPV column. 
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Table 4-6: Sensitivity, specificity, positive and negative predictive values obtained after 
SMLR leave-one-out cross validation with fluorescence, diffuse reflectance and the 
combination of the two. Modalities providing the best results for each classification are 
indicated in bold. Grey boxes indicate undefined negative predictive values. 
Sensitivity Specificity PPV NPV
Fluorescence 75 60 60 75
Reflectance 50 80 67 50
Combined 75 70 67 78
Fluorescence 75 88 86 78
Reflectance 88 88 88 88
Combined 75 100 100 80
Fluorescence 100 100 100 100
Reflectance 100 0 73
Combined 100 100 100 100
Fluorescence 100 67 96 100
Reflectance 100 0 90
Combined 96 67 96 67
Fluorescence 94 71 89 83
Reflectance 94 57 85 80
Combinated 89 71 89 71
Fluorescence 94 100 100 80
Reflectance 94 50 89 67
Combined 94 100 100 80
Fluorescence 100 75 96 100
Reflectance 96 34 89 50
Combined 100 75 96 100
Dysplasia versus Normal, 
Inflammation
Upper GI 
Lower GI
Normal   versus Inflammation 
Normal versus Barret's 
Normal versus Cancer
Cancer versus Normal, Barret's, 
Inflammation
Normal  versus Inflammation 
Normal versus Dysplasia 
 
 
Fluorescence spectroscopy outperformed diffuse reflectance spectroscopy in five out 
of seven classifications. The two cases where diffuse reflectance performed equally 
or better than fluorescence were, respectively, to distinguish normal from inflamed 
sites and normal oesophageal tissue from Barrett’s oesophagus tissue sites. 
Fluorescence has the advantage of the biochemical specificity over diffuse 
reflectance, because it probes the tissue fluorophore distribution, yet a more likely 
explanation of the fluorescence superior performance lies probably in the ex vivo 
nature of this work, which implies a disruption in the blood flow in the investigated 
tissue sites. This impacts the haemoglobin oxygenation and concentration, both of 
which contribute to the diffuse reflectance spectrum shape as mentioned earlier. Yet 
tissue oxygenation and vascularisation have been shown to be important disease 
markers especially for tumours, which might help to explain the impossibility to 
recognize cancerous sites in the upper GI with diffuse reflectance data [22]. Overall, 
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the highest classification accuracy using fluorescence data was obtained when 
separating normal upper GI sites from cancerous ones (with sensitivity, specificity, 
PPV, NPV of 100%). The lowest accuracy was when discriminating normal upper GI 
sites from inflamed ones (sensitivity, specificity, PPV, NPV of 75%, 60%, 60%, 75% 
respectively). This is expected since cancer entails the most dramatic changes in the 
tissue biochemistry; however the results of this classification in particular need to be 
confirmed on a larger patient population as the spectra of cancerous sites have been 
recorded from only three sites of a single patient.  
The perfect classification accuracy obtained for differentiating upper GI 
cancerous sites from normal sites slightly decreased when comparing cancerous 
sites from normal, Barrett’s oesophagus and inflamed sites (sensitivity, specificity, 
PPV, NPV of 100%, 67%, 96%, 100% respectively). It was noted in another study 
that inflamed upper GI sites were responsible for a decrease of the NPV when 
separating high grade dysplasia from low-grade and non-dysplastic tissue with 
fluorescence [23]. 
In the lower GI, fluorescence was found to be better at discriminating normal 
sites from dysplastic ones than separating normal sites form inflamed ones, while 
diffuse reflectance provided similar performances in the two classifications. The 
classification accuracy obtained for differentiating lower GI dysplastic sites from 
normal sites with fluorescence (sensitivity, specificity, PPV, NPV of 94%, 100%, 
100%, 80% respectively) dropped only marginally when discriminating dysplastic 
sites from normal and inflamed sites (sensitivity, specificity, PPV, NPV of 100%, 
75%, 96%, 100% respectively). 
Direct comparisons between studies are always difficult because of the 
differences in the sample pool size, the instrumentation, and the data processing. 
However, it is interesting to situate these results in relation with previous work. An in 
vivo study involving 16 patients, fluorescence spectra from oesophagus tissue 
excited at 337 nm enabled discrimination of normal and low grade dysplasia from 
high grade dysplasia tissue with sensitivity and specificity of 100% and 98% 
respectively, both of which decreased at 79% and 88% when separating low and 
high grade dysplasia from normal tissue [13]. Another in vivo fluorescence 
spectroscopy analysis looking at 24 patients at 330 nm excitation reached a 
sensitivity of 86% and a specificity of 95% to differentiate normal Barrett’s 
oesophagus sites from neoplastic ones [24]. Sensitivity and specificity of 92% and 
60% respectively were obtained with diffuse reflectance to distinguish cancer and 
high-grade dysplasia from normal tissue and low-grade dysplasia in an ex vivo study 
with 81 patients presenting Barrett’s oesophagus [17]. 
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Fluorescence spectra recorded at 370 nm excitation from twenty patients in 
vivo in the colon permitted differentiation of adenoma (benign tumour) from normal 
and hyperplastic sites with sensitivity, specificity and PPV of 100%, 97% and 94% 
respectively [18]. Another in vivo fluorescence spectroscopy analysis performed with 
spectra at 337 nm excitation from 86 normal colonic sites, 35 hyperplastic polyps, 49 
adenomatous polyps, and 7 adenocarcinomas led to sensitivity, specificity, PPV and 
NPV of 80%, 92%, 82%, and 91% respectively to distinguish neoplastic sites from 
non-neoplastic sites [25]. 
Finally, the combination of fluorescence and diffuse reflectance showed better 
performance than the two methods taken separately in two classifications: normal 
versus inflammation and normal versus Barrett’s oesophagus both in the upper GI, 
indicating that the combined optical modality approach is required when it comes to 
accurately discriminate inflamed or Barrett’s oesophagus tissue from normal ones. 
The combined modalities performed as well as fluorescence alone in all the other 
classifications except the normal versus inflammation classification in the lower GI. 
Even if the combination of fluorescence and diffuse reflectance spectroscopy seems 
natural, the diagnostic improvement brought by this method led to mixed results in 
previous studies and seems to be organ and pathology dependent. In a study looking 
at classifying invasive ductal carcinoma, fibroadenoma and normal tissue in the 
breast, the overall individual classification accuracies of fluorescence and diffuse 
reflectance were improved from 71% and 72% to 84% with the combined use of 
fluorescence and diffuse reflectance [26]. In another breast study, the combined 
modalities approach did not performed better than fluorescence alone at classifying 
malignant and non-malignant tissue [27]. In a work classifying normal, inflamed and 
cancerous pancreas tissue, combined fluorescence and diffuse reflectance only 
slightly improved the classification performance [28]. 
4.4 Conclusion  
 
In this chapter, the development of a combined fluorescence and diffuse reflectance 
has been presented. Diffuse reflectance spectra were acquired with a standard 
colour chart, and the sRGB values retrieved were compared with the manufacturers’ 
values. The total percentage error between the data sets was found to be equal to 
5.6%.  
This system was then used to acquire fluorescence and diffuse reflectance 
spectra from upper and lower GI tissue with various conditions. A two step algorithm 
has been developed to select spectral features that discriminate between pathology 
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groups and their diagnostic power has been assessed by cross-validation using the 
same SMLR classifier that was used in chapter 3 to categorize liver tissue. This 
approach yielded an overall 81% classification accuracy. Also, the combined used of 
fluorescence and diffuse reflectance enabled discrimination of normal upper GI tissue 
from inflamed tissue and the differentiation of normal tissue from Barrett’s 
oesophagus sites superior to the discrimination provided by these modalities taken 
separately showing the value of the combined modality approach. This study has 
been conducted on biopsies from a very limited number of patients. Increasing the 
patient pool is required to confirm the diagnostic power of fluorescence and diffuse 
reflectance spectroscopy. However this work provides solid reasons to believe that 
fluorescence and diffuse reflectance spectroscopy could be a valuable tool to assist 
clinicians in upper and lower disease detection. 
This study has been conducted ex vivo on biopsies, but one of the 
advantages of biophotonic techniques is that they can probe tissue in vivo by 
introducing the spectroscopic probe into the working channel of endoscopes. Some 
challenges will have to be overcome to ensure they can be used in a clinical theatre 
in combination with endoscopy as pointed out in [29]. For example, the re-localisation 
of a suspicious site highlighted by spectroscopy for a confirmatory biopsy can turn 
out to be difficult because of the small field of view of endoscopes and the movement 
in the GI caused by the heartbeat. Also, it takes time to switch between optical probe 
and the biopsy forceps, most of the endoscopes having only one working channel. In 
addition, oesophagus and colon are narrow, which means probes can approach the 
surface of the mucosa with a limited angle. To solve this problem, it has been 
proposed to use a “side-view” probe where optical fibres were cut at 45˚ to illuminate 
and collect light at 90˚ [22]. 
Finally, the spectral feature selection performed in this study has enabled the 
choice of suitable emission filters that will be used in chapter 5 in combination with a 
laparoscope to translate the spectroscopic point limited measurements into imaging 
for tumour extent assessment. 
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Chapter 5  
 
Fluorescence and Diffuse 
Reflectance Laparoscopic 
Imaging for Oesophagus Tumour 
Resection Guidance and Nerve 
Localisation  
 
So far in this work, tissues have been probed with spectroscopic systems furnishing 
rich spectral information at one point only. As it will be detailed in this chapter, the 
knowledge of the extent of a lesion is, in several situations, a crucial piece of 
information to assess its cause and severity and to cure it. Another medical 
application prompting the need of spatial information is the localisation of some type 
of tissue that are difficult to spot during surgery, but essential to situate not to 
damage them. An evolution from probe-based spectroscopy to optical imaging which 
combines spectral and spatial information is consequently required. The optical 
components enabling this transition are presented. Their performance in terms of 
spectral and spatial resolution, acquisition time, optical transmission, and 
compactness are compared in order to select the dispersive system adequate to our 
applications. Then, a brief description of minimally invasive surgery (MIS) procedures 
is given. Finally, our system, a novel multispectral fluorescence/reflectance imaging 
laparoscope incorporating a filter wheel and a cooled CCD camera is described. Two 
experiments were conducted with it: 
• the optimal wavelengths to differentiate normal and cancerous oesophageal 
tissue determined in chapter 4 are put into good use to select the appropriate 
filters to delineate tumourous tissue in the oesophagus  
• the multispectral laparoscope is employed in combination with an exogenous 
fluorophore to image in vivo nerves during a porcine trial. 
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5.1 Motivation and challenges associated with the 
transition from point spectroscopy to spectral 
imaging 
 
Point spectroscopy, often called “optical biopsy” in the context of medical diagnosis, 
is performed with an optical fibre probe (see chapter 3 and 4) and provides a high-
resolution spectrum from the tissue surface, which is then analyzed to rapidly and 
non-traumatically detect spectral changes inherent to the progression from a normal 
tissue to a diseased tissue. However, like the traditional biopsy, the point-limited 
nature of optical biopsy means that it is difficult to use it to assess the extent of the 
lesion. Yet, the knowledge of the spatial distribution of a lesion is capital information 
to cure it. For instance, the exact localisation and extent estimation of an ischemic 
area (insufficient blood supply see chapter 6) in the colon helps to understand which 
artery is involved. The cure of the Hirschprung’s disease, a hereditary lack of 
ganglion cells affecting the lower colon leading to severe constipation, consists in 
identifying the boundary between the aganglionic and normal portion of the colon to 
section the diseased section of the colon and then stitch the remaining normal part to 
the rectum. An excessive or incomplete colon resection leads to chronic diarrhoea 
and constipation, respectively, which highlights the importance of precisely identify in 
the diseased area [1]. In brain cancer treatment, the amount of tumour removed 
during a craniotomy correlates with the patient’s survival rate and quality of life [2]. 
Likewise, the surgical stage of breast cancer treatment requires that no tumourous 
cells remain at a specific distance of the tumour border, which necessitates accurate 
location of the tumour margin. In general, the stake of cancer cure is to remove as 
much tumour as possible without altering the organ function.  
While techniques including ultrasound, CT and MRI are useful to localise a 
tumour, they can not be used to precisely delineate tumour margins because of their 
poor spatial resolution [3, 4]. Spectral imaging consists in producing a 3D dataset 
made up of the spectrally resolved images, in other words, it is a spatial extension of 
the point spectroscopy. Its principle is to utilise the optical contrast between diseased 
and normal tissue to visualize lesions that would be otherwise invisible to the naked 
eye. The contrast comes from the difference in intensity or/and line shape of the 
fluorescent and diffuse reflected light. Apart form the biomedical applications; 
spectral imaging has been extensively used in remote sensing to classify urban area 
types (water zone, parking lots, trees, asphalt) [5] or to assess forest health [6]. 
Spectral imaging is referred to as multispectral imaging where more than one 
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spectral band is involved and to hyperspectral imaging where spectral bands can be 
arbitrarily tuned. From the stack of recorded images (an image per each wavelength), 
it is possible to reconstruct the reflectance or fluorescence spectrum at each pixel, 
depending on the imaging modality used. Therefore optical imaging combines 
spectral and spatial information, whereas probe based spectroscopy yields a 
spectrum at a single point only. Tissue parameters can be extracted from this 
spectrum making possible the construction of pseudo-colour maps where pixel 
intensities equal the value of the retrieved tissue parameter.  
A variety of strategies has been employed to perform optical imaging. They 
are described in the following paragraphs. 
 
Spatial scanning 
The spatial scanning method consists in recording the complete spectrum of a 
portion of the ROI at a time. The entire ROI is spectrally imaged by moving either the 
imaging setup or the sample to be imaged. One of the first implementation has been 
realized with a spectrograph/CCD system with which a region of interest is spectrally 
imaged line by line by moving either the imaging setup or the sample to be imaged. A 
line from one of the images of the resulting spatial/spectral cube corresponds hence 
to the spectrum of a pixel belonging to the imaged line. Such a device was used for 
tongue area segmentation, an important step of computer aided tongue diagnosis [7]. 
A hyperspectral cube was recorded between 400 nm and 1000 nm by translating the 
spectrograph slit, and the cube was then analysed with a support machine vector 
algorithm. The quality of the tongue separation form neighbouring tissue (lips, face, 
teeth), was improved compared to current techniques. A similar instrument was 
employed to identify defects in apples. In this work, it was the fruit to be analysed 
which was translated instead of the slit to generate the hyperspectral cube [8]. The 
hyperspectral cube was acquired in the infrared between 954 nm and 1350 nm. The 
examination of the data cube with a partial least squares algorithm enabled 
identification of bitter pit lesions on the apple surface. In another work, an 
hyperspectral setup featuring a spectrograph was used to detect tumours on poultry 
skins with a classification accuracy of 90.6% [9].  
Systems using a two dimensional scanning mirror have been used to obtain 
fluorescence and diffuse reflectance multispectral images in the colon [10] and the 
brain [11]. As opposed to the other optical imaging techniques based on multipixel 
illumination and detection, “flying-spot” scanning systems illuminate only one pixel at 
a time and the light emitted from it is subsequently collected. Spectral images are 
generated by the scanning the light beam in the x and y dimension thanks to the 2D 
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scanning mirror of the full spectral information collected at each point. An advantage 
of flying-spot instruments is a lower price than multipixel imaging devices, which 
require expensive high-power light sources needed to illumine large area with 
sufficient power density per area unit as well as costly CCD cameras to detect low-
level signal. They nevertheless suffer from a slow acquisition speed compared to 
multipixel systems [11] and are not suited for MIS procedures.  
 
Spectral scanning 
In this approach; images are acquired one wavelength at a time over the entire ROI. 
The ROI is imaged at several wavelengths through a filtering element transmitting at 
selectable wavelength (Figure 5-1). This is the method of choice of this work 
presented in this chapter and in chapter 6. An alternative to the spatial scanning is to 
perform a spectral scanning to generate the spatial/spectral cube. An early 
implementation of this approach was done with motorized filter wheel.  
 
Figure 5-1: Optical imaging as implemented in this thesis: a series of images are 
acquired at different wavelengths forming a data cube with two spatial dimensions and 
one spectral dimension. By recording multiple images, it becomes possible to build the 
spectrum (fluorescence or diffuse reflectance) at each pixel forming the image.  
 
Skin burn injuries were studied with a setup including four filters (in the blue, green, 
red and infrared) [12]. Blood volume and oxygenation of the wounds were extracted 
form the multispectral images with the Kubelka-Munk model and then used to predict 
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the probability of wound curing. Because of the limited number of filters that a filter 
wheel can host, detailed spectral information of region of interest can not be obtained 
if acquisition time is a consideration. The availability of solid state filters, namely the 
liquid crystal tuneable filters (LCTF) and the acousto-optic tuneable filters (AOTF), 
considerably increased the number of accessible wavelengths. Furthermore, the 
wavelength tuning is faster with solid state filters (even though recently released filter 
wheel models have a switching time of 50 ms i.e. close to LCTF switching time), 
achieved without moving parts, hence allowing spectral switching without noise and 
vibration, and eliminating in this way potential mechanical problem. LCTF presents 
several advantages over the AOTF: it exhibits a higher rejection for out-of-band 
transmission and it can be constructed with a larger aperture [13]. On the other hand, 
AOTF has an adjustable bandwidths whereas LCTF bandwidth is fixed (typically 10 
nm according to our measurements), and a faster switching time (of the order of the 
microseconds [14]) compared to that of LCTF (measured typically as of 20 ms) 
although it should be noted that it is the CCD exposure time which limits the 
acquisition speed especially when fluorescence signals are recorded. AOTF systems 
were often used in spectral fluorescence and reflectance animal studies [14-17]. 
LCTF devices were shown to have promising potential to localise tumours in the 
breast [3] and the brain [4], to probe the pH of resected tumours [18] and were 
regularly used in tissue oxygenation monitoring (detailed in chapter 6). 
 
Interferometry 
Other groups used a Sagnac interferometer to perform hyperspectral imaging [1]. 
The light beam coming from the sample and entering the Sagnac interferometer was 
separated into two beams which followed an identical path but in an opposite 
direction. Subsequent to the introduction of an optical path difference between the 
two beams, an interferogram of each pixel of the sample image is acquired with a 
detector [19]. The interferometer is then rotated to select another set of optical 
frequencies. Once a number of interferograms sufficient to cover the desired spectral 
range was obtained, a Fast Fourier Transform was applied to transform each pixel 
interferogram into spectra. Interferometers have a higher optical throughput than 
spectral scanning systems because they collect light at all the wavelengths 
simultaneously whereas spectral scanning systems capture only photon from the set 
spectral window [19]. Nevertheless, a study demonstrated the LCTF system 
superiority over interferometers in terms of signal-to-noise ratio [20]. Moreover, 
interferometers, like spatial scanning systems, do not offer the possibility to choose 
only a subset of pre-selected meaningful wavelengths as swiftly as spectral scanning 
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systems. Such a feature allows for faster acquisition and lesser size of stored data. 
Interferometric imagers were mostly used to carry out multispectral chromosome 
karyotyping [21]. 
 
Snapshot hyperspectral system  
Some newly developed hyperspectral imaging instruments permit the simultaneous 
capture of full spatial and spectral information. They require large array CCD sensors 
and generally include sophisticated optics such as diffractive elements [22] or a 
mirror facet/prism module [23]. The use of the two aforementioned optical elements 
with a CCD sensor produces a raw image where spatial and spectral information are 
multiplexed and require unmixing algorithms to reconstruct the data cube. A simpler 
device was reported, containing a lens plate and a filter block hosting eighteen 
lenses and filters respectively disposed in front of the CCD camera to record at once 
eighteen images of the same scene at eighteen different wavelengths [24]. The major 
advantage of snapshot cameras is their speed of acquisition and elimination of 
motion artefacts caused by the sample movement during the acquisition. However, 
this approach imposes a choice between spectral and spatial resolution because of 
the limited size of the CCD chip. 
In summary, the choice of a multispectral imaging system depends on the 
requirements imposed by the application: the spectral resolution, spatial resolution, 
speed of acquisition, compactness, optical throughput.  
For instance, multispectral fluorescence imaging necessitates high throughput 
systems such as flying-spot devices, filter wheel systems or interferometers because 
the amplitude of the fluorescence signal is low. Snapshot systems are indicated for 
experiments with a fast moving scene, thanks to their short acquisition time, but as a 
technique trading-off spatial resolution versus resolution, may not be appropriate for 
tumour delineation which requires high spatial resolution.  
In this work, fluorescence and reflectance multispectral imaging were 
conducted with a laparoscope including a camera and the filter component proximally 
attached. This imposes stringent requirements on the weight and the size of the filter 
element so that the laparoscope can be comfortably manipulated by the surgeon. 
Bulky interferometers, snapshot cameras, AOTF were therefore inadequate for this 
application.  
Spatial scanning systems are especially suited for applications where spectral 
information is only sought for regions of interest within the field of view of the camera. 
In this situation, the acquisition can be speeded-up by only acquiring spectra from 
these specific locations. Instead, the primary aim of our work was to identify diseased 
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regions with some prior knowledge of their spectral features rather than prior 
knowledge of their positions. The spectral scanning instruments were hence more 
adapted since they allow imaging the complete FOV at some selected wavelengths. 
In consequence, filter wheels and LCTF (see chapter 6) were chosen for their 
wavelengths selection flexibility and their compactness. As described earlier, LCTFs 
have several advantages over filter wheels, but their low optical transmission 
prevents them from being used for low level fluorescence imaging, especially when 
employed in combination with low transmission optics such as the laparoscope.  
Of note, some groups, mostly in tissue oxygenation studies, performed 
multispectral reflectance imaging by filtering the excitation light, that is before 
reflection from the object to be imaged instead of filtering it at the emission stage 
(after reflection) [25-27]. This approach, called narrow-band imaging, sometimes 
enhances image contrast during navigation. For instance, spectral regions where 
haemoglobin is important compared to others tissue constituents (in the green) can 
be selected to visualize blood vessels.  
5.2 Minimally invasive surgery and laparoscope 
 
Minimally invasive surgery (MIS) is a type of surgery performed in the abdominal 
cavity through millimetre incisions [28] (Figure 5-2). MIS represents a considerable 
improvement over open surgery, which consists in executing large incisions to gain 
direct access to the abdomen. MIS produces reduced pain [29], scars [30], recovery 
time [31], and infections [32]. A typical MIS procedure involves CO2 insufflation of the 
abdominal cavity to produce a working space, introduction of a minimum of two 
trocars (tool made up of a canula and a sharp triangular end to pierce the abdomen): 
one for the introduction of the laparoscope and the other(s) for the introduction of 
surgical instruments, the resection or visualisation of diseased tissue, and finally the 
removal of trocars [33]. 
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Figure 5-2: (a) Front and (b) side views of a typical minimally invasive surgery scene. 
Small incisions are performed through the abdomen with trocars to enable the passage 
of laparoscope and surgical apparatus. Adapted from [34]. 
 
The foremost instrument which made the development of MIS possible is the 
laparoscope. Laparoscopes are long (between 10 cm and 1 m) and narrow (between 
0.1 and 2 cm [35]) optical relays allowing clinicians to distantly visualise internal 
organs. They are made up of a central optical system consisting of an objective, a 
rod lens relay system, and an eyepiece (or an objective/ CCD camera) surrounded 
by peripheral illumination fibre bundle (Figure 5-3) [36]. Laparoscopes are used in 
combination with powerful mercury, halogen or xenon light sources connected to the 
laparoscope light port and a colour CCD capturing the image of the abdomen cavity 
generally visualized on a monitor [35].  
 
 
Figure 5-3: Cross-section of a laparoscope. Adapted from [37]. 
 
(a) (b) 
Trocar 
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 When screening long, narrow, hollow organs such as the colon, rigid 
laparoscopes are unsuitable and endoscopes are employed instead. The relay 
system is not anymore rod lenses, but a bundle of thousands of optical fibres of 
micrometric diameter [35]. Procedures involving flexible endoscopes are called 
natural orifices transluminal endoscopic surgery (NOTES) as endoscopes in the body 
introduced through natural orifices. 
 
5.3 Existing multispectral fluorescence endoscopic 
systems 
 
Apart from [14, 16], all the optical systems used in the applications described in 
section 5.1 were free space and could not be used in vivo during NOTES or MIS 
operations. Several multispectral (flexible) endoscopic systems were designed for 
NOTES operations and were tested mostly for lung, bronchus, and colon tumour 
localisations. In [38], a conventional bronchoscope was modified to add a 
fluorescence imaging functionality in addition to the white light imaging modality. Its 
principle relies on the differences of green and red fluorescence intensities between 
normal and dysplastic tissue which we briefly recall: the most salient discrepancy is 
the significantly higher green band fluorescence intensity of normal tissue compared 
to that of cancerous tissue. Another characteristic feature is the similar or slightly 
superior relative red fluorescence level of cancerous tissue compared to that of 
normal tissue (for more details see chapter 2, section 2.1.6). A xenon lamp provided 
the white light illumination and a helium–cadmium laser (emitting at 442 nm) acted as 
the fluorescence light source. An optical fibre was connected to the latter and was 
fed in one of the biopsy channel to convey the laser light at the endoscope proximal 
end. The fluorescence images were recorded with two intensified CCD cameras 
while the white light image obtained with a colour CCD camera. This system collects 
green (500-580 nm), red (≥630 nm) fluorescence images and a colour image. For 
contrast enhancement, the green fluorescence image which contains most of the 
healthy/diseased tissue contrast was overlaid on the red fluorescence image, which 
was used as a (supposed) constant background. A singular capability of this system 
is the real-time display of the ratio of the red fluorescence image over the green 
fluorescence image for objective and quantitative colour display in order to minimize 
false-negative and positive rates. The study presented in [39] exemplifies the 
importance of this red/green ratio feature. A site in the human tracheobronchial tree 
was declared cancerous following subjective visualisation of the overlaid green and 
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red fluorescence images, whilst an offline image processing consisting in dividing the 
red and green fluorescence image revealed that it was in fact a false positive. This 
was later confirmed by a biopsy justifying the importance of the live quantitative 
red/green ratio image display feature. Besides the diagnostic value provided by the 
ratio of red and green images, it allows reduction of the effects of spatially non-
uniform illumination [40], as well as the effects of spatially varying collection 
efficiency of emitted fluorescence introduced by the illumination angle and distance 
or uneven surface, for instance [41]. This work served as a base for the development 
of a commercial system, the Lung Imaging Fluorescence Endoscope (LIFE, Xillix 
Tech. Corp. (acquired by QImaging Corp.), Canada).  
Several others commercial systems from Pentax (Japan), Karl Storz GmbH 
(Germany) and Richard Wolf GmbH (Germany) were developed based on concepts 
close to the LIFE device [42]. The Pentax SAFE-1000 endoscope light source is a 
filtered Xenon lamp allowing white light illumination (no filter) and fluorescence 
excitation in the blue (bandpass filter with a transmission between 420-480 nm) [43]. 
The fluorescence is detected in only one spectral band in the green (490-590 nm), 
which is much larger in normal tissue than in cancerous tissue. The fluorescence 
mono-channel detection permits the reduction of the system price (one intensified 
CCD instead of two) and complexity, but its efficiency is doubtful as no ratio is 
calculated and therefore the geometric effects of illumination are not compensated. 
Indeed, in the hypothetical situation where a dysplastic tissue is closer to the 
illumination than adjacent normal tissue and detection channel than a normal site, the 
fluorescence excitation and collection efficiency of the dysplastic site will be superior 
to the ones of the normal tissue. This can lead to a green fluorescence recorded from 
the tumourous site as high as or even larger than that of the normal tissue in spite of 
the greater intrinsic green fluorescence of the latter potentially leading to a raise of 
false-negative rates. Conversely, normal tissue distant from illumination and 
detection channels or overshadowed could be counted as false-positive as it is the 
case in [44], where an endoscopic fluorescence system similar to the Pentax 
endoscope was used to demarcate colonic adenomatous polyps. In this study, 
normal sites overshadowed by mucosa folds were counted as dysplastic sites. 
The Storz system takes advantage of a three chip CCD endoscope camera 
(one chip for each of the R, G, B channels) to perform colour imaging (using the R 
,G.B channels of the CCD camera), as well as autofluorescence imaging by using the 
red (600 nm - 800 nm) and green (470 nm – 600 nm) channels [45]. The light source 
used in the Storz device is a xenon lamp filtered between (380 nm - 460 nm) for 
fluorescence imaging. As opposed to the Xillix endoscope, the red/green 
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fluorescence ratio is not directly available in the Storz apparatus. Instead, the 
dysplastic/normal sites contrast comes from the green fluorescence signal drop 
observed in dysplastic tissue, which will appear darker than surrounding normal 
tissue. A particularity of the Storz instrument is that in fluorescence mode, the 
emission filters leaked 1% of the blue excitation light in order to facilitate navigation, 
allowing the surgical instruments (such as the biopsy forceps) to be localised in the 
field of view in fluorescence mode, and improving the contrast. Indeed, the back-
reflected blue light excitation is supposed to enhance the healthy/diseased contrast 
by providing a constant background unaffected by the tissue optical properties. The 
use of a single three-CCD chips camera means that the Storz system is very 
compact and can be directly clipped to the ocular of an endoscope; however this 
CCD camera is not intensified which means that longer integration times are required 
to detect the fluorescence with an acceptable signal-to-noise ratio. 
It was mentioned earlier that the background images of the Xillix and Storz 
apparatus were the red fluorescence and the backscattered blue light excitation 
images, respectively. They were assumed to be “constant”, i.e. independent of 
optical properties change. This is of course inaccurate because even though the 
differences in red fluorescence between normal tissue and cancerous lesions are 
less important than in the green range, they still exist. Moreover, should the Xillix 
system be used in the colon, presence of faecal matter rich in porphyrins, a 
fluorophore emitting in the red, would create artefacts [46]. Similarly, back-reflected 
blue light background images are not independent of optical changes, since 
haemoglobin absorbs highly in the blue spectral range, and the presence of highly 
vascularised sites could disrupt the signal [44]. 
These limitations were addressed in a modified DAFE (Diagnostic 
Fluorescence Endoscopy) system (Richard Wolf GmbH, Germany), which operates 
in the same way as the Storz apparatus, except that a portion of red light, weakly 
absorbed in the red, is leaked by the excitation and emission filters [39]. The contrast 
between healthy and neoplastic tissue in the bronchus using the backreflected red 
light as background image instead of the red fluorescence image was improved by a 
factor of 2.7. It is interesting to note that, with the exception of the Storz system, all 
aforementioned fluorescence imaging units clipped to the eyepiece of the flexible 
endoscopes, are cumbersome since they include more than one camera and could 
cause difficultly when used on rigid laparoscopes, which require a compact and light 
camera unit to be easily manipulated and not to cause excessive strain on the 
trocars. The system we developed was compact enough to be clipped on a rigid 
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laparoscope and operated during a surgical procedure. It also combined multispectral 
fluorescence and reflectance imaging. 
Clinical trials performed with Xillix, Pentax, and the Storz systems showed a 
dramatic improvement of the sensitivity for the detection of cancerous lesions in the 
bronchus when conventional white light endoscopy and autofluorescence were used 
in parallel. However, this came with a lower or limited specificity caused by a high 
false positive rate [44, 47] attributed to non-cancerous yet abnormal sites such as 
inflamed areas whose fluorescence properties differ from normal sites leading to their 
misclassification [48]. Cancer detection in the oesophagus is complicated by the 
abnormal fluorescence of Barrett’s oesophagus sites, which often precedes the 
apparition of oesophageal adenocarcinoma and is responsible for an elevated 
number of false positives [48]. In a study of fifty patients suffering from Barrett’s 
oesophagus, a PPV for neoplasia detection as low as 28% was obtained in the 
autofluorescence mode with the Xillix instrument [49].  
None of these three commercial systems were spectrally optimized, i.e. 
preceded by a spectroscopic study consisting in recording spectra from sites of the 
organs and pathologies of interest in order to select the spectral bands that enable 
the optimal detection of lesions. Such an optimization was performed in the DAFE 
instrument employed for cancerous lesions in the bronchus [39] as well as on a 
modified version of the Xillix used for dysplastic lesions detection in the GI [41]. In the 
study involving the DAFE system and performed on fifteen patients, sensitivity 
obtained with fluorescence imaging was twice the sensitivity reached with white light 
imaging. Furthermore, a PPV of 100% was reached with fluorescence and white light 
modes combined, denoting an absence of false positives. This pilot study indicates 
therefore, that a spectral optimization improves the diagnostic performances of 
fluorescence endoscope.  
Another strategy to lower the number of false positives limiting the diagnostic 
performance of autofluorescence imaging consists in, like in spectroscopy, combining 
several modalities. For instance, narrow-band imaging was used in combination with 
autofluorescence imaging in a study involving twenty patients with Barrett’s 
oesophagus and suspected high-grade neoplasia. In the fluorescence imaging mode, 
all lesions were detected and the false positive rate was found to be 40%, the latter 
being reduced to 10% when fluorescence imaging was used together with narrow- 
band imaging [50]. The combination of modalities seems to improve the diagnostic 
accuracy of neoplastic lesions, since this approach decreased the number of false 
positives obtained with autofluorescence alone.  
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5.4 Multispectral fluorescence/ diffuse reflectance 
laparoscopic imaging system 
 
The schematic of the multispectral imaging laparoscope, used in the two studies 
presented in this chapter (oesophagus cancer imaging and nerve delineation), is 
presented in Figure 5-4. It comprises a 200 W metal-halide lamp unit with a built-in 
six position filter wheel (Prior Scientific, Inc., USA). The 5 mm light guide, originally 
designed to be coupled with microscopes, is connected to the light port of a 
laparoscope (0˚ viewing angle, 10 mm diameter, Olympus Ltd, Japan) via a custom 
made connector. A second filter wheel (Thorlabs, Inc., USA) containing the emission 
filters is placed between the laparoscope and a CCD camera (RetigaExi, QImaging, 
Inc., Canada). In white-light mode, both filter wheels were set on “no filters” positions, 
and in fluorescence mode, filter wheel slots with the appropriate combination of 
excitation/emission filters were selected. The number and specifications of the filters 
used in the two studies are detailed in sections 5.5.1 and 5.6.2. 
 
Figure 5-4: Schematic of the multispectral laparoscopic imaging system.  
 
During experiments, the laparoscope was used in combination with an 
articulated arm (Figure 5-5) to minimize the camera movement during the acquisition. 
The image formed after the laparoscope eyepiece was focussed onto the chip of the 
camera with a 30 mm focal length objective lens. A LabVIEW program enabled 
control of the excitation-emission filters combination, the camera settings and the 
image acquisition. 
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Figure 5-5: Photograph of the laparoscope setup. 
 
5.5 Design of a dual-modality laparoscope for 
oesophagus cancer detection  
 
The initial goal of the work presented in this section was to image ex vivo an 
oesophagus including tumours, but it has not been possible to do so due to the 
unavailability of a suitable specimen during the six months that  this study lasted. It 
was possible to get hold of two specimens yet the first one presented a tumour 
deeply buried and hence inaccessible to fluorescent light. The tumour present on the 
second specimen was completely resected by the clinician straight after the 
oesophagectomy for histopathological examination. However, we believed that the 
design of the system described below was relevant to the thesis. 
Spectrally optimized instruments and systems incorporating several 
modalities were presented in section 5.3. They were shown to enhance the 
diagnostic performance of autofluorescence endoscopes, which itself improve the 
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diagnosis power of traditional white-light endoscopy. None of these systems were 
both spectrally optimized and multi-modalities. The laparoscope presented in this 
thesis is the first, to our knowledge, to include these two features as it was spectrally 
optimized thanks to the study presented in chapter 4, and it incorporated 
fluorescence and diffuse reflectance modalities. It is hoped that the spectral 
optimization alongside the dual modality capability will further enhance cancerous 
tissue detection in the oesophagus. Of note, rigid laparoscopic multispectral systems 
similar to ours exist, but they can only perform either fluorescence imaging [51] or 
reflectance imaging [52].  
5.5.1 Selection of filters 
 
All the filters used in this experiment were acquired from Semrock, Inc., USA. The 
central wavelengths of the excitation filters were chosen based on the emitting 
wavelengths of the laser diodes used in the spectroscopy study (375 nm and 405 
nm), as well as on the manufacturer catalogue availability. The central wavelengths 
of the emission filters were chosen according to the spectral analysis conducted in 
chapter 4 and on the manufacturer catalogue availability. The choice of the 
bandwidth was the result of a compromise between spectral selectivity, sufficient 
signal level, and manufacturer catalogue availability. The instrument was designed to 
host two fluorescence imaging channels, one at 375 nm excitation and the other one 
at 405 nm, and a diffuse reflectance channel in addition to the white light imaging. 
For 375 nm excitation generation, a bandpass filter centred at 379 nm with a 34 nm 
bandwidth (379/34) and encompassing the light source peak at around 370 nm, was 
chosen (Figure 5-6). For 405 nm excitation, a 417/60 nm bandpass filter was 
selected, the spectral range covered by this filter included two illumination peaks 
centred at 400 nm and 435 nm. The optical power densities obtained at the tip of the 
laparoscope with these filters were measured at 0.25 mW/cm2 and 4 mW/cm2 at 375 
nm and 405 nm excitation, respectively, and at 35 mW/cm2 in white light mode (no 
excitation filter).  
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Light source 
Excitation filter: 379/34   
Excitation filter: 417/60 
Emission filter: 483/32
Emission filter: 605/15
Emission filter: 655/40
 
Figure 5-6: Spectrum of the metal-halide light source and transmission profiles of the 
chosen emission and excitation filters. 
 
Following spectral analysis, the pair of wavelengths whose intensity ratio 
optimized the separation between cancer tissue from the normal tissue were found to 
be (491 nm, 662 nm) for 375 nm excitation fluorescence and (605 nm, 676 nm) for 
diffuse reflectance (see Table 4-5). In chapter 4, no spectral optimization was 
performed for 405 nm excitation fluorescence yet the pair (480 nm, 660 nm) was 
found to be optimal to separate normal sites form cancerous sites in the oesophagus 
in another study [53]. In consequence, the following emission filters (central 
wavelength (nm)/ bandwidth (nm)) were chosen for the two fluorescence channels: 
483/32, and 655/40. For diffuse reflectance imaging, the selected filters were 605/15 
(the same one as for fluorescence imaging) and 655/40. Table 5-1 summarizes the 
excitation and emission filters employed in each imaging mode.  
 
Table 5-1: Correspondence between imaging modes and their excitation/emission filter 
combination. 
White-light 375 nm 
fluorescence
405 nm 
fluorescence
Diffuse reflectance
Excitation filter None 379/34 417/60 None
Emission filter None 483/32; 655/40 483/32; 655/40 605/15; 655/40
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5.5.2 Fluorescent phantom imaging 
 
The low magnitude of autofluorescence signal, coupled with the low optical 
throughput of laparoscopes is the main difficulty to overcome when performing 
fluorescence laparoscopic imaging. The system validation detailed in this section, 
was purely qualitative, and simply aimed at verifying the system sensitivity to 
fluorescence signal by recording images from a fluorescent phantom. As a result, 
only the fluorescence images are shown and not the diffuse reflectance images. 
Solutions of 2 µM of protoporphyrins IX (PpIX) and FAD, two fluorophores involved in 
carcinogenesis [54], coumarin 334 (C334), a fluorophore emitting in the visible, and a 
control sample of water were prepared. The solutions were transferred to a 100 µL 
multi-well plate as illustrated in Figure 5-7. 
 
 
Figure 5-7: Location of the solutions of protoporphyrins IX, coumarin 334, FAD, and the 
control solution (water). 
 
Figure 5-8 presents the pair of fluorescence images obtained form the phantom at 
375 nm and 405 nm excitation with respective exposure times of 1000 ms and 300 
ms. For both excitations, C334 fluorescence signal appeared important with the 
483/32 bandpass filter and low with the 655/40 bandpass filter, which was expected 
as its fluorescence spectrum peaks in the region of 490 nm [55]. Conversely, 
fluorescence levels from PpIX were visually low with the 483/32 filter and important 
with the 655/40 filter as fluorescence intensity of PpIX remains low until 600 nm and 
peaks at 635 nm [56]. FAD fluorescence seemed low or moderate on the four 
images, as expected since FAD fluorescence maximum is in the region of 550 nm 
PpIX C334 
FAD Water 
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(see Figure 2-3). Finally, no fluorescence was detected from the control well filled 
with water.  
The phantom study validated therefore the capacity of the laparoscopic system to 
excite and capture fluorescence.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-8: Raw intensity fluorescence images of the fluorescent phantoms at each 
excitation/ emission filter combination of interest. 
 
Last two paragraphs moved to conclusion 
5.6 In vivo brachial plexus nerve identification  
5.6.1  Nerve visualization relevance and previous work 
 
Unintended nerve damage or transection can occur during surgery leading to chronic 
pain, atrophy, paralysis, and dysfunction, yet thin and buried nerves in muscles are 
difficult to visualize. Current methods rely on the surgeon’s experience or electric 
stimulation (electromyographic monitoring) [57], which is not an imaging technique. 
Nerves can be labelled with fluorescent dyes injected either directly in the nerve tract 
or systemically. The former approach presents two drawbacks: it can highlight only 
one tract and is time consuming as axonal uptake and transport is very slow (a 
complete nerve labelling can take days) [58]. 
Emission  
Excitation  
483/32 
655/40 
405 excitation 
(417/60 filter) 
375 excitation 
(379/34 filter) 
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  It is proposed in this work to use fluorescence imaging intraoperatively in 
combination with a fluorescent dye intravenously injectable. While this thesis aimed 
to capitalize on differences of tissue autofluorescence distribution as exogenous 
fluorophores present drawbacks such as toxicity, time for regulatory approval for 
animal and human use, and length to reach optimal contrast, the lack of fluorescent 
contrast between nerves and surrounding tissue prompted the need to resort to dyes. 
Exogenous fluorophores have nevertheless some advantages: their optical 
properties are well characterized (even though they might vary depending on the 
biochemical environment) and they are significantly brighter than endogenous 
fluorophores which facilitates the direct location of the tissue of interest without 
complex image post-processing to extract the valuable signal. This work is to my 
knowledge the first reported attempt of fluorescence nerve imaging during a MIS 
procedure using a laparoscope. In previously published studies, nerves and 
surrounding tissue were either imaged ex vivo under a fluorescence microscope [59, 
60] or in vivo during open field surgery [61]. 
The nerve dye used here, named GE3111, belongs to a family of nerve 
contrast agents under development by a team at General Electric Healthcare Global 
Research and designed to meet the following characteristics: traverse the blood-
nerve frontier, bind specifically to the myelin present in nervous tissue, remain in 
nerves a few hours, and emit fluorescence in the visible/infrared. The dye optical 
properties were studied and it was successfully used to image nerves in mice and 
rats with an open-field multispectral camera by Cristina Tan Hehir and Victoria 
Cotero from General Electric. The objective of the present experiment was to 
translate this experiment in vivo using the multispectral laparoscope to image the 
brachial plexus of a pig. 
5.6.2 Dye fluorescence properties and filter selection  
 
The excitation and emission filters were chosen to optimally excite and detect the dye 
fluorescence (Figure 5-9). A bandpass filter (central wavelength: 405 nm, bandwidth: 
60 nm, Semrock, Inc., USA) centred close to the dye maximum fluorescence 
excitation was chosen which, depending on the solvent it is dissolved in, varies 
between 410 nm and 425 nm. The resulting violet-blue light was within the 375-445 
nm range, and contains a peak at 398 nm and a second peak at 430 nm close to the 
dye absorption maximum. 
The selected emission filter was 550 nm long pass (Thorlabs, Inc., USA). It 
was picked not to overlap with the excitation filter transmission profile to merely 
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record fluorescent light (and no backreflected excitation light) and to cut as much 
tissue autofluorescence as possible while enabling the collection of the fluorescence 
signal within a reasonable timeframe (exposure time of a few seconds maximum). 
Ideally, a bandpass filter with a small bandwidth centred at the dye peak emission 
fluorescence around 610 nm should have been used, but this would have led to long 
exposure times inappropriate for in vivo imaging with a moving scene. In other words, 
spectral specificity had to be compromised to reach acceptable speed acquisition; 
this is due to the weakness of fluorescence signal. 
The optical power densities obtained at the tip of the laparoscope were measured as 
35 mW/cm2 and 4 mW/cm2 in white light and fluorescence mode, respectively.  
 
Light source 
Dye excitation 
Dye emission 
Excitation filter
Emission filter
 
Figure 5-9: Metal-halide source spectrum, fluorescence excitation and emission 
spectra and transmission profiles of the excitation and emission spectra. 
5.6.3 Phantom imaging 
 
The excitation and emission filters described in Figure 5-9 were inserted in the 
multispectral imaging laparoscope. The imaging procedure involved the acquisition of 
the white-light image followed by the acquisition of the fluorescence image with 
respective exposure times of 40 ms and 1000 ms. A phantom consisting of tubes 
containing either the fluorescent dye formulation or water was imaged. A total volume 
of 200 mL of dye solution was formulated at a 1.10-2 g/L concentration. 50 ml of the 
dye was used for the phantom. 
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Figure 5-10: (a) Black and white light image of tubes containing water or the dye 
solution (indicated by red dots), (b) corresponding fluorescence image. 
 
While water tubes were undistinguishable from dye tubes in the white light 
image (Figure 5-10-a), the distinction between them became clearly apparent in the 
fluorescence image (Figure 5-10-b). To quantify the contrast between dye and water 
tubes, the mean intensity of a 20×20 pixels region was calculated for the six tubes, 
and the average nerve tube intensity was divided by the average water tube intensity 
leading to a contrast of 8.5. This preliminary experiment indicated that the system 
illumination channel delivered a power density/ pixel sufficient to excite the dye 
fluorescence, and validated the system detection channel ability to detect and record 
the dye fluorescence signal. 
5.6.4 In vivo brachial plexus imaging 
 
In this section, the results of the study involving a pig injected with the nerve 
fluorescent contrast agent are detailed. The aim was to investigate in vivo the 
fluorescence laparoscope ability to delineate nerves. It was decided to image nerve 
tracts in the axilla (armpit) region as it hosted a section of a well-known network of 
nerve fibres, the brachial plexus, and it was easily accessible without disturbing the 
workflow of other experiments performed in parallel in the porcine abdomen. The 
brachial plexus is essential to the movements of the arm and the hand; surrounding 
tissues include the axillary artery and vein, and pectoral/serratus muscle [62]. The 
resection of tumours located at the top of lungs, referred to as Pancoast tumours, is a 
an example of a surgical procedure during which there is a danger of damaging the 
brachial plexus and where the approach described here would be of interest [63]. 
(a) (b) 
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5.6.4.1 Imaging procedure 
At the start of the experiment, the totality of the available dye (30 mg) mixed in a 
volume of 150 ml, was intravenously injected into the pig which correspond to a 0.43 
mg/kg dose the pig’s weight being 70 kg. During the pig trial, the brachial plexus and 
surrounding area were imaged regularly during 5 hours through a mini-incision 
carried out in the axilla (Figure 5-11) before (for control). The exposure times were 
between 40 ms and 60 ms for white light imaging and ranged from 2 s to 3.5 s 
making the total acquisition inferior to 5 s.  
 
 
Figure 5-11: View of the laparoscope illuminating the brachial plexus at the axilla level 
with blue light (417/60 nm bandpass excitation filter). 
 
The working distance between the distal end of the laparoscope and the tissue was 
maintained at about 10 cm, and the incision (Figure 5-11) was covered with an 
opaque sheet to isolate the imaged scene from ambient light room. Following the 
trial, the imaged nerves and axillary vein were harvested, kept in formalin and sent to 
the GE team for ex vivo imaging with an open-field hyperspectral camera (Nuance 
camera, CRI, Inc., USA). Cross-sections of them were prepared using a reagent 
system (Ventana Medical Systems, Inc., USA) to be examined under a fluorescence 
microscope (Carl Zeiss Meditec, Inc., Germany). 
5.6.4.2 Brachial plexus images  
Figure 5-12 shows a set of white light and fluorescence images acquired 5 h after the 
contrast agent injection. It features the brachial plexus, the pectoral/serratus muscle 
region and the axillary vein. Fluorescence signal was collected from both the brachial 
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plexus and the pectoral/seratus muscle, whilst the axillary vein did not show 
significant fluorescence levels (Figure 5-12-b). However, the contrast between the 
brachial plexus and the surrounding pectoral/serratus muscle did not visually 
appeared more important in the fluorescence image than in the white light image 
(Figure 5-12-a). The low level fluorescence distinguishable in the axillary vein came 
from the few straggly wisps of white tissue overlying the vein (clearly visible on the 
white light image). 
 
 
 
Figure 5-12: Right axilla looking anteroposteriorly (images acquired with the 
laparoscope system). (a) White light image featuring a large bifurcating trunk of 
brachial plexus (green arrow), axillary vein (yellow arrow), medial muscular border of 
axilla–pectoral/serratus muscle (blue arrow) 5 h after injection and (b) corresponding 
fluorescence image .  
 
Similar observations were made by the GE research team as for the 
fluorescence intensity recorded ex vivo from the harvested fractions of the brachial 
plexus and the axillary vein with a hyperspectral camera (Figure 5-13): important 
fluorescence from the different trunks of the brachial plexus was detected, whereas 
the axillary vein appeared dark as expected since it is a highly absorbing media 
(strong concentration of haemoglobin). 
 
(a) (b) 
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Brachial plexus: 
Large bifurcating trunk 
Brachial plexus: 
smaller trunk 
Axillary vein
 
Figure 5-13: In vivo fluorescence image of an axilla ROI taken with the multispectral 
laparoscope (left) and ex vivo fluorescence images of the brachial plexus and the 
axillary vein acquired with the open-field hyperspectral camera (Nuance camera, CRI, 
Inc., USA) (right).) 
 
In order to quantify the nerve-to-muscle contrast progress with time, the 
fluorescence images were divided by the reflectance images to correct for non-
uniform illumination (see section 5.3) and the temporal evolution of the nerve-to-
muscle ratio was calculated from the resulting images by averaging the pixel intensity 
in a rectangular area of 100 over 200 pixels in both the brachial plexus nerve and 
pectoral/seratus muscle region. 
 
Figure 5-14: Temporal evolution of the nerve-muscle contrast (t=0 min corresponds to 
the time of injection). 
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It is apparent from the graph (Figure 5-14) that no clear trend in the nerve-muscle 
ratio could be observed. The contrast values oscillate around 1, a maximum of 1.37 
was reached 71 min post-injection, and a minimum of 0.74, 2h51min post-injection. 
Several assumptions can be formulated to explain the absence of contrast. It 
is possible that no dye was present in the imaged region of interest (ROI). The 
examination under microscope of the cross-sectional images of a control brachial 
plexus from a rat injected with the dye formulation agent (Figure 5-15-a) and the 
brachial plexus resected from the pig injected with the dye (Figure 5-15-b) allowed 
eliminating this hypothesis. The comparison of the two images revealed indeed on 
the pig nerve image, bright doughnut structures (some of which are indicated by the 
red arrows on Figure 5-15-b) easily visible on the nerve periphery and characteristic 
of contrast agent bound to the nerve myelin sheath. Such pattern was not observable 
on the control image whose (weak) fluorescence signal came from autofluorescence 
from all likelihood.  
Another hypothesis is that dye was present in the ROI, and that, the absence 
of increased fluorescence in the nerve is either due to a. an unspecific binding of the 
dye (i.e. there was dye in both the brachial plexus and the muscle) along with a 
similar kinetics profile. The examination of the temporal evolution of the fluorescence 
intensities in nerves and muscles which did not show any rise in fluorescence (data 
not shown) permitted to eliminate the hypothesis 
Consequently, the absence of nerve-muscle contrast in the fluorescence 
image was attributed to a low dye concentration leading to a fluorescence signal too 
low to be excited and/or recorded by the laparoscopic fluorescence imaging setup 
(fluorescence imaging through low transmission systems like laparoscopes remains 
challenging because fluorescence signals are generally weak). 
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Figure 5-15: Cross-sectional images of (a) a control rat brachial plexus nerve injected 
with the formulation agent and (b) the dye-injected pig brachial plexus. Doughnut 
structures pointed out by red arrows illustrate examples of nerves fibres where 
contrast agent aggregated. 
 
Past studies on nerve fluorescence imaging established that a minimal dose 
of the contrast agent was required to observe nerve-to-muscle contrast [59, 61], 
below which, the contrast of temporal evolution does not show any trend. In [61], two 
different contrast agents, both variants of the GE3111 used here, were injected in a 
mice and the evolution of the contrast with the dose was studied to determine the 
optimal dose leading to a maximum of contrast for each of the two dyes. Scaling 
these two values by the body surface area of a 30 kg pig, the dose needed was 
found to be equal to 2.3 mg/kg and 1.1mg/kg for the first and second dye 
respectively. At the time of the experiment, a total of 40 mg of contrast agent was 
available, 10 mg of which was used for the phantom experiment, leaving 30 mg for 
the in vivo imaging of the 70 kg pig trial resulting on the 0.43 mg/kg mentioned 
earlier. No preliminary study on the optimal dose of the GE3111 dye for maximum 
contrast has been performed prior to the trial. It is therefore difficult to definitely 
determine if the contrast agent dose injected the day of the experiment was 
sufficient. However, while recognizing that the optimal dose is contrast agent specific 
as it depends on its myelin bonding ability, its solubility, and its blood nerve 
penetration [62], it can be noted that the dose we administrated to the pig was more 
than twice below the lowest dose of the study presented in [61]. 
Another observation is that, although fluorescence was visible throughout the 
nerve section (Figure 5-15-b), the fluorescence intensity distribution appeared 
inhomogeneous with higher fluorescence near the nerve border than in the middle 
indicating an incomplete dye uptake by the nerve. In previous studies using variants 
(a) (b) 
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of the GE3111 dye, fluorescence generated by the contrast agents was detected 
from nerves [60-62], microscope analysis of the resected tissue sections revealed 
high level of fluorescence evenly distributed throughout the nerve section and not 
only in the nerve periphery.  
Figure 5-15 deleted  
The previous observations all tend to confirm that the absence of 
fluorescence signal from the GE3111 contrast agent was due to a quantity of dye too 
low to be detected. An alternative to using a higher dose would be to enhance the 
multispectral laparoscope performances by acting on the system illumination power 
(to reach a power-per-pixel sufficient to excite the dye fluorescence even at a very 
low local concentration) alongside the system sensitivity. The former could be 
achieved by using a higher power light source and higher transmission light delivery 
channel, yet the power lamp employed in this work is already 200 W and light 
delivery system consisting in the light guide and the laparoscope illumination channel 
cannot be dramatically improved. As for the system sensitivity, it could be improved 
by increasing the system collection efficiency and the detector sensitivity. A higher 
sensitivity and collection efficiency would enable the use of a bandpass filter centred 
on the dye peak fluorescence instead of using a long-pass filter. A bandpass filter 
would have the advantage to isolate the contrast agent fluorescence from the 
background (i.e. the tissue autofluorescence). Indeed, a large portion of the 
fluorescence emitting by the contrast agent overlaps with the fluorescence emitted by 
the tissue fluorophores (see figure 2-3, chapter 2) which means that the weak 
fluorescence stemming from low dye concentration could be “drown “in the tissue 
fluorescence. In our system, the collection efficiency was limited by the laparoscope 
reduced entrance pupil diameter and therefore could not be significantly boosted. 
Furthermore, the detector employed here was a cooled CCD camera with a very high 
sensitivity. In consequence, our system collection efficiency and sensitivity can not 
be dramatically improved and the only way to detect the contrast agent with the 
fluorescence imaging endoscope is to use higher contrast agent dose. 
5.6.5 Conclusion  
 
The development of a fluorescence imaging system adaptable to any 
commercial laparoscopes was presented. As a follow-up of the spectroscopic studies 
presented in chapter 4, a multispectral imaging laparoscope was built and validated 
on fluorescent phantoms. It should be noted that in future oesophagus studies, the 
pair of images recorded in each of the fluorescence and diffuse reflectance modes 
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would be divided against each other to generate the ratio image supposed to 
maximize the contrast between healthy and cancerous tissue since the spectral 
optimization was performed on intensity ratios in chapter 4. The image ratio has the 
added advantage to diminish the influence of geometric effects on the intensity 
values as mentioned in section 5.3.  
This system will have to be tested on a significant number of oesophagus 
specimens to assess its diagnosis performances for tumour detection. It is hoped 
that, in the future, its suitability to help the surgeon diagnosis will be demonstrated.  
Unusually, in this work, the multispectral laparoscope was used with a dye in 
an attempt to mark nerves out by fluorescence imaging. This dye is still under 
development and has only been tested on small animals so far. In consequence, 
many unknowns remained on its kinetics and dose in big animals. Our results 
indicated that the injected dose was too low to be captured by our laparoscopic 
system. However, this experiment demonstrated our system ability to capture the 
contrast agent fluorescence in a phantom, and nerve autofluorescence in vivo.and 
minimally invasively, making it a promising candidate for nerve imaging during 
minimally invasive procedures, providing the dose of the dye is sufficient.  
In summary, the design of florescence/reflectance multispectral laparoscope 
features a six position illumination filter wheel and a six positions emission filter 
wheels allowing up to 25 excitation-emission fluorescence imaging combinations in 
addition to white light imaging. Filters and therefore excitation and emission 
wavelengths can be modified depending on the organ and conditions investigated 
making the multispectral imaging laparoscope a versatile platform useable in a vast 
array of applications. In its full potential, this system could be used prior to 
sigmoidectomy [65], for instance, to simultaneously delineate the tumour in the colon 
while preserving the pelvic nerve during the tumour removal. 
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Chapter 6  
Hyperspectral Laparoscope for in 
vivo Vasculature Imaging 
 
In chapter 5, the low intensity of the fluorescence signal, together with the use of low 
transmission optical system such as a laparoscope led us to trade spectral resolution 
against signal-to-noise ratio and use high-transmission and large bandwidth filters in 
combination with filter wheels to record spectrally resolved signals. This chapter 
describes a spectrally-resolved laparoscope similar to the system described in 
chapter 5, except that it was designed to record diffuse reflectance images only. 
Reflectance level signals are several orders of magnitude higher than fluorescence 
signals which allows reflectance measurements at a higher spectral resolution. The 
filtering element of the system presented here was modified in consequence.  
As highlighted in section 2.3.2, the shape of the spectrum of the visible light 
reflected from tissue is largely dependent on the haemoglobin concentration and 
oxygenation, and scattering. This principle is already turned to good account in 
hospitals with the use of pulse oximeters. Like spectroscopic probes, pulse oximeters 
do not give spatial information making them inadequate for the assessment of the 
spatial extent of the ischemic area. In this chapter, a concise overview of the existing 
blood imaging systems as well as the current methods of ischaemia diagnosis will 
reveal that none of them can be used intraoperatively. In an attempt to fulfil this need, 
we built a hyperspectral laparoscope whose design and performance is then 
described. Phantoms with varying haemoglobin concentration and oxygenation were 
imaged with the hyperspectral laparoscope to generate haemoglobin concentration 
and oxygenation maps. The same system was subsequently used in two animal 
trials: (1) to monitor in situ the colon oxygenation temporal evolution immediately 
after pig euthanasia and (2) to observe the tissue re-oxygenation in a recipient rabbit 
following uterus transplantation 
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6.1 Current imaging methods for vasculature 
monitoring 
 
Ischaemia is characterised by an insufficient blood supply to tissue. Its 
consequences depend on the type of organ affected but, in all cases, results 
potentially in severe tissue injury due to hypoxia. Two types of ischemic injuries are 
distinguished, the first one caused by the initial decrease or absence of blood flow 
and the second one, subsequent to tissue re-perfusion, leading to more serious 
damage [1]. It is therefore important not only to detect ischemic tissue but also to 
monitor its re-perfusion. 
The first type of ischaemia studied was intestinal ischaemia whose origins 
and current diagnostics methods are more varied than ischaemia following 
transplantation. Intestinal ischaemia can be classified according to its cause. 
Thrombosis and embolism where one or several clots form, can impair or stop the 
blood flow in the colon [2, 3]. Ischaemia can also be induced from outside the blood 
vessels and arises during or as a result of an operation on the colon such as 
anastomosis [4] where two colon parts are joined together. Low blood pressure which 
may occur during heart surgery [5] or colon strangulation consecutive to a hernia or a 
volvulus (twisted intestine) can also cause ischaemia [6]. Ischaemia differs in its 
length: acute or chronic; its localisation: small or large bowel; and its extent: localised 
or widespread [7]. 
The second clinical case of ischaemia examined in this work was consecutive 
to the retrieval of a uterus from a donor rabbit for transplantation. The critical stage of 
this operation is the uterus re-perfusion in the recipient rabbit during which ischemic 
injury can cause parenchyma and microcirculatory function impairment [8]. 
Ultrasound is sometimes used post-operatively to check the uterus perfusion but no 
intraoperative imaging method exists to monitor uterus vasculature after the 
transplantation [3]. In the animal model, a pulse oximeter providing oxygen saturation 
and blood volume is usually employed but only provides point-limited information.  
 Early diagnosis leads to a significant reduction in the mortality rate of 
intestinal ischaemia [10]: a study showed that the mortality rate increased from 54% 
to 95% when acute mesenteric ischaemia was diagnosed more than 24 hours after 
the symptoms appeared [11]. The diagnosis of intestinal ischaemia is difficult 
because there is no single set of symptoms [9] clearly related to it. Angiography is 
considered to be the reference diagnosis modality [12, 13], while use of MRI [14] and 
CT [15, 16] is becoming more frequent with increasingly good results. However, 
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these techniques provide information on anatomic modifications resulting from 
ischaemia, like bowel wall thickening, or bowel lumen dilatation [15], which are 
consequences of ischaemia but could have been caused by other pathologies [17]. 
Moreover, the processing time of these techniques is long, whereas early diagnosis 
is crucial for patient survival. Finally, this time-consuming process means that the use 
of angiography and MRI is not recommended for chronic mesenteric ischaemia, 
because the patient’s colon blood flow may return to normal before the diagnostic 
images are generated [18]. Ultrasound is also used and has a high specificity (92%-
100%) but also a limited sensitivity (70-89%) [19, 20]. Moreover, ultrasound probes 
are not straightforward to use, and require extensive training. Finally and most 
importantly, none of these techniques, apart from ultrasound, can be used during an 
operation. 
Methods stemming from biomedical optics could turn out to be useful thanks 
to their ability to provide intraoperative diagnostic information directly related to 
haemoglobin concentration and saturation of oxygen. For instance, diffuse 
reflectance spectroscopy in the visible range has very recently been successfully 
used to diagnose chronic mesenteric ischaemia during an endoscopic procedure [17, 
21]. 
 
 
Figure 6-1: Anatomy of the lower digestive system showing the colon (also called large 
intestine or large bowel) and small intestine (also called small bowel). Reproduced 
from [22]. 
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In this approach, the endoscope reaches the colon via the rectum (Figure 6-1) 
and the small intestine from the oesophagus. The optical fibre probe, used to detect 
ischaemia is then inserted in the endoscope biopsy channel. This method presents 
two drawbacks. Firstly, the sinuous track of the small intestine implies that the 
endoscope can not be inserted very far away from the small intestine extremities 
making impossible the diagnosis of ischaemia arising in the central portion of the 
small intestine. Secondly, the measurements are point limited. Extension of this 
method to an imaging approach may prove useful to help the surgeon to assess the 
extent of the ischaemia.  
Unlike the aforementioned imaging techniques, multispectral or hyperspectral 
imaging directly probes functional parameters specific of ischaemia (including blood 
volume and oxygenation)and whose impairments precede the structural change 
induced by isch (such as bowel wall thickening). Their value can be extracted from 
the spectrum recorded at every pixel making possible the construction of pseudo-
colour maps where pixel intensities equal to the value of the retrieved tissue 
parameter. This method was employed to gauge oxygenation and/or perfusion in 
various organs or tissue type including skin [23-25], brain [26-28], kidney [29], eye 
fundus [30], heart [31, 32], and tumour (known to be hypervascularised and hypoxic) 
[33]. None of the photonics equipment used in the aforementioned studies of internal 
organs (brain, kidney, heart) could be applied minimally invasively; therefore the 
hyperspectral imaging had to be performed through a large incision. A hyperspectral 
instrument was also employed to diagnose porcine colon ischaemia from the spectral 
variations between normal and ischemic tissue, but did not relate these differences 
with tissue parameters such as haemoglobin concentration [35], which can be 
disconcerting for a doctor. To the best of our knowledge, diffuse reflectance 
spectroscopy or hyperspectral imaging techniques have not been used during 
transplantation operation. 
It is proposed in this chapter to use a hyperspectral laparoscope as a 
vasculature imaging monitoring tool during a pig’s termination procedure and a rabbit 
uterus transplant operation. In the former experiment, colon haemoglobin 
concentration and oxygenation evolution were monitored during the pig’s termination 
(blood vessel clamping simulates more closely an ischaemia than pig’s termination 
but we lacked ethics approval). In the latter experiment, the goal was to more 
specifically check tissue re-oxygenation in the recipient postuterus removal 
ischaemia artery and vein re-anastomosis. Results of these experiments are 
presented after the hyperspectral laparoscope description and performance 
characterization. 
  147
6.2 Hyperspectral laparoscopic system 
6.2.1 Instrumentation 
 
The hyperspectral laparoscope (Figure 6-2) included a LCTF (VariSpec, Cambridge 
Research & Instrumentation, Inc., USA) that transmitted light with a bandwidth of 15 
nm in average with a computer controlled central wavelength between 400-720 nm. 
The Xenon light source (model 20133020, Storz GmbH, Germany) emitted light 
between 400 nm and 700 nm (Figure 6-3) which was then transmitted by a fibre 
bundle light guide and coupled into the 12 mm rigid 30 degree laparoscope (Storz 
GmbH, Germany). The sample was placed 50 mm from the distal tip of the 
laparoscope and the reflected light was imaged by the central Hopkins rod lens 
channel of the laparoscope in the usual way. An additional 50 mm focal length lens 
was inserted at the proximal end to form an image on a monochrome CCD camera 
(DCU223M, Thorlabs, Inc., USA). This lens was mounted in a helicoid barrel (1 inch 
linear travel) to adapt the image plan to the laparoscope-sample distance. The LCTF 
was placed between the lens and the CCD. The laparoscope was attached to the 
LCTF via a clip which allowed easy removal of the LCTF/CCD block. 
 
 
 
 
 
 
 
 
 
 
Figure 6-2: Hyperspectral laparoscopic system consisting in a CCD camera and a LCTF 
attached to a regular rigid laparoscope.  
 
The hardware was controlled with a LabVIEW program which enabled control 
of the camera settings, as well as a choice of wavelength range and increment at 
which images were acquired and saved. A live RGB video was also displayed by 
combining three images at 450 nm, 550 nm and 650 nm. Furthermore, a MATLAB 
program enabled generation and display of the spectrum at each pixel of the image 
by storing intensities for all the images of a stack. Each image being acquired at a 
LCTF CCD Objective lens 
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known wavelength, it was therefore possible to draw the spectrum by plotting the pair 
(wavelength, intensity) for every pixel of the image.  
 
 
Figure 6-3: Emission spectrum of the Xenon lamp emitting in the visible. Output 
intensity gradually increases from 390 nm and drops rapidly above 665 nm. 
 
The instrument spatial and spectral resolutions were measured. The spatial 
resolution was quantified by acquiring an image of a paper 1951 USAF test pattern 
(Edmund Optics, Inc., USA) (Figure 6-4). It consists of sets of horizontal and vertical 
bars separated by decreasing spacings when going clockwise from the left bottom of 
the target to its centre. 
 
 
Figure 6-4: 1951 USAF test patterns. This target was used to determine optical system 
resolution.  
 
The spatial resolution was assumed to be equal to the smallest spacing for which the 
peak-to-valley ratio of the intensity line profile drawn across image of the test pattern 
is equal or superior to 2  (Figure 6-5). 
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Figure 6-5: Example of an intensity profile along one of the 1951 USAF test chart 
patterns. 
 
The spectral resolution, understood here as the bandwidth of the LCTF transmission 
spectra, was evaluated every 10 nm between 420 nm and 680 nm by recording the 
light reflected by the Xenon lamp from a spectralon reflectance standard (Labsphere, 
Inc., USA) through the hyperspectral laparoscope (minus the camera) with a 
spectrometer (HR4000, Ocean Optics, Inc., USA). The bandwidths were calculated 
at the Full Width at Half Maximum (FWHM) of the transmission spectra.  
Because the principle of measurement of haemoglobin is based on the 
intensity of the reflected light, it was crucial to ensure the system response was 
proportional to the sample emitted light and the CCD exposure time (to compare 
stack of images acquired with different exposure time). The system linearity with 
sample emission was assessed by recording the light from the standard reflectance 
target and by inserting neutral density filters of increasing optical density. The 
linearity with exposure times was checked by acquiring images at increasing 
exposure times. 
6.2.2 Setup considerations for non-invasive intestinal 
ischaemia diagnosis with hyperspectral imaging 
 
The key element of hyperspectral imaging is a tuneable filter whose band-pass can 
be electronically tuned. This generates more finely spaced band-pass wavelengths 
than filter wheels with a lower filter switching time, and without any moving parts. 
Hyperspectral imaging is implemented by three main technologies: Fourier 
interferometry, acousto-optic tuneable filter, and liquid crystal tuneable filter (LCTF). 
A comparative study has demonstrated that even though the Fourier system provides 
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the highest optical throughput, the LCTF yields the highest signal-to-noise ratio in 
both fluorescence and spectral imaging [34] (more details section 5.1).  
A LCTF is made up of several stages, each of them consisting of a quartz 
birefringence retarder and layers of liquid crystal, sandwiched between two 
polarisers. The principle of the LCTF is to select the desired bandpass by adjusting 
the retardance of the polarized light. The bandpass wavelength can then be selected 
by modulating the electric field applied to the liquid crystals, thus changing the 
retardance and therefore the transmission efficiency through the polarisers. The 
bandpass transmitted by the LCTF is the one whose wavelengths are in phase with 
the polarisers at each stage. 
The LCTF compact dimensions (7.6×7.6×3.1 cm) make the use of the 
hyperspectral system practical for the surgeon. Additionally, these dimensions allow 
the hyperspectral system insertion in a sterile plastic sleeve (normally used to isolate 
the camera of video laparoscope from the patient) which is required as the 
CCD/LCTF block is non-sterile (Figure 6-6). The hyperspectral laparoscope is 
introduced in the sheath by one extremity, only the distal end of the laparoscope 
(sterilised by autoclave) exits the sleeve by a narrow window. 
 
 
Figure 6-6: Sterile sheath used to isolate laparoscope non-sterile camera and video 
cables from the patient. The red circle indicates the exit window through which the 
laparoscope is inserted. 
 
 
 
 
 
7.5 cm 
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6.3 System characterisation 
 
The peak-to-valley ratios calculated from the intensity profiles of the USAF targets 
recorded with the hyperspectral laparoscope are presented in Figure 6-7. The limit of 
2  was reached for the pattern whose line spacing was equal to 56 µm, considered 
to be the resolution of our system.  
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Figure 6-7: Evolution of the peak-to-valley ratio with lines spacing of the successive 
targets. 
 
Figure 6-8: Spectral profiles provided by the LCTF for wavelength set between 420 nm 
and 660 nm with a 10 nm increment. 
 
Figure 6-8 illustrates the transmission spectra of the hyperspectral system without 
the camera recorded by the spectrometer for wavelengths tuned with 10 nm 
increment between 420 nm and 660 nm. The overall increase in the bandwidths with 
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growing wavelength is apparent and was quantified by taking the spectra FWHM 
which ranged from 6.3 nm at 420 nm to 28.1 nm at 650 nm (Figure 6-9). 
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Figure 6-9: LCTF bandwidth evolution with wavelength. 
 
The graphs (Figure 6-10) demonstrate the linearity of the measured intensities with 
both exposure time (linear regression coefficient R2: 0.998) and sample emission (R2: 
0.9917). 
 
 
Figure 6-10: Linear relationship between measured intensity and (a) exposure time and 
(b) sample emission. 
 
As the haemoglobin concentration was computed from the measured reflected light, 
it was crucial to check if the intensity of the recorded signal was linear with the two 
main factors that affect it: the CCD exposure time, and the sample-emitted light itself. 
The graphs (Figure 6-10) ensure this is the case so that measured intensities 
correlated with the haemoglobin concentration and images acquired at different 
exposure times could be compared. 
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6.4 Extraction of the haemoglobin maps from the 
hyperspectral image stack 
 
Generally, oxy and deoxyhaemoglobin concentrations are inferred from the fitting of 
the measured diffuse reflectance spectra with more or less complex models using 
oxy and deoxyhaemoglobin as free parameters. The fitted models are broadly 
classified in two categories: models of light transport as described in section 2.4 like 
in [36] where a hybrid-P3 model was employed to recover oxygen saturation, or 
Beer-Lambert law modified to take into account biological scattering. The choice of 
model depends on the application or the required level of precision on the retrieved 
haemoglobin parameters (relative or absolute values). 
The main challenge in recovering haemoglobin concentration and saturation 
is to deconvolute absorption (originating mainly from haemoglobin in the visible) from 
scattering. The precision of the light transport description depends on the inclusion in 
the models of the scattering effects. They are well described in the numerical or 
analytical models mentioned in section 2.4, yet they require an exact knowledge of 
the source detector-geometry making them useful for studies with optical fibre probes 
but not easily applicable to imaging systems with complex illumination-detection 
geometry. 
In the majority of the studies looking at tissue perfusion, the preferred 
description of light-tissue interaction is the modified Beer-Lambert law. It is referred 
as “modified” because its expression is similar to the conventional Beer-Lambert law 
which describes the transmittance through a transparent medium as a linear 
combination of the absorption coefficients of the chromophores present in the 
medium multiplied by a constant pathlength corresponding to the thickness of this 
medium. However, unlike the conventional Beer-Lambert law, the modified version 
describes the attenuation of light back-reflected from a turbid sample after multiple 
scattering events. The light attenuation is related to the reflected light via Equation 
6-1 [24, 31, 32]. 
)log(RA −=  
 
Equation 6-1 
 
The difficulty is to evaluate the distance travelled in tissue by the photons between 
their emission and their detection. This distance depends on the source-detector 
geometry (distance between emission and detection fibres, diameter, and numerical 
aperture), and the photon’s wavelength, since scattering is a wavelength-dependent 
effect. In consequence, the influence of scattering on reflected light attenuation is 
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two-fold: it affects the magnitude of the light attenuation A and modifies the photon 
path length with a wavelength dependence which translates in equation as follows 
[37-39]:  
)()(.. λλε GDCA +=  Equation 6-2 
where ε is the extinction coefficient, C the concentration of the chromophores. As 
shown in section 2.3.2, the major absorbing chromophore in the visible is 
haemoglobin in its oxygenated and deoxygenated forms. As a result, ε is the sum of 
the oxyhaemoglobin extinction coefficient εHbO2 and the deoxyhaemoglobin extinction 
coefficient εHb and C the sum of their concentrations. D is usually referred as the 
mean pathlength and corresponds to the mean distance travelled by photons. D 
depends on the absorption coefficient, the scattering coefficient and the illumination-
detection distance. In order to more precisely highlight the effects of scattering, D is 
sometimes presented as the product of DPF, called the differential pathlength and x, 
the linear source-detection distance. DPF expresses the increase in the distance 
travelled by photon in scattering media [37]. The factor G models the modification of 
light attenuation magnitude caused solely by scattering, G depends therefore on the 
scattering coefficient sµ , and the source-detector geometry but is independent of the 
absorption coefficient aµ  (the product of the excitation coefficient and the 
concentration). 
Most of the studies looking at tissue vascularisation are based on Equation 
6-2. It becomes apparent from it that light attenuation is not a linear function of 
chromophores concentration anymore in turbid media and that knowledge of D and G 
is required if absolute chromophores concentrations are to be calculated. The 
estimation of D is complex, but feasible with Monte Carlo simulations if the baseline 
absorption and scattering coefficients and the source-detector geometry are known. 
G, however, is very difficult to estimate, especially for imaging where the source-
detection geometry is not well defined. As a result, various approximations of 
Equation 6-2 have been applied from the most elaborate ones taking into account the 
non-linear effects of scattering on D and G [40], to studies modelling scattering as a 
constant baseline and a slope variable with wavelength [41].  
A less refined estimate of Equation 6-2 is to consider D and G wavelength-
independent. The latter approximation is reasonable in the visible range [42, 43], the 
former is more a rough approximation, however, this model, which reduces the 
effects of scattering to a constant background, was successfully used in several 
tissue perfusion studies [32, 33, 45] to provide relative values of oxy and deoxy 
haemoglobin concentration maps. The two models used to process the images 
  155
recorded during the uterus transplantation experiment and the pig trial, and chosen 
for their simplicity and speed, were based on these two approximations. 
6.5  Porcine colon vasculature imaging 
6.5.1 Haemoglobin phantoms preparation and imaging 
procedure 
 
Haemoglobin phantoms were imaged to test the hyperspectral imaging system 
response to haemoglobin concentration and saturation in oxygen. Two series of 
phantoms at different concentrations and oxygen saturations were prepared in a well 
plate (Figure 6-11). In each of them, ferrous stabilized human haemoglobin (H0267, 
Sigma Aldrich, Co., USA) at 0.5, 1, 3, 6 g/L mixed with a solution of phosphate buffer 
saline were prepared. One group was oxygenated at atmospheric pressure and 
sodium dithionite, a reducing agent, was added into the second group at a final 
concentration of 10 g/L to reduce oxyhaemoglobin in its deoxygenated form. In the 
rest of this section, the phantoms of the first group are referred to as oxyhaemoglobin 
samples and the ones of the second group are referred as deoxyhaemoglobin 
samples. 
During the pig operation, the hyperspectral laparoscope was used to follow 
the temporal evolution of the colon’s oxyhaemoglobin and deoxyhaemoglobin 
concentrations and oxygen saturations during the pig’s termination. It was introduced 
in the abdomen by a clinician through a trocar and the images were recorded across 
the visible range from 450 to 680 nm in 10 nm steps or 24 images. Exposure times 
ranged from 60 ms to 100 ms and the working distance was about 5 cm. The colon 
was imaged 1 min before the pig’s termination and during 6 min every 1 min after the 
termination. 
6.5.2 Image processing and haemoglobin model  
 
Throughout the experiment, the movement of the instrument and/or the field of view 
made image registration necessary. In consequence, images were manually 
registered subsequently to the experiment by applying translations and rotations in 
order to ensure that all of the spectral points of a given spectrum were from a unique 
spatial point.  
However, the manual registration of a complete image stack consisting of 24 
images (and even more so the registration of images from different image stacks), 
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turned out to be an inextricable task for several reasons. Firstly, the relatively small 
FOV of the laparoscope meant that even small movement could cause the loss of the 
ROI on some of the images. Secondly, setup or tissue motion concomitant to the 
acquisition caused image blurring which, meant that it was not possible to align 
images due to the loss of sharp features. Finally, rotation and translation are linear 
transformation which can not correct for soft-tissue deformation of the colon, hence 
images on which tissue deformation were too significant, could not be accurately 
registered.  
Nevertheless, one particular ROI was found to be consistently appearing on 
many images throughout the experiment. Using an approach successfully used in a 
human skin vasculature study [24] and enabling the imaging of haemoglobin 
parameters from the absorbance at three wavelengths, images at 530 nm, 560 nm, 
620 nm were chosen to be aligned as they shared a common ROI with sharp 
features. 
“Brightfield” images from a standard reflectance target (Labsphere, Inc., 
USA), which reflects isotropically 99% of the light, were acquired to account for the 
illumination spectrum, instrument response, and illumination non-uniformity. 
“Darkfield” images were taken with the illumination turned off to take into account for 
the system dark offset and the room light. The reflectance signal R was generated at 
each wavelength for the whole image from the sample backreflected signal S, the 
brightfield, B, and darkfield, D, signals according to this relationship:  
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Equation 6-3 
 
Assuming D and G constant, Equation 6-2 can be written at the three selected 
wavelengths as follows: 
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Equation 6-4 
 
with 
2HbO
C and HbRC  being the oxyhaemoglobin and deoxyhaemoglobin 
concentrations respectively. This linear system can be rewritten in function of 
2HbO
C and HbRC  which cancel out the geometry factor G: 
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Equation 6-5 
 
 
Oxyhaemoglobin and deoxyhaemoglobin maps were computed as well as the 
haemoglobin oxygen saturation map by applying these two formulae at each pixel. 
The differential pathlength D is used as a scaling factor in this report. The system 
and the model were tested on haemoglobin phantoms. 
6.5.3 Haemoglobin phantoms experiment 
 
As a validation experiment, images from a well plate containing solutions of 
haemoglobin at different concentrations and oxygen saturations were acquired. The 
absorption spectra, with a 10 nm spectral resolution, of the 6 g/L deoxyhaemoglobin 
and oxyhaemoglobin phantoms are presented in Figure 6-11. It can be noticed that 
the maximum of the deoxyhaemoglobin spectrum was reached at 560 nm; the 
oxyhaemoglobin spectrum presented two peaks at 540 nm and 570 nm and a 
secondary minimum at 560 nm. They exhibited the typical shape of 
deoxyhaemoglobin and oxyhaemoglobin spectra respectively. The 
deoxyhaemoglobin spectrum comprised a maximum of intensity at 560 nm and the 
oxyhaemoglobin spectrum included two maxima at 540 nm and 570 nm and a 
secondary minimum at 560 nm. These values correlated well with [44] (absorbance 
spectra of oxy and deoxyhaemoglobin with a 2 nm resolution), which reports a 
maximum in absorption at 556 nm for deoxyhaemoglobin and maxima at 542 nm and 
576 nm and a secondary minimum at 560 nm for oxyhaemoglobin. This 
demonstrates the capacity of this system to recover sample spectral features. 
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Figure 6-11: Absorption spectrum between 500 nm and 650 nm (spectral resolution: 10 
nm) taken at one pixel within the well containing the 6 g/L solutions of (a) 
deoxyhaemoglobin and (b) oxyhaemoglobin.  
 
The deoxyhaemoglobin and oxyhaemoglobin maps were produced by processing the 
images acquired at 530 nm, 560 nm and 620 nm (Figure 6-12). On these maps, the 
intensity of each pixel is equal to the deoxyhaemoglobin or oxyhaemoglobin 
concentrations. The differential pathlength was arbitrarily set at 1.68 mm to scale the 
generated concentrations to the real concentrations.  
 
 
 
 
 
 
 
 
 
Figure 6-12: (a) Deoxyhaemoglobin and (b) oxyhaemoglobin maps of the well plate 
containing the haemoglobin phantoms. Dark blue colour corresponds to low 
concentrations (0 g/L) and dark red colour indicates high concentrations (7 g/L). 
 
It is noticeable from the deoxyhaemoglobin map that the estimated 
concentration of deoxyhaemoglobin increased from the left to the right in the top row 
containing the deoxyhaemoglobin samples following the rise in deoxyhaemoglobin 
concentrations of the prepared samples. This was also the case for the 
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oxyhaemoglobin samples (bottom row). The oxyhaemoglobin map shows that the 
estimated concentration of oxyhaemoglobin increased according to the concentration 
of oxyhaemoglobin of the prepared solutions as expected. An increase in 
oxyhaemoglobin concentration of the top row samples, (supposed to be 
deoxygenated by the sodium dithionite), was also observed, and is discussed later in 
this section.  
Then, in order to assess the ability of the system to retrieve the total 
haemoglobin concentration, the deoxyhaemoglobin map and the oxyhaemoglobin 
map were summed to produce a “total haemoglobin map”. The concentrations within 
a rectangle of 40 pixels over 20 pixels were averaged for each of the four wells of the 
top row. 
 
Figure 6-13: Comparison of measured haemoglobin concentrations with the real 
concentrations. 
 
The graph (Figure 6-13) demonstrated a good correlation between estimated and 
real haemoglobin concentrations. The retrieved mean ± standard deviation 
concentrations are 0.62±0.24 g/L, 0.90±0.20 g/L, 3.99±0.23 g/L, and 5.94±0.32 g/L, 
compared to expected concentrations of 0.5 g/L, 1 g/L, 3 g/L, and 6 g/L respectively. 
Hence, the concentrations were retrieved with a relative error averaged over the four 
concentrations of 16.5%. 
Finally, the oxygen saturation map (Figure 6-14) was created by dividing the 
oxyhaemoglobin map by the sum of the deoxyhaemoglobin and oxyhaemoglobin 
maps.  
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Figure 6-14: Haemoglobin oxygen saturation map. Dark blue colour corresponds to low 
saturation (0) and dark red colour indicates high saturation (1). 
 
It can be seen from this image (Figure 6-14) that the oxygen saturation was, as 
expected, lower in the wells of the top row containing the deoxyhaemoglobin samples 
than in the wells containing the oxyhaemoglobin solutions (bottom row). The oxygen 
saturation was averaged for each of the eight wells in the same way as described 
above. It increased from 7% to 27% for the deoxyhaemoglobin samples and was 
contained between 62% and 71% for the oxyhaemoglobin samples. 
A rise in deoxyhaemoglobin concentration of the oxyhaemoglobin samples 
was also observed on the deoxyhaemoglobin map (Figure 6-12-a) as well as an 
augmentation of oxyhaemoglobin concentration of the deoxyhaemoglobin samples 
on the oxyhaemoglobin map (Figure 6-12-b). These observations have to be 
correlated with the oxygen saturation map (Figure 6-13). Indeed, the fact that the 
oxygen saturation remained low and stable for the 0.5 g/L and 1 g/L 
deoxyhaemoglobin samples (7% and 5% respectively) and then increased to 17% 
and 26% for the 3 g/L and 6 g/L samples respectively, suggests that the 10 g/L 
solution of sodium dithionite reduced all the oxyhaemoglobin in the 0.5 g/L and 1 g/L 
deoxyhaemoglobin samples, but was not in sufficient concentration to reduce the 
whole oxyhaemoglobin in the 3 g/L and 6 g/L solutions. The oxygen saturation of the 
oxyhaemoglobin samples were found to be contained between 62 % and 73% 
(Figure 6-14). This means that they are not fully oxygenated, which explains the 
presence of deoxyhaemoglobin in the oxyhaemoglobin samples (Figure 6-12-a). 
There was no dissolved oxygen sensor (a device which probes the partial pressure of 
dissolved oxygen in solution and converts into haemoglobin oxygen saturation with 
the Hill equation) at disposal to check the oxygen saturation values.  
Thus, the hyperspectral imaging system presented here is capable of 
reconstructing images where the contrast comes from the difference in haemoglobin 
concentration. Regions with different haemoglobin concentration and oxygen 
saturation could be clearly visualised.  
7±44 3±16 18±7 27±7 
71±22 62±13 63±5 63±7 
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6.5.4 In vivo imaging of colon vasculature 
 
Subsequent to validation on phantoms, the hyperspectral laparoscope was moved to 
the operating theatre and in vivo imaging of a pig’s colon vasculature were acquired 
according to the procedure detailed section 6.5.1, instantly after euthanasia was 
induced.  
The maps, illustrated in Figure 6-15, provide the relative deoxyhaemoglobin 
and oxyhaemoglobin values 6 min after the pig’s termination. These maps cover a 
550* 800 pixels area, which was only a portion of the 1024*768 pixel images 
recorded. This region of interest was chosen because of its important blood vessel 
density, whose sharp features were helpful for image alignment. The rest of the 
imaged surgical scene could not be aligned mainly due to the absence of landmarks.  
As expected, the deoxyhaemoglobin concentration values were found to be higher 
than the oxyhaemoglobin as the mean deoxyhaemoglobin concentration was 4.9 
times higher than the mean oxyhaemoglobin concentration. Both maps also showed 
that the total haemoglobin concentration was significantly higher in blood vessels 
than in the surrounding perfused tissue. 
 
 
 
 
Figure 6-15: (a) Deoxyhaemoglobin and (b) oxyhaemoglobin maps of a region of 
interest (approximate dimensions: 3.5×5cm) of the porcine colon 6 min after 
termination. Blue colour indicates low concentrations and red colour indicates high 
concentrations. 
 
The temporal evolution of the oxyhaemoglobin and deoxyhaemoglobin 
concentrations alongside the oxygen saturation after the pig’s termination was 
monitored. The image registration, already difficult within a stack of images acquired 
at a given time turned out to be more challenging for several stacks of images each 
acquired at different times subsequently to the pig’s termination. This led to a 
reduction of the size of the studied region of interest from 550*800 pixels area to a 
100*50 area to ensure that the same area could be tracked and aligned for the 
totality of the images. The pixel intensities within this region were averaged and 
processed to retrieve the haemoglobin concentrations and saturation. 
(b) (a) 
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Figure 6-16: Temporal evolution of oxy and deoxyhaemoglobin concentrations and 
oxygen saturation subsequent to pig’s termination. 
 
The graph, Figure 6-16, underlines the clear fall in oxyhaemoglobin 
concentration, together with the oxygen saturation which dropped by 77% and 64%, 
respectively, between the pig’s termination and 6 min after termination. 
Deoxyhaemoglobin concentration slowly rose by 17.4%. It is important to note that 
the values indicated on the y-axis are not absolute but relative values. No 
explanation was found as for the concomitant slight increase of oxyhaemoglobin and 
the slight decrease of deoxyhaemoglobin between 5 min and 6 min post-termination. 
Hyperspectral studies of organs perfusion have already been performed in 
the past, but none of them in real surgical conditions. In [32] and [45], the perfusion 
and oxygenation of a resected and arrested heart and a hand respectively were 
monitored throughout an induced ischemic event. In [34], the colon ischemic area 
localization was realised in vivo during open surgery, cumbersome flood illuminators 
were used in the three studies. This work is hence the first to our knowledge to image 
haemoglobin concentration and oxygen saturation in real MIS conditions 
endoscopically. The goal and focus were to assemble a MIS hyperspectral system 
capable of providing real-time information on the tissue vasculature. The model of 
haemoglobin parameters extraction we used was simple and did not take into 
account the distorting non-linear effect of scattering on absorbance values. However, 
it supplied satisfactory results as demonstrated by the phantom experiments and the 
pig’s trial. The major difficulty in this work was the compensation of the surgical 
scene movement. This problem was not addressed in the aforementioned studies as 
the imaged scenes were steady. For example, an isolated beating heart was 
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hyperspectrally imaged in [32] and motion artefacts were reduced by synchronising 
image acquisition with the heart cycle. However, this approach increases the 
acquisition to 4 min and it only corrects for the movement of the heart, yet motion 
artefacts can also be caused by the setup and/or the clinician movements.  
The manual registration in this work turned out to be a very tedious and time 
consuming task, several of the images being blurred because of motion during the 
acquisition, which made the tracking of features difficult. Moreover, the program did 
not permit accounting for tissue deformation as merely translation and rotation could 
be applied.  
Noting the absence of efficient method for registration of hyperspectral 
images recorded in vivo from organs in motion, Dr. Neil Clancy (Research associate 
in the biophotonics) is currently developing a trinocular laparoscope integrating the 
LCTF/black and white camera block presented in Figure 6-2 for hyperspectral 
imaging in addition to two other channels with colour cameras for stereo vision. The 
detail of the system is presented in Figure 6-17. It is based on a three-channel 
laparoscope (Intuitive Surgical, Inc., USA). Beams coming out from two channels 
were focussed onto two colours CCD cameras (model uEye 2230-C, IDS Imaging, 
GmbH, Germany) for colour stereo viewing. Light from the third channel was 
reflected at 45° by a mirror, filtered at chosen wavelengths by the LCTF and imaged 
on a monochrome CCD camera (model DCU 223M, Thorlabs , Inc; USA). The light 
source and light guide were the same models than those described for the 
hyperspectral laparoscope presented earlier in this chapter. The simultaneous 
acquisition of the pair of stereo colour images and the spectrally resolved image of 
the same FOV was controlled with a LabVIEW code incorporating the program 
detailed in section 6.2.1.  
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Figure 6-17: A schematic of the trinocular laparoscope detailing the specifications of 
the optics for the two channels for colour stereo vision and the hyperspectral imaging 
channel. Adapted from [46]. 
 
It was possible from this set of three images to automatically register the 
hyperspectral images using techniques stemming from computer vision and 
developed for 3D reconstruction from stereo images and motion tracking. The details 
of the registration procedure are available in [47].  
In summary, a hyperspectral laparoscope was built, characterized, validated 
with haemoglobin phantoms, and used during a MIS procedure during which, in spite 
of motion artefacts, the decrease in oxyhaemoglobin concentration and oxygen 
saturation alongside an increase in deoxyhaemoglobin concentration subsequent to 
pig’s termination was observed.  
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6.6 Transplanted uterine vasculature follow-up 
 
The data collection for this experiment was performed in collaboration with Dr. Neil 
Clancy, research associate in the Hamlyn Centre who then processed the results. 
The rationale for its discussion here is to provide an example of vasculature study 
where the scene to be imaged remained steady enough during the acquisition of the 
hyperspectral cube to use the totality of the images constituting it, as opposed to the 
previous experiment.  
6.6.1 Image processing and haemoglobin model 
 
The uterus to be transplanted was imaged before removal from the donor rabbit 
which underwent a laparotomy and after transplantation on the recipient rabbit. 29 
images were recorded between 440 nm and 720 nm in 10 nm step. The exposure 
time was set at 250 ms and the working distance was 15 cm. 
In order to correct for the motion artefacts (considerably less pronounced than in the 
pig’s study) caused by breathing and tissue deformation, an algorithm detecting and 
tracking features was applied on the images to align them. Details of this algorithm 
are beyond the scope of this thesis and can be found in [47]. After registration, the 
reflectance was converted into absorbance according to Equation 6-1. The 
absorbances were modelled according to Equation 6-2 where D, the mean 
pathlength, and G, the geometry factor, were supposed constant with wavelength.  
D was iincorporated into the oxy and deoxyhaemoglobin concentrations to 
form the free parameters of a multivariate fitting procedure applied at each pixel to 
determine the best set of combinations of haemoglobin and deoxyhaemoglobin 
concentrations minimizing the differences between the measured absorbance 
spectra made up of 29 points and the linear combination of pure oxy and 
deoxyhaemoglobin absorption spectra as measured in [44]. Oxy and 
deoxyhaemoglobin concentration factors (the product of the concentrations with D) 
retrieved at each pixel were used to generate oxygen saturation maps of the uterus 
before and after transplantation. 
 
6.6.2 Uterus transplant oxygen saturation imaging  
 
Figure 6-18 presents the colour images (computed from the hyperspectral images 
with a RGB filter) together with their corresponding saturation maps of the uterus pre 
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and post transplantation. The oxygen saturation map of the pre-transplant 
demonstrated a well-oxygenated organ with a mean oxygenation calculated at 60±3 
%. The non-uniformity of the oxygen saturation, with for instance a lower oxygenated 
area in the centre, originates from the inhomogeneous vein and artery density or a 
less vascularised region. Oxygen saturation map, processed from a hyperspectral 
image stack acquired immediately after aorta and inferior vena cava re-anastomosis, 
demonstrated a successful anastomosis as highlighted by the high oxygen saturation 
regions close to the region where aorta was re-connected (indicated by the black 
circle Figure 6-18-d). The mean oxygen saturation was found to be 48±6 %. Values 
of oxygen saturations lower in post-transplant than in pre-transplant were also 
measured with pulse oximeters in previous operations performed by our 
collaborators.  
 
 
Figure 6-18: (a) RGB image of the uterus in the donor rabbit, (b) corresponding oxygen 
saturation map, (c) RGB image of the uterus shortly after the transplantation in the 
recipient rabbit, (d) corresponding oxygen saturation map. The black circle indicates 
(d) the approximate localisation of the aorta. Colour scale varies between dark blue (0) 
and dark red (1). 
 
 
In summary, hyperspectral imaging could be an efficient tool to temporally and 
spatially follow tissue reoxygenation subsequent to re-anastomosis. Blood flow is 
gradually re-established in the uterus vessel network consisting of: aorta, uterine 
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arterial tree, internal iliac artery, uterine arterial and venous trees, and inferior vena 
cava.  
6.7 Conclusion  
 
The system built in this chapter is in its principle similar to the laparoscopic system 
described in chapter 5: it records spectrally resolved images. However, the nature of 
the detected signal is reflectance whose intensity levels are higher than fluorescence 
which means that standard CCD camera and (low transmission) LCTF could be used 
instead of cooled CCD camera and filter wheel respectively. This leads to a more 
compact instrument with a much higher spectral resolution. The system spectral and 
spatial performance was characterized, its linear response with exposure time and 
sample emission was verified, and its ability to recover haemoglobin parameters 
were successfully tested on phantoms. The decrease of oxygen saturation 
subsequent to the pig’s termination was highlighted in spite of the simplicity of the 
haemoglobin model used, and important motions artefacts that limited the number of 
useable images and, as a result, decreased the available spectral information. In the 
uterus transplantation, the minor movement of the surgical scene could be corrected 
to permit the registration of the complete stack of images. The oxygen saturation 
maps of the pre and post-transplant could this time be generated from spectral 
information over the entire visible range, and allowed visualising a highly close region 
by the aorta/uterus junction sign of successful re-anastomosis of bloods vessels.  
Just like the rest of this work, the goal of the work presented in this chapter was 
to translate biophotonics techniques into operating theatres, therefore the emphasis 
was given to system development rather than complex haemoglobin model 
elaboration. The adaptation of hyperspectral imaging to laparoscopes was a step in 
this direction, yet motion artefacts correction will need to be addressed if this 
technology is to be used during MIS procedures. The triple endoscope currently in 
development could tackle this challenge. 
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Chapter 7  
 
Conclusion 
 
7.1 Thesis accomplishments and limitations 
 
The subject of this thesis was the use of biophotonics techniques to probe tissue and 
detect lesions. Its purpose was three-fold: (1) enlarge the spectrum of pathologies 
diagnosable with biophotonics techniques by demonstrating the suitability of the 
fluorescence spectroscopy for NAFLD diagnosis, (2) combine two biophotonics 
modalities, fluorescence and diffuse reflectance to improve diagnostic accuracy (3) 
propose solutions to move fluorescence/reflectance spectroscopy and imaging 
techniques from the optical bench to the operating theatre to help the diagnosis of a 
range of pathologies during MIS procedures.  
The first goal was reached by performing a fluorescence spectroscopy study 
of NAFLD in the mouse model in two trials presented in chapter 3, which established 
its clinical utility for NAFLD diagnosis. In particular, in the first study, fluorescence 
spectroscopy performed better than the blood test samples including ALT tests, a 
diagnosis method already in use in hospitals. While this study constitutes strong 
evidence in favour of the use of fluorescence spectroscopy for NAFLD detection, the 
disease model involved NAFLD mice only where the distinction between disease 
states was unambiguous. In practice, NAFLD severity may need to be distinguished 
from other inflammatory conditions and from varying degrees of cirrhosis or fibrosis. 
A follow-up study on a large number of human liver samples is needed to further 
ascertain the fluorescence spectroscopy performance for NAFLD diagnosis. The 
addition of the second laser diode, which in this study did not result in better 
discrimination, might help to improve the classification accuracy when looking at 
more ambiguous samples.  
The second objective was addressed in the context of a 
fluorescence/reflectance spectroscopy study of lesions in the digestive tract 
presented in chapter 4. The comparison of the usual diagnostic performance 
variables (sensitivity, specificity, PPV and NPV) obtained from single modality 
spectra with the ones obtained with concatenated fluorescence and reflectance 
spectra, showed that, in some instances, the combined modality approach led to 
  173
better diagnosis results. A common weakness of the spectroscopic studies is their 
retrospective nature where training sets and samples to classify are mixed up, 
leading to a biased classification [1]. The K-fold cross-validation, where the classifier 
was trained on all the spectra, except the ones to be classified, ensured the 
classification was performed in an unbiased manner like in a prospective study. As 
stated above, studies performed in chapter 3 and chapter 4 included a small 
number of samples mainly because of time constraints. More specimens are needed 
not only to ascertain the clinical viability of fluorescence and reflectance 
spectroscopy, but also to avoid the curse of dimensionality mentioned in section 
4.3.3 which arises when the number of classification features is largely higher than 
the number of samples, and which can result in a degraded classification.  
Furthermore, 375 nm and 405 nm might not be the optimal excitation 
wavelengths to discriminate the pathologies considered here. Further investigation 
should be conducted with a wavelength tuneable laser for instance to select the laser 
diodes emitting at the most favourable wavelengths. 
The third and last aim was attained by building optical imaging laparoscopes 
to allow intraoperative fluorescence/reflectance imaging. With the hardware currently 
available, it is possible to design light and compact spectrally resolved fluorescence 
and reflectance imaging systems. Our approach to adapt fluorescence and 
reflectance imaging to intraoperative diagnosis was simple; it consisted in mounting a 
camera/filter unit onto a laparoscope to make fluorescence and reflectance imaging a 
de facto useable MIS procedure. To conduct the two imaging studies presented in 
chapter 5, a cooled CCD camera and a filter wheel were employed. The first 
experiment was a combined fluorescence/reflectance study originally aimed at 
locating oesophageal tumours. However, the limited supply of tissue for these two 
experiments resulted on the impossibility to image a suitable oesophagus specimen. 
Emission filters were chosen based on the optimal wavelengths selected following 
the spectroscopic experiment conducted in chapter 4. The laparoscopic system was 
successfully tested on fluorescent phantoms including some endogenous 
fluorophores and samples of the nerve contrast agent dye. We hope to demonstrate 
the efficiency of our system at demarcating tumour in the oesophagus in the future. 
Of note, we acknowledge that tumour detection in a hollow organ like the 
oesophagus is done in practice with a flexible endoscope and not a rigid 
laparoscope, yet the oesophagus was the only organ from which we could hope to 
obtain tissue samples (for the spectroscopic study) and specimens (for the imaging 
study) at the time of the study. However, our approach would be applicable to cancer 
detection in solid organs present in the abdomen that would normally be observed 
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with laparoscopes such as liver or pancreas. In addition, the filter/CCD unit would be 
easily adaptable to flexible endoscopes to investigate oesophagus or any other 
hollow organs.  
In the second study, which was on nerve fluorescence imaging, filters were 
selected according to the excitation and emission filters of the exogenous nerve 
contrast agent. The nerve imaging study concluded that the cause of the absence of 
contrast was likely to originate from an insufficient dose. This dye is one of the last 
iteration of a family of nerve contrast agents under development in a research team 
of General Electric Global Research. The optimal dose was found to vary greatly 
between the successive versions of the dye and no analysis looked specifically at the 
dose needed to be injected in a pig to obtain contrast at the time of our experiment. 
Such a study is a requisite for future fluorescence imaging studies. Fluorescence 
laparoscopy is expected to be of great help to the surgeon in order to assist in 
avoiding nerve tracts during surgery.  
The hyperspectral reflectance laparoscope (chapter 6) was similar in its 
concept to the previous setup, yet different in its implementation. Reflectance signal 
levels being significantly higher than the fluorescence ones, the filter wheel could be 
substituted for a LCTF, a filtering element with an optical throughput lower than 
traditional filters, but much more versatile, and a traditional CCD camera replaced the 
cooled CCD camera. The objective of the first experiment we presented was to 
evaluate the hyperspectral laparoscope as an intraoperative ischaemia diagnosis 
tool. Tests carried out on haemoglobin phantoms proved that the hyperspectral 
laparoscope could probe haemoglobin concentrations and oxygen saturation. Results 
during a porcine trial exemplify the effectiveness of the system at monitoring in vivo 
the temporal evolution of haemoglobin concentration and oxygen saturation of a 
region of interest of the animal’s intestine after its termination. The disease model of 
ischaemia in this study was imperfect for three reasons: the exact time of the pig’s 
death is unknown, the kinetics and the magnitude of the haemoglobin concentration 
and oxygen saturation evolutions subsequent to the death are not well-known, a 
pulse-oximeter could not be used as a control measurement because the pig’s heart 
was not beating anymore after its death. A more realistic and convenient model, for 
which we did not have ethics approval at the time of the study, would have been to 
clamp a blood vessel supplying the intestine such as the mesenteric artery.  
One of the major challenges of this experiment and of in vivo study in general, 
is to account for motion artefacts by registering images. In our study, we managed to 
correctly align images at only one temporal point to produce maps of oxy-
haemoglobin and deoxyhaemoglobin concentrations. Devices such as the trinocular 
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described in chapter 6 appear to be a more realistic approach for intraoperative 
imaging of moving scenes. The strength of this system and the associated image 
registration algorithm lies in the possibility to track features on the bright, sharp 
colour images to then automatically align the dark (due to low LCTF transmission) 
and motion blurred (caused by long acquisition times) hyperspectral images. 
Nevertheless, several obstacles have to be overcome if this technique is to be 
employed intraoperatively: the size and the weight of the trinocular will need to be 
reduced or used robotically ( in combination with the robotic arm of platforms such as 
the daVinci Surgical Workstation), the current setup being difficult to manipulate at 
the moment even with the assistance of an articulated arm; the registration technique 
will need to be real-time which is not the case presently (images are aligned offline); 
the acquisition duration will have to be shortened to make the system truly real-time. 
Finally, the acquisition in in vivo condition of a complete image set i.e an 
hyperspectral image and its corresponding pair of colour images takes in average 1 s 
(mainly because of the light throughput of the hyperspectral channel ) in the current 
system configuration. The shortening of the acquisition procedure would also 
attenuate motion artefacts. 
Providing that they are reduced in size, snapshot camera systems could also 
represent an excellent solution for intraoperative imaging with the apparition of 
sensors of increasing size and resolution owing to the possibility to acquire several 
spectral images in one shot (see section 5.1 for more details). Another ischaemia 
study on a rabbit uterus transplant demonstrated the hyperspectral imaging 
laparoscope observing tissue oxygen saturation. The oxygen saturation map 
processed from the hyperspectral image stack suggested a successful uterus 
anastomosis in the recipient rabbit. An improvement of this study and the porcine 
intestine work would consist in developing a more advanced model of the light 
reflected from vascularised tissue which would take more precisely into account the 
effects of scattering. 
In spite of these limitations, this work showed that (1) fluorescence 
spectroscopy is a promising tool for NAFLD diagnosis (2) combining fluorescence 
and reflectance spectroscopy can, in some instances, increase the performance of 
pathologies diagnosis in the digestive tract (3) optical imaging laparoscopic systems 
are useful devices for diagnostic imaging during MIS procedures for non or 
moderately moving scenes. In the rest of the conclusion, we briefly discuss the 
clinical role of fluorescence and reflectance modalities and their diffusion in hospitals. 
 Also presented in this thesis (chapter 3), was the manipulation of the 
fluorescence spectroscopic probe with a robotic endoscope. Fluorescence and 
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reflectance probes have already been used in vivo, their small diameter permitting 
their introduction through the working channel of endoscopes. By doing so, clinicians 
have a limited control on the probe trajectory as well as on the pressure applied by 
the probe on the tissue surface. While the latter is easily controllable ex vivo, it is not 
anymore the case in vivo (with the probe inserted in the working channel) where 
there is a possibility, in the absence of haptic feedback, that the surgeon pushes too 
hard on the probe to ensure it contacts the tissue surface. The section 3.6.6 showed 
how the force adaptive robotic endoscope promises to solve these difficulties by 
authorizing the scanning of the probe on the tissue surface with controlled trajectory 
and applied pressure. Force sensitive robotic endoscope hence enhances the 
practicability of intraoperative measurements with spectroscopic probes. To be fully 
tested, this set up will need to be assessed in real intraoperative conditions in the 
future.  
7.2 Clinical translation 
 
Large-scale human trials are still needed to formulate a definitive answer to the 
impact of fluorescence and reflectance spectroscopy and imaging on diagnostic 
procedures. At a minimum, it seems reasonable to think that, in combination with 
algorithms such as SMLR, they could efficiently complement biopsies by signalling 
suspicious tissue regions. With a protocol including fluorescence and/or diffuse 
reflectance screening performed prior to biopsies, more measurements could be 
taken non-invasively which would decrease the miss rate as well as the number of 
unnecessary biopsies. Spectra could be then analyzed with algorithms like SMLR 
and only sites with posterior probability of belonging to a disease class above a 
chosen threshold would undergo biopsies and histological analysis. The time taken to 
perform the additional fluorescence-diffuse reflectance measurements would hence 
be largely regained by diminishing the number of histological examinations.  
Besides their intrinsic diagnostic power, the great strength of fluorescence 
and diffuse reflectance and biophotonics techniques in general is their adaptability to 
other healthcare technologies (they could easily be integrated in robotic surgery 
platform for example) or diagnostic methods. We have already mentioned that 
biophotonics techniques can be used together with biopsies (as explained in the 
paragraph above), but they could also complement the established clinical imaging 
modalities. For instance, a hybrid MRI-diffuse reflectance platform was built for 
breast cancer detection [2]. Tumour masses were localized with MR images to guide 
the spectroscopic measurements from which oxyhaemoglobin and haemoglobin 
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concentrations were retrieved. The impact of such an approach in terms of diagnostic 
accuracy was not assessed, but the addition of information form each modality is 
likely to improve it.  
When looking at the clinical translation of a new technology, its benefits can 
not be considered separately from its cost, which includes the cost of equipment, the 
cost of the medical staff time (training and procedure lengths) and the (potential) 
savings it permits (savings spawned from an earlier disease detection exempting 
from further treatment for instance) [3, 4]. While it is premature to answer these latter 
issues, we foresee that expenditure on hardware and training will remain moderate. 
Table 7-1 shows the price of the four systems designed during the thesis. They are 
calculated from the sum of the market price of components they incorporate. The 
price of the more expensive system, the fluorescence-diffuse reflectance 
spectroscopy setup does not exceed £25,000 (a price that could certainly be 
decreased by choosing a lower cost spectrograph/CCD unit which account for 75% 
of the price) whilst the minimum price of the routinely used imaging modalities (MRI, 
CT, PET) is estimated at £65,000 [5]. 
 
Table 7-1: Cost of the four optical systems designed in this thesis. 
Setup
Dual-excitation fluorescence 
spectroscopy system 
Fluorescence-diffuse 
reflectance spectroscopy 
system 
Filter wheel 
laparoscope
LCTF 
laparoscope
Price (£) 22,820 23,050 17,700 17,200
 
 
The straightforward integration of biophotonics into existing clinical 
instruments suggests that they may not require modification of present clinical 
procedures [6], and hence will not necessitate lengthy training. The acquisition of 
additional measurements will nonetheless lead to longer examination time even if 
biophotonics techniques are fast. However, as stated above, the time saved by 
decreasing the number of needless biopsies (which then undergo lengthy histological 
preparation) largely compensates the time lost at taking these data. A study involving 
100 patients and including all these cost considerations found that the addition of 
fluorescence spectroscopy to the traditionally used colposcopes for cervix precancer 
diagnosis enabled a reduction in the miss rate and also the cost of diagnosis [4]. 
In conclusion, we hope this thesis has demonstrated the value of 
fluorescence and diffuse reflectance modalities for probing tissue states and we 
believe that these could play an important role in standard clinical procedures for 
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pathologies screening and diagnosis as a stand alone modality or in combination with 
others. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  179
7.3 References 
 
[1] N. Ramanujam, “Fluorescence spectroscopy of neoplastic and non-neoplastic 
tissues,” Neoplasia, vol. 2, no. 1-2, pp. 89-117, Jan-Apr, 2000. 
[2] V. Ntziachristos, A. Yodh, M. D. Schnall, and B. Chance, “MRI-guided diffuse 
optical spectroscopy of malignant and benign breast lesions,” Neoplasia (New 
York, NY), vol. 4, no. 4, pp. 347, 2002. 
[3] R. Richards-Kortum, Biomedical engineering for global health: Cambridge 
University Press, 2009. 
[4] S. B. Cantor, M. F. Mitchell, G. Tortolero-Luna, C. S. Bratka, D. C. Bodurka, 
and R. Richards-Kortum, “Cost-effectiveness analysis of diagnosis and 
management of cervical squamous intraepithelial lesions,” Obstetrics & 
Gynecology, vol. 91, pp. 270-277, 1998. 
[5] R. Weissleder, “Scaling down imaging: Molecular mapping of cancer in mice,” 
Nature Reviews Cancer, vol. 2, no. 1, pp. 11-18, 2002. 
[6] B. C. Wilson, “Detection and treatment of dysplasia in Barrett's esophagus: a 
pivotal challenge in translating biophotonics from bench to bedside,” Journal 
of Biomedical Optics, vol. 12, no. 5, Sep-Oct, 2007. 
 
 
 
 
 
